
<html lang="en"     class="pb-page"  data-request-id="9fbc64a7-edd5-4b2b-917f-9f34b238f38b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2020.63.issue-17;article:article:10.1021/acs.jmedchem.9b02101;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of BMS-986235/LAR-1219: A Potent Formyl Peptide Receptor 2 (FPR2) Selective Agonist for the Prevention of Heart Failure" /></meta><meta name="dc.Creator" content="Yoshikazu  Asahina" /></meta><meta name="dc.Creator" content="Nicholas R.  Wurtz" /></meta><meta name="dc.Creator" content="Kazuto  Arakawa" /></meta><meta name="dc.Creator" content="Nancy  Carson" /></meta><meta name="dc.Creator" content="Kiyoshi  Fujii" /></meta><meta name="dc.Creator" content="Kazunori  Fukuchi" /></meta><meta name="dc.Creator" content="Ricardo  Garcia" /></meta><meta name="dc.Creator" content="Mei-Yin  Hsu" /></meta><meta name="dc.Creator" content="Junichi  Ishiyama" /></meta><meta name="dc.Creator" content="Bruce  Ito" /></meta><meta name="dc.Creator" content="Ellen  Kick" /></meta><meta name="dc.Creator" content="John  Lupisella" /></meta><meta name="dc.Creator" content="Shingo  Matsushima" /></meta><meta name="dc.Creator" content="Kohei  Ohata" /></meta><meta name="dc.Creator" content="Jacek  Ostrowski" /></meta><meta name="dc.Creator" content="Yoshifumi  Saito" /></meta><meta name="dc.Creator" content="Kosuke  Tsuda" /></meta><meta name="dc.Creator" content="Francisco  Villarreal" /></meta><meta name="dc.Creator" content="Hitomi  Yamada" /></meta><meta name="dc.Creator" content="Toshikazu  Yamaoka" /></meta><meta name="dc.Creator" content="Ruth  Wexler" /></meta><meta name="dc.Creator" content="David  Gordon" /></meta><meta name="dc.Creator" content="Yasushi  Kohno" /></meta><meta name="dc.Description" content="Formyl peptide receptor 2 (FPR2) agonists can stimulate resolution of inflammation and may have utility for treatment of diseases caused by chronic inflammation, including heart failure. We report ..." /></meta><meta name="Description" content="Formyl peptide receptor 2 (FPR2) agonists can stimulate resolution of inflammation and may have utility for treatment of diseases caused by chronic inflammation, including heart failure. We report ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 14, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b02101" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b02101" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b02101" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b02101" /></link>
        
    
    

<title>Discovery of BMS-986235/LAR-1219: A Potent Formyl Peptide Receptor 2 (FPR2) Selective Agonist for the Prevention of Heart Failure | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b02101" /></meta><meta property="og:title" content="Discovery of BMS-986235/LAR-1219: A Potent Formyl Peptide Receptor 2 (FPR2) Selective Agonist for the Prevention of Heart Failure" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0021.jpeg" /></meta><meta property="og:description" content="Formyl peptide receptor 2 (FPR2) agonists can stimulate resolution of inflammation and may have utility for treatment of diseases caused by chronic inflammation, including heart failure. We report the discovery of a potent and selective FPR2 agonist and its evaluation in a mouse heart failure model. A simple linear urea with moderate agonist activity served as the starting point for optimization. Introduction of a pyrrolidinone core accessed a rigid conformation that produced potent FPR2 and FPR1 agonists. Optimization of lactam substituents led to the discovery of the FPR2 selective agonist 13c, BMS-986235/LAR-1219. In cellular assays 13c inhibited neutrophil chemotaxis and stimulated macrophage phagocytosis, key end points to promote resolution of inflammation. Cardiac structure and functional improvements were observed in a mouse heart failure model following treatment with BMS-986235/LAR-1219." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b02101"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02101">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b02101&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b02101&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b02101&amp;href=/doi/10.1021/acs.jmedchem.9b02101" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 9003-9019</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00491" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Drug Annotation</span><a href="/doi/10.1021/acs.jmedchem.0c00566" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of BMS-986235/LAR-1219: A Potent Formyl Peptide Receptor 2 (FPR2) Selective Agonist for the Prevention of Heart Failure</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Yoshikazu Asahina</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yoshikazu Asahina</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</div></div><span class="conrtib-corresp"><strong>*</strong>Y.A.: email, <a href="/cdn-cgi/l/email-protection#61180e1209080a001b144f00120009080f00210c034f0a180e13080f4c110900130c4f020e4f0b11"><span class="__cf_email__" data-cfemail="20594f5348494b415a550e41534148494e41604d420e4b594f52494e0d504841524d0e434f0e4a50">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yoshikazu++Asahina">Yoshikazu Asahina</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nicholas R. Wurtz</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nicholas R. Wurtz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States</div></div><span class="conrtib-corresp"><strong>*</strong>N.R.W.: email, <a href="/cdn-cgi/l/email-protection#600e0903080f0c01134e171512141a20020d134e030f0d"><span class="__cf_email__" data-cfemail="721c1b111a1d1e13015c050700060832101f015c111d1f">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas+R.++Wurtz">Nicholas R. Wurtz</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2574-9440" title="Orcid link">http://orcid.org/0000-0003-2574-9440</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kazuto Arakawa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kazuto Arakawa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kazuto++Arakawa">Kazuto Arakawa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nancy Carson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nancy Carson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nancy++Carson">Nancy Carson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kiyoshi Fujii</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kiyoshi Fujii</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kiyoshi++Fujii">Kiyoshi Fujii</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kazunori Fukuchi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kazunori Fukuchi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kazunori++Fukuchi">Kazunori Fukuchi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ricardo Garcia</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ricardo Garcia</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ricardo++Garcia">Ricardo Garcia</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mei-Yin Hsu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mei-Yin Hsu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mei-Yin++Hsu">Mei-Yin Hsu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Junichi Ishiyama</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Junichi Ishiyama</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Junichi++Ishiyama">Junichi Ishiyama</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bruce Ito</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bruce Ito</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bruce++Ito">Bruce Ito</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ellen Kick</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ellen Kick</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ellen++Kick">Ellen Kick</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3498-4194" title="Orcid link">http://orcid.org/0000-0003-3498-4194</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John Lupisella</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John Lupisella</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John++Lupisella">John Lupisella</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shingo Matsushima</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shingo Matsushima</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shingo++Matsushima">Shingo Matsushima</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kohei Ohata</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kohei Ohata</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kohei++Ohata">Kohei Ohata</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jacek Ostrowski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jacek Ostrowski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jacek++Ostrowski">Jacek Ostrowski</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yoshifumi Saito</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yoshifumi Saito</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yoshifumi++Saito">Yoshifumi Saito</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kosuke Tsuda</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kosuke Tsuda</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kosuke++Tsuda">Kosuke Tsuda</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Francisco Villarreal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Francisco Villarreal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Francisco++Villarreal">Francisco Villarreal</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hitomi Yamada</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hitomi Yamada</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hitomi++Yamada">Hitomi Yamada</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Toshikazu Yamaoka</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Toshikazu Yamaoka</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Toshikazu++Yamaoka">Toshikazu Yamaoka</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ruth Wexler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ruth Wexler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ruth++Wexler">Ruth Wexler</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David Gordon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David Gordon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bristol-Myers Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David++Gordon">David Gordon</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Yasushi Kohno</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yasushi Kohno</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratories, Kyorin Pharmaceutical Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yasushi++Kohno">Yasushi Kohno</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b02101&amp;href=/doi/10.1021%2Facs.jmedchem.9b02101" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 9003–9019</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 14, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 December 2019</li><li><span class="item_label"><b>Published</b> online</span>14 May 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 September 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b02101" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02101</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9003%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYoshikazu%2BAsahina%252C%2BNicholas%2BR.%2BWurtz%252C%2BKazuto%2BArakawa%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D17%26contentID%3Dacs.jmedchem.9b02101%26title%3DDiscovery%2Bof%2BBMS-986235%252FLAR-1219%253A%2BA%2BPotent%2BFormyl%2BPeptide%2BReceptor%2B2%2B%2528FPR2%2529%2BSelective%2BAgonist%2Bfor%2Bthe%2BPrevention%2Bof%2BHeart%2BFailure%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9019%26publicationDate%3DSeptember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b02101"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3251</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b02101" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of BMS-986235/LAR-1219: A Potent Formyl Peptide Receptor 2 (FPR2) Selective Agonist for the Prevention of Heart Failure&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yoshikazu&quot;,&quot;last_name&quot;:&quot;Asahina&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;R. Wurtz&quot;},{&quot;first_name&quot;:&quot;Kazuto&quot;,&quot;last_name&quot;:&quot;Arakawa&quot;},{&quot;first_name&quot;:&quot;Nancy&quot;,&quot;last_name&quot;:&quot;Carson&quot;},{&quot;first_name&quot;:&quot;Kiyoshi&quot;,&quot;last_name&quot;:&quot;Fujii&quot;},{&quot;first_name&quot;:&quot;Kazunori&quot;,&quot;last_name&quot;:&quot;Fukuchi&quot;},{&quot;first_name&quot;:&quot;Ricardo&quot;,&quot;last_name&quot;:&quot;Garcia&quot;},{&quot;first_name&quot;:&quot;Mei-Yin&quot;,&quot;last_name&quot;:&quot;Hsu&quot;},{&quot;first_name&quot;:&quot;Junichi&quot;,&quot;last_name&quot;:&quot;Ishiyama&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;Ito&quot;},{&quot;first_name&quot;:&quot;Ellen&quot;,&quot;last_name&quot;:&quot;Kick&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Lupisella&quot;},{&quot;first_name&quot;:&quot;Shingo&quot;,&quot;last_name&quot;:&quot;Matsushima&quot;},{&quot;first_name&quot;:&quot;Kohei&quot;,&quot;last_name&quot;:&quot;Ohata&quot;},{&quot;first_name&quot;:&quot;Jacek&quot;,&quot;last_name&quot;:&quot;Ostrowski&quot;},{&quot;first_name&quot;:&quot;Yoshifumi&quot;,&quot;last_name&quot;:&quot;Saito&quot;},{&quot;first_name&quot;:&quot;Kosuke&quot;,&quot;last_name&quot;:&quot;Tsuda&quot;},{&quot;first_name&quot;:&quot;Francisco&quot;,&quot;last_name&quot;:&quot;Villarreal&quot;},{&quot;first_name&quot;:&quot;Hitomi&quot;,&quot;last_name&quot;:&quot;Yamada&quot;},{&quot;first_name&quot;:&quot;Toshikazu&quot;,&quot;last_name&quot;:&quot;Yamaoka&quot;},{&quot;first_name&quot;:&quot;Ruth&quot;,&quot;last_name&quot;:&quot;Wexler&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Gordon&quot;},{&quot;first_name&quot;:&quot;Yasushi&quot;,&quot;last_name&quot;:&quot;Kohno&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;9003-9019&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b02101&quot;},&quot;abstract&quot;:&quot;Formyl peptide receptor 2 (FPR2) agonists can stimulate resolution of inflammation and may have utility for treatment of diseases caused by chronic inflammation, including heart failure. We report the discovery of a potent and selective FPR2 agonist and its evaluation in a mouse heart failure model. A simple linear urea with moderate agonist activity served as the starting point for optimization. Introduction of a pyrrolidinone core accessed a rigid conformation that produced potent FPR2 and FPR1 agonists. Optimization of lactam substituents led to the discovery of the FPR2 selective agonist 13c, BMS-986235/LAR-1219. In cellular assays 13c inhibited neutrophil chemotaxis and stimulated macrophage phagocytosis, key end points to promote resolution of inflammation. Cardiac structure and functional improvements were observed in a mouse heart failure model following treatment with BMS-986235/LAR-1219.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02101&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02101" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02101&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02101" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02101&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02101" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b02101&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02101&amp;href=/doi/10.1021/acs.jmedchem.9b02101" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b02101" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b02101" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b02101%26sid%3Dliteratum%253Aachs%26pmid%3D32407089%26genre%3Darticle%26aulast%3DAsahina%26date%3D2020%26atitle%3DDiscovery%2Bof%2BBMS-986235%252FLAR-1219%253A%2BA%2BPotent%2BFormyl%2BPeptide%2BReceptor%2B2%2B%2528FPR2%2529%2BSelective%2BAgonist%2Bfor%2Bthe%2BPrevention%2Bof%2BHeart%2BFailure%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D17%26spage%3D9003%26epage%3D9019%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/jmcmar.2020.63.issue-17/20200910/jmcmar.2020.63.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02101&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Formyl peptide receptor 2 (FPR2) agonists can stimulate resolution of inflammation and may have utility for treatment of diseases caused by chronic inflammation, including heart failure. We report the discovery of a potent and selective FPR2 agonist and its evaluation in a mouse heart failure model. A simple linear urea with moderate agonist activity served as the starting point for optimization. Introduction of a pyrrolidinone core accessed a rigid conformation that produced potent FPR2 and FPR1 agonists. Optimization of lactam substituents led to the discovery of the FPR2 selective agonist <b>13c</b>, BMS-986235/LAR-1219. In cellular assays <b>13c</b> inhibited neutrophil chemotaxis and stimulated macrophage phagocytosis, key end points to promote resolution of inflammation. Cardiac structure and functional improvements were observed in a mouse heart failure model following treatment with BMS-986235/LAR-1219.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27122" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27122" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Formyl peptide receptors (FPRs) constitute a G-protein-coupled chemotactic receptor (GPCR) family, which are mainly expressed in neutrophils and monocytes and play an important role in host defense and inflammation. In humans, three subtypes (FPR1, -2, -3) have been identified.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> FPR1 initiates inflammatory responses such as neutrophil chemotaxis, degranulation, respiratory burst, and cytokine release when activated with ligands such as <i>N</i>-formyl-methionyl-leucyl-phenylalanine (fMLF) produced by bacteria.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> FPR2 is involved in both initiation and resolution of inflammation. FPR2 peptide ligands, such as serum amyloid A (SAA), are associated with production of proinflammatory cytokine interleukin (IL)-8,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> while ligands such as lipoxin A4 and annexin A1 have been shown to inhibit migration of neutrophils, differentiate macrophages into prowound healing phenotypes, and upregulate antiinflammatory cytokines such as IL-10.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> Thus, FPR2 activates both inflammatory and proresolution responses depending on the ligand and its binding regions.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a></div><div class="NLM_p">Since the first small-molecule FPR agonist was reported in 2004,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> research groups in academia and industry have reported a diverse set of FPR agonists and antagonists.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14">(11−14)</a> Representative FPR agonists include pyrazolone ureas (compound <b>43</b>),<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> benzimidazoles,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> bridged spiro[2.4]heptanes,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and aminotriazoles (ACT-389949)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Among these compounds, dual FPR2/FPR1 compound <b>43</b> has been used for proof of concept in vivo studies, including the preservation of cardiac function and prevention of adverse remodeling in rodent heart failure models.<a onclick="showRef(event, 'ref8 ref16 ref20'); return false;" href="javascript:void(0);" class="ref ref8 ref16 ref20">(8,16,20)</a> FPR2 agonist ACT-389949 was dosed in phase 1 clinical trials and induced plasma biomarker changes (e.g., IL-10 and leukocyte levels) in humans after one dose; however, the authors reported tachyphylaxis in the multiday dosing study.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Although there are no compounds launched as therapeutic agents to date, FPR2 remains a promising target to resolve chronic inflammation and promote the wound healing processes.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0001.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of selected reported FPR2 agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02101&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of reported FPR biology, we focused on the discovery of FPR2 agonists with proresolution activity and selectivity over FPR1. We selected simple urea derivative AG-26 (<b>1</b>)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> as a promising starting point with multiple options for future structural transformation.</div><div class="NLM_p">Investigation of substituents on the 2-(4-methoxypheny)ethyl moiety of compound <b>1</b> resulted in carbamoyl derivative <b>2d</b> with enhanced FPR2 activity (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). In order to investigate conformationally constrained analogs of <b>2d</b>, four- to six-membered lactam derivatives <b>3</b>–<b>7</b> were prepared. Among these, five-membered pyrrolidinone derivatives <b>5</b> and <b>6</b> showed significantly improved activity. Of four optical isomers of <b>5</b> and <b>6</b>, the (3<i>S</i>,4<i>R</i>)-form was confirmed to be the most potent FPR2 agonist. Preliminary investigation of the Ar<sup>2</sup> group led to 4-fluorophenyl (3<i>S</i>,4<i>R</i>) analog <b>11b</b>, which exhibited better activity than the 4-chlorophenyl (3<i>S</i>,4<i>R</i>) analog. Optimization of the Ar<sup>1</sup> group led to <b>12g</b> bearing the 2,6-difluoro-4-methoxyphenyl group which dramatically improved selectivity over FPR1 without decreasing FPR2 activity. Finally, reoptimization of the Ar<sup>2</sup> group to further improve FPR2 selectivity resulted in the selection of clinical candidate <b>13c</b>. Details of this research are described below.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure–activity relationship (SAR) summary of pyrrolidinone urea FPR2 agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02101&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18258" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18258" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All synthesized compounds were evaluated for agonistic activity to induce Ca<sup>2+</sup> mobilization in HEK293 cells overexpressing hFPR2 and HEK293 cells overexpressing hFPR1.</div><div class="NLM_p">First, the hFPR2 agonistic activity of acyclic urea derivatives <b>1</b> and <b>2a</b>–<b>d</b> was evaluated to determine the effect of substitution on the 4-methoxyphenylethyl moiety (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Compound <b>1</b> showed weaker hFPR2 activity than that described in the literature, which may be due to assay conditions and expression levels of the receptor in the reporter cell lines. By contrast, compounds <b>2a</b>–<b>d</b> exhibited 32- to 275-fold more potent hFPR2 activity than <b>1</b>. Carbamoyl derivative <b>2d</b> exhibited the strongest hFPR2 activity (EC<sub>50</sub> = 3.6 nM) and was selected as a template for structural modifications.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Human FPR2 Agonist Activity for Acyclic Analogs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0010.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">hFPR2 EC<sub>50</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">990</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2b</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">6.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2c</b></td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="left">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2d</b></td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">3.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values were determined by Ca<sup>2+</sup> mobilization in HEK293 cells overexpressing hFPR2.</p></div></div></div><div class="NLM_p">We designed four- to six-membered lactam derivatives <b>3</b>–<b>7</b> to constrain the conformation of <b>2d</b> without changing the steric bulk of the carbamoyl moiety and the lipophilicity of the molecule. In addition to the hFPR2 activity of compounds <b>3</b>–<b>7</b>, the agonist activity for hFPR1 was measured to evaluate receptor selectivity (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The template compound <b>2d</b> had excellent hFPR2 selectivity (hFPR1/2 ratio of >2800). The hFPR2 activity of <i>cis</i>- and <i>trans</i>-oriented azetidinone urea derivatives <b>3</b> and <b>4</b> was 3- to >28-fold less potent than <b>2d</b>. By contrast, <i>cis</i>- and <i>trans</i>-oriented pyrrolidinone urea derivatives and <i>trans</i>-oriented piperidinone derivative <b>5</b>–<b>7</b> were 4- to 33-fold more potent for hFPR2 over <b>2d</b>. However, hFPR1 activity of <b>5</b>–<b>7</b> also increased, and hFPR1/2 selectivity of these compounds was lower than that of <b>2d</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Activity of <b>3</b>–<b>7</b> in HEK293 Cells Expressing Human FPR2 and FPR1</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0011.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0012.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values were determined by Ca<sup>2+</sup> mobilization in HEK293 cells overexpressing hFPR2 or hFPR1.</p></div><div class="footnote" id="t2fn2"><sup><sup>c</sup></sup><p class="last">Not calculated.</p></div></div><div></div></div><div class="NLM_p">On the basis of the results described above, we selected pyrrolidinone derivatives <b>5</b> and <b>6</b> for further optimization since they offered the best combination of potency and selectivity. The four optically active isomers <b>8</b>–<b>10</b> and <b>11a</b> were assayed to ascertain the most active stereoisomer (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). In the <i>cis</i>-oriented isomers, (+)-enantiomer <b>9</b> had 5-fold more potent hFPR2 activity than (−)- <b>8</b>. In the <i>trans</i>-oriented isomers, (3<i>S</i>,4<i>R</i>)-enantiomer <b>11a</b> was 360-fold more potent for hFPR2 than the (3<i>R</i>,4<i>S</i>)-enantiomer <b>10</b>. From comparison of the hFPR2 activity of diastereomers <b>9</b> and <b>11a</b>, <b>11a</b> was 10-fold more active than <b>9</b>, demonstrating that the (3<i>S</i>,4<i>R</i>)-isomer was the most active stereoisomer. However, <b>11a</b> was only moderately selective over FPR1 (42×). Compound <b>11b</b> bearing a 4-fluorophenyl group had similar hFPR2 activity and selectivity to <b>11a</b>, so we selected <b>11b</b> as the lead compound for detailed structure–activity relationship (SAR) studies to identify a candidate compound.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Activity of <b>8</b>–<b>11</b> in HEK293 Cells Expressing Human FPR2 and FPR1</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0013.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0014.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values were determined by Ca<sup>2+</sup> mobilization in HEK293 cells overexpressing hFPR2 or hFPR1.</p></div></div><div></div></div><div class="NLM_p">After the core pyrrolidinone was selected, optimization of the 4-methoxyphenyl group was carried out (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Introduction of a fluorine atom to the 2- or 3-position of the 4-methoxyphenyl group (<b>12a</b>, <b>12b</b>) resulted in 5- to 10-fold decreased hFPR2 activity relative to <b>11b</b> and did not improve hFPR2 selectivity. Furthermore, 2-chloro (<b>12c</b>), 2-methyl (<b>12d</b>), or 4-chloro (<b>12e</b>) analogs also had nanomolar hFPR2 activity. By contrast, compounds <b>12f</b> and <b>12g</b> with an additional fluorine atom at position 5 or 6 of <b>12a</b> maintained picomolar hFPR2 activity. Remarkably, a dramatic decrease in FPR1 activity was observed in the compound <b>12g</b> bearing 2,6-difluoro-4-methoxyphenyl group as Ar<sup>1</sup>. Compound <b>12g</b> showed excellent hFPR2 activity (EC<sub>50</sub> = 0.14 nM) and high hFPR2 selectivity (FPR1/2 ratio = 2000). Whereas the 3-fluoro-5-methoxypyridin-2-yl group (<b>12h</b>) maintained FPR2 activity, the selectivity over hFPR1 was reduced relative to <b>12g</b>. Furthermore, replacement of the 4-methoxy group of <b>12g</b> with an ethoxy (<b>12i</b>), an ethyl (<b>12j</b>), a cyano (<b>12k</b>), or a methylamino (<b>12l</b>) group resulted in a 10- to 700-fold decreased hFPR2 activity over <b>12g</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Activity of <b>12</b> in HEK293 Cells Expressing Human FPR2 and FPR1</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0015.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0016.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values were determined by Ca<sup>2+</sup> mobilization in HEK293 cells overexpressing hFPR2 or hFPR1.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Not tested.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Not calculated.</p></div></div><div></div></div><div class="NLM_p">We next evaluated the substituent effect of Ar<sup>2</sup> for a series of 4-(2,6-difluoro-4-methoxyphenyl)pyrrolidinone derivatives <b>13a</b>–<b>q</b> (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). The 3-fluorophenyl and 2-fluorophenyl derivatives <b>13a</b> and <b>13b</b> showed 7- and 310-fold less hFPR2 activity than <b>12g</b>. On the other hand, the phenyl, 4-chorophenyl, and 4-bromophenyl derivatives <b>13c</b>–<b>e</b> showed comparable hFPR2 activity to <b>12g</b>. Among these compounds, phenyl derivative <b>13c</b> showed higher hFPR2 selectivity (FPR1/2 = 6800) than <b>12g</b>. Other 4-position substituents, including cyano, methyl, and methoxy derivatives <b>13f</b>–<b>h</b>, were 6- to 23-fold less active than <b>12g</b>. The 3,4-disubstituted phenyl derivatives <b>13i</b>–<b>l</b> showed comparable hFPR2 activity to <b>12g</b>. Among these compounds 3,4-difluorophenyl derivative <b>13i</b> and 3-hydroxy-4-methylphenyl derivative <b>13l</b> showed higher hFPR2 selectivity (hFPR1/2 = 5100 and 13000, respectively) than <b>12g</b>. Although the aromatic heterocycle derivatives <b>13m</b>–<b>q</b> showed 2- to 32-fold reduced activity compared to <b>12g</b>, 5-chlorothiophen-2-yl derivative <b>13n</b> showed good hFPR2 activity (EC<sub>50</sub> = 0.29 nM) and higher hFPR2 selectivity (FPR1/2 = 4100) than <b>12g</b>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Activity of <b>13a</b>–<b>q</b> in HEK293 Cells Expressing Human FPR2 and FPR1</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0017.gif" alt="" id="fx8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0018.gif" alt="" id="fx9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values were determined by Ca<sup>2+</sup> mobilization in HEK293 cells overexpressing hFPR2 or hFPR1.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Not tested.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Not calculated.</p></div></div><div></div></div><div class="NLM_p">Finally, to select a candidate compound, in vivo efficacy and CYP3A4 inhibition were evaluated for 5 analogs, <b>12g</b>, <b>13c</b>, <b>13i</b>, <b>13l</b>, and <b>13n</b>, which had potent in vitro hFPR2 activity (EC<sub>50</sub> < 0.50 nM) and high hFPR2 selectivity (hFPR1/2 > 2000). In vivo efficacy was evaluated in a mouse inflammation model by measuring inhibition of neutrophil infiltration into lung after oral administration at 1 mg/kg (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). The 4-fluorophenyl derivative <b>12g</b>, phenyl derivative <b>13c</b>, and 5-chlorothiophen-2-yl derivative <b>13n</b> showed excellent in vivo efficacy (inhibition >80%), while the disubstituted phenyl derivatives <b>13i</b> and <b>13l</b> showed weaker in vivo efficacy.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Effect of Selected Compounds on LPS-induced Neutrophil Infiltration in Mouse Lungs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0019.gif" alt="" id="fx10" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0020.gif" alt="" id="fx11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values were determined by Ca<sup>2+</sup> mobilization in HEK293 cells overexpressing hFPR2 or mFPR2.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">Inhibition (%) was determined by measurement of neutrophils in BALF of LPS-dosed mice after oral dosing of 1 mg/kg.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">IC<sub>50</sub> values were determined with recombinant human CYP3A4.</p></div></div><div></div></div><div class="NLM_p">Among the three compounds that inhibited neutrophil infiltration in mice, selection for advanced in vivo studies relied on several factors. Analog <b>13n</b> was excluded as a candidate compound due CYP3A4 inhibition. Higher FPR2 selectivity in the Ca<sup>2+</sup> flux assay was measured for <b>13c</b> versus <b>12g</b> (6800- vs 2000-fold, <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>); in addition, only oxidative metabolites were observed after hepatocyte incubation with <b>13c</b>, while oxidative defluorination was observed with <b>12g</b> (data not provided). On the basis of these differences, <b>13c</b> was progressed to additional studies.</div><div class="NLM_p">Additional in vitro assays examined more detailed cellular signaling of FPR2 agonist <b>13c</b> (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). Inhibition of cAMP levels was observed in cells overexpressing either hFPR2 or hFPR1, consistent with G<sub>i</sub> coupling, with an 80× selectivity for hFPR2. β-Arrestin recruitment was also observed. Potency was right shifted in both assays compared to calcium mobilization, which could be due to different assay conditions, including the level of receptor expression in the cell lines. Confirming cross species selectivity, <b>13c</b> demonstrated 1000× selectivity for FPR2 over FPR1 in the cAMP assay using CHO cells overexpressing the mouse receptors. The impact on inflammatory cells was measured in two key cellular assays: compound <b>13c</b> inhibited chemotaxis of a neutrophil-like cell line against a gradient of SAA and stimulated phagocytosis by mouse macrophages at low nanomolar potency. These assays show the potential of FPR2 agonists to prevent proinflammatory neutrophil infiltration, and the ability to promote a wound healing phenotype in macrophages, which are key characteristics of compounds that stimulate resolution of inflammation.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Mechanistic in Vitro Assays, <b>13c</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">assay</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> or IC<sub>50</sub><a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hFPR2 cAMP</td><td class="colsep0 rowsep0" align="left">5.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hFPR1 cAMP</td><td class="colsep0 rowsep0" align="left">400</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mFPR2 cAMP</td><td class="colsep0 rowsep0" align="left">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mFPR1 cAMP</td><td class="colsep0 rowsep0" align="left">500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">β-arrestin recruitment</td><td class="colsep0 rowsep0" align="left">130</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">chemotaxis</td><td class="colsep0 rowsep0" align="left">57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">phagocytosis</td><td class="colsep0 rowsep0" align="left"><1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values for cAMP were determined in Chinese hamster ovary cells (CHO) overexpressing hFPR1, hFPR2, mFPR1, or mFPR2 receptors. β-Arrestin values were measured in a DiscoverX Pathhunter cell line. Phagocytosis assays used mouse peritoneal macrophages. IC<sub>50</sub> value for the chemotaxis assays used a HL-60 cell line.</p></div></div></div><div class="NLM_p">In vivo pharmacokinetic (PK) data and in vitro intrinsic clearance values in liver microsomes and hepatocytes for compound <b>13c</b> are listed in <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>. Compound <b>13c</b> had high clearance in rat and mouse but moderate clearance in dog and monkey with good bioavailability. The clearance values in human microsomes and human hepatocytes were about 10-fold lower than those of rat, dog, and monkey, suggesting that <b>13c</b> is more metabolically stable in humans than in these animal species.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Cross Species Comparison of in Vivo PK Parameters and in Vitro Intrinsic CL of <b>13c</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">iv</th><th class="rowsep1 colsep0" colspan="5" align="center">po</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">dose<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>dss</sub><a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">CL<sub>tot</sub><a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">dose<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub><a class="ref internalNav" href="#t8fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center">AUC<sub>0–inf</sub><a class="ref internalNav" href="#t8fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center">BA (%)</th><th class="colsep0 rowsep0" align="center">liver microsome int CL<a class="ref internalNav" href="#t8fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">hepatocyte int CL<a class="ref internalNav" href="#t8fn7" aria-label="g">g</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">90</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">160</td><td class="colsep0 rowsep0" align="left">0.68</td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t8fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t8fn8" aria-label="h">h</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">49</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">240</td><td class="colsep0 rowsep0" align="left">3.8</td><td class="colsep0 rowsep0" align="left">640</td><td class="colsep0 rowsep0" align="left">67</td><td class="colsep0 rowsep0" align="left">0.021</td><td class="colsep0 rowsep0" align="left">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">0.98</td><td class="colsep0 rowsep0" align="left">6.6</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">820</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">5700</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">0.042</td><td class="colsep0 rowsep0" align="left">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">800</td><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left">5800</td><td class="colsep0 rowsep0" align="left">49</td><td class="colsep0 rowsep0" align="left">0.030</td><td class="colsep0 rowsep0" align="left">28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t8fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t8fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t8fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t8fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t8fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t8fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t8fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t8fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">0.0033</td><td class="colsep0 rowsep0" align="left">3.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last">Dose is expressed in mg/kg.</p></div><div class="footnote" id="t8fn2"><sup><sup>b</sup></sup><p class="last"><i>V</i><sub>dss</sub> is expressed in L/kg.</p></div><div class="footnote" id="t8fn3"><sup><sup>c</sup></sup><p class="last">CL<sub>tot</sub> is expressed in mL min<sup>–1</sup> kg<sup>–1</sup>.</p></div><div class="footnote" id="t8fn4"><sup><sup>d</sup></sup><p class="last"><i>C</i><sub>max</sub> is expressed in nmol/L.</p></div><div class="footnote" id="t8fn5"><sup><sup>e</sup></sup><p class="last">AUC<sub>0–inf</sub> is expressed in (nmol/L)·h.</p></div><div class="footnote" id="t8fn6"><sup><sup>f</sup></sup><p class="last">CL is expressed in (mL/min)/mg protein.</p></div><div class="footnote" id="t8fn7"><sup><sup>g</sup></sup><p class="last">CL is expressed in mL min<sup>–1</sup> kg<sup>–1</sup>.</p></div><div class="footnote" id="t8fn8"><sup><sup>h</sup></sup><p class="last">Not tested.</p></div></div></div><div class="NLM_p">A major cause of heart failure is adverse cardiac remodeling after myocardial infarction (MI) during a period characterized by dysregulated chronic inflammation. FPR2 agonists have the potential to resolve this inflammation and improve cardiac structure and function. To investigate the role of FPR2 agonism in the setting of heart failure, the selective FPR2 agonist <b>13c</b> was evaluated in a mouse model of myocardial infarction (MI), which leads to heart failure develpment. In these studies, the left anterior descending (LAD) artery was permanently occluded with a surgical suture. Noninfarcted surgical sham mice had sutures placed around the LAD artery but not tightened. The lowest dose of <b>13c</b> that showed a significant effect on IL-10 stimulation (0.3 mg/kg) in mice treated with LPS was selected for testing in the myocardial infarction model. Vehicle and <b>13c</b> were dosed daily by oral gavage for 24 days starting 4 days after MI. The angiotensin converting enzyme inhibitor (ACEi), captopril, was provided in the drinking water (∼100 mg kg<sup>–1</sup> day<sup>–1</sup>) to compare a standard of care therapy for acute MI.</div><div class="NLM_p">After 28 days, infarct scar expansion and left ventricular chamber remodeling were evaluated. The passive mechanics of the left ventricle (LV) were analyzed using a modified Langendorff apparatus. A deflated balloon attached to a pressure transducer was inserted into the LV cavity. The passive compliance of the left ventricle was evaluated following three inflation and deflation cycles of the balloon. <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">3</a></a>A shows mean left ventricular pressure–volume (<i>P</i>–<i>V</i>) curves obtained from the various treatment groups as well as surgical sham mice. Treatment with vehicle yielded a right-shifted <i>P</i>–<i>V</i> curve relative to noninfarcted sham hearts shown at the left of the plot. The results indicate that infarcted mouse hearts treated with vehicle have dilated LV chambers at each measured pressure. By contrast, the <i>P</i>–<i>V</i> curve obtained with the FPR2 agonist <b>13c</b> is left shifted relative to vehicle, indicating smaller LV chambers with treatment. Treatment with captopril also yielded a left shifted <i>P</i>–<i>V</i> curve relative to vehicle but to a lesser degree than that obtained with compound <b>13c</b>. The findings suggest that LV chamber remodeling is attenuated with both compound <b>13c</b> and captopril treatments after MI. Heart weights for compound <b>13c</b> and captopril treatment groups were reduced relative to the vehicle group (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">3</a></a>B). These findings indicate that compound <b>13c</b> can attenuate left ventricle and global cardiac remodeling.</div><figure id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of <b>13c</b> and captopril (ACEi) treatment on myocardial structure and function after LAD in mice. (A) Left ventricular pressure–volume curves. (B) Heart weights 28 days after MI. (C) Representative heart cross sections by histology depicting the degree of myocardial infarction. Noninfarcted surgical sham animals are shown for comparison. (D) Scar length 28 days after MI. Doses: <b>13c</b>, 0.3 mg kg<sup>–1</sup> d<sup>–1</sup>; captoril, 100 mg kg<sup>–1</sup> d<sup>–1</sup>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02101&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Cross sections of the left ventricle were analyzed for histomorphometric assessments of infarct structure. Representative images showing the size of the MI and LV chambers are shown for all groups (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">3</a></a>C). Infarct length was quantified for all groups as an indicator of overall scar expansion. As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">3</a></a>D, vehicle-treated mice yielded the largest scar lengths. By contrast, treatment with compound <b>13c</b> reduced infarct length by 39% relative to vehicle (<i>P</i> < 0.05). Despite the decreases in heart weight and decreased LV chamber areas noted in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">3</a></a>A and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">3</a></a>B, treatment with captopril was unable to reduce scar length to a degree similar to that obtained with compound <b>13c</b>.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67338" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67338" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The syntheses of racemic <i>cis</i>- and <i>trans</i>-oriented azetidine urea derivatives <b>3</b> and <b>4</b> are shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Reaction of imine <b>14</b> with 2-(1,3-dioxoisoindolin-2-yl)acetyl chloride in the presence of triethylamine gave <b>15</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> as the mixture of <i>cis</i> and <i>trans</i> isomers. Removal of the 4-methoxyphenyl group of <b>15</b> with cerium(IV) ammonium nitrate (CAN) provided <i>cis</i> isomer <b>16</b>. Treatment of <b>16</b> with hydrazine monohydrate, followed by treatment with HCl, gave <b>17</b>. Reaction of <b>17</b> with 4-chlorophenyl isocyanate in the presence of saturated aqueous sodium hydrogen carbonate provided <i>cis</i>-oriented <b>3</b>. Azidation of a hydroxyl group of <i>cis</i>-isomer <b>18</b>,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> followed by deprotection of the 4-methoxyphenyl group of <i>trans</i>-<b>19</b> with CAN, gave <b>20</b>. A Staudinger reaction followed by treatment with 4-chlorophenyl isocyanate provided <i>trans</i>-oriented <b>4</b>. The stereochemistry of the C-3 and C-4 positions of all compounds was determined by comparison of the coupling constant of the C-3 and C-4 hydrogen atom in the <sup>1</sup>H NMR (<i>J</i><sub>3,4</sub> > 4.0 Hz for the <i>cis</i> isomer, <i>J</i><sub>3,4</sub> < 3.0 Hz for the <i>trans</i> isomer).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Azetidinone Urea Derivatives <b>3</b> and <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02101&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-(1,3-dioxoisoindolin-2-yl)acetyl chloride, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 28%; (b) CAN, MeCN–THF–H<sub>2</sub>O, 62%; (c) (1) hydrazine monohydrate, dioxane, (2) HCl, 53%; (d) 4-chlorophenyl isocyanate, sat. NaHCO<sub>3</sub> aq, AcOEt, 63%; (e) (1) MsCl, Et<sub>3</sub>N, (2) NaN<sub>3</sub>, DMF, 89%; (f) CAN, MeCN, 85%; (g) (1) PPh<sub>3</sub>, THF, (2) H<sub>2</sub>O, (3) 4-chlorophenyl isocyanate, 48% (three steps) .</p></p></figure><div class="NLM_p">The synthesis of racemic <i>cis</i>- and <i>trans</i>-oriented pyrrolidinone urea derivatives <b>5</b> and <b>6</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) began with the reaction of <b>21</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and <i>tert</i>-butyl (2,2,2-trifluoroacetyl)glycinate in the presence of lithium bis(trimethylsilyl)amide (LHMDS) to give compound <b>22</b>. After removal of the <i>tert</i>-butyl ester group with trifluoroacetic acid (TFA), treatment of <b>23</b> with iodomethane in the presence of potassium hydrogen carbonate provided <b>24</b>. Reduction of the nitro group using zinc powder and ammonium chloride, followed by treatment with titanium(III) chloride and sodium acetate,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> gave pyrrolidinone <b>25</b> as a <i>cis</i> and <i>trans</i> mixture. Removal of the trifluoroacetyl group under basic conditions and subsequent treatment of <b>26</b> with 4-chlorophenyl isocyanate were followed by separation of the diastereomers by column chromatography to provide <i>cis</i>-oriented <b>5</b> and <i>trans</i>-oriented <b>6</b>.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Pyrrolidinone Urea Derivatives <b>5</b> and <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02101&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>tert</i>-butyl (2,2,2-trifluoroacetyl)glycinate, LHMDS, THF, 88%; (b) TFA, 58%; (c) MeI, KHCO<sub>3</sub>, DMF, 92%; (d) (1) Zn, NH<sub>4</sub>Cl, MeOH–H<sub>2</sub>O, (2) 20% TiCl<sub>3</sub>, NaOAc, MeOH–H<sub>2</sub>O 63% (two steps); (e) 1 M aq NaOH, MeOH; (f) 4-chlorophenyl isocyanate, EtOAc, 4% (two steps for <b>5</b>), 44% (2 steps for <b>6</b>).</p></p></figure><div class="NLM_p">Racemic <i>trans</i>-oriented piperidinone urea derivative <b>7</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) was synthesized by conjugate addition of dimethyl malonate to compound <b>27</b> in the presence of sodium methoxide,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> followed by reduction of the cyano group in <b>28</b> using nickel boride to give piperidinone <b>29</b>. After hydrolysis of ester <b>29</b> under basic conditions, treatment of <b>30</b> with diphenylphosphoryl azide (DPPA) in the presence of triethylamine followed by the reaction with 4-chloroaniline provided piperidinone <b>7</b>.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Piperidinone Urea Derivative <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02101&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) dimethyl malonate, NaOMe, MeOH, 24%; (b) NaBH<sub>4</sub>, NiCl<sub>2</sub>·6H<sub>2</sub>O, MeOH, 65%; (c) 1 M NaOH, MeOH, 92%; (d) DPPA, Et<sub>3</sub>N, toluene, then 4-chloroaniline (6.5%).</p></p></figure><div class="NLM_p">The synthesis of optically active <i>cis</i>-oriented pyrrolidinone urea derivatives <b>8</b> and <b>9</b> is shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. After the reaction of <b>21</b> with ethyl 2-[(diphenylmethylene)amino]acetate in the presence of lithium diisopropylamide (LDA), removal of the diphenylmethylene group under acidic condition followed by treatment with di-<i>tert</i>-butyl dicarbonate (Boc<sub>2</sub>O) in the presence of saturated aqueous sodium hydrogen carbonate gave <b>31</b>. Reduction of the nitro group with nickel boride, followed by isolation of enantiomers using HPLC chromatography (CHIRALPAK ID), gave (−)-<i>cis</i>-isomer <b>32</b> and (+)-<i>cis</i>-isomer <b>33</b>. Deprotection of the Boc group of <b>32</b> and <b>33</b> under acidic conditions, followed by treatment with 4-chlorophenyl isocyanate in the presence of saturated aqueous sodium hydrogen carbonate, gave (−)-<i>cis</i>-isomer <b>8</b> and (+)-<i>cis</i>-isomer <b>9</b>, respectively.</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Optically Active <i>Cis</i>-Oriented Pyrrolidinone Urea Derivatives <b>8</b> and <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02101&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (1) ethyl 2-[(diphenylmethylene)amino]acetate, LDA, THF, (2) AcOH, H<sub>2</sub>O, (3) Boc<sub>2</sub>O, NaHCO<sub>3</sub> aq, THF, 63% (three steps); (b) (1) NaBH<sub>4</sub>, NiCl<sub>2</sub>·6H<sub>2</sub>O, MeOH, 84%, (2) HPLC separation, CHIRALPAK ID, 35% (for <b>32</b>), 43% (for <b>33</b>); (c) (1) TFA, CH<sub>2</sub>Cl<sub>2</sub>, (2) 4-chlorophenyl isocyanate, sat. NaHCO<sub>3</sub>, THF, 56% (two steps for <b>8</b>), 56% (two steps for <b>9</b>).</p></p></figure><div class="NLM_p">The synthesis of <i>trans</i>-oriented (3<i>R</i>,4<i>S</i>)- and (3<i>S</i>,4<i>R</i>)-pyrrolidinone urea derivatives <b>10</b> and <b>11</b> is shown in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. Enantioselective Michael addition<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> of dimethyl malonate to <b>21</b> using Ni(II)-bis[(<i>R</i>,<i>R</i>)-<i>N</i>,<i>N</i>′-dibenzylcyclohexane-1,2-diamine]bromide<a onclick="showRef(event, 'cit29a'); return false;" href="javascript:void(0);" class="ref cit29a">(29a)</a> followed by reduction of the nitro group using nickel boride gave (3<i>R</i>,4<i>S</i>)-isomer <b>35</b>. After hydrolysis of ester <b>35</b> under basic condition, reaction of acid <b>36</b> with DPPA in the presence of triethylamine, followed by treatment with 4-chloroaniline, provided (3<i>R</i>,4<i>S</i>)-isomer <b>10</b>. The (3<i>S</i>,4<i>R</i>)-isomer <b>38</b> was synthesized in the same manner as described for <b>35</b> using Ni(II)-bis[(<i>S</i>,<i>S</i>)-<i>N</i>,<i>N</i>′-dibenzylcyclohexane-1,2-diamine]bromide as the catalyst. After hydrolysis of ester <b>38</b> under basic condition, reaction with DPPA in the presence of triethylamine, followed by the treatment with 4-chloroaniline or 4-fluoroaniline, gave <b>11a</b> and <b>11b</b>, respectively.</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Optically Active <i>Trans</i>-Oriented Pyrrolidinone Ureas <b>10</b> and <b>11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02101&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) dimethyl malonate, Ni(II)-bis[(<i>R</i>,<i>R)</i>-<i>N</i>,<i>N</i>′-dibenzylcyclohexane-1,2-diamine]bromide (3 mol %), toluene; (b) dimethyl malonate, Ni(II)-bis[(<i>S</i>,<i>S</i>)-<i>N</i>,<i>N</i>′-dibenzylcyclohexane-1,2-diamine]bromide (3 mol %), toluene; (c) NaBH<sub>4</sub>, NiCl<sub>2</sub>·6H<sub>2</sub>O, MeOH, 73% (two steps for <b>35</b>), 68% (two steps for <b>38</b>); (d) 1 M NaOH aq, MeOH, 88%, (for <b>36</b>), 98% (for <b>39</b>); (e) DPPA, Et<sub>3</sub>N, toluene, then 4-chloroaniline, 53% (for <b>10</b>), 24% (for <b>11a</b>); (f) DPPA, Et<sub>3</sub>N, toluene, then 4-fluoroaniline, 18% (for <b>11b</b>).</p></p></figure><div class="NLM_p">The synthesis of the selected compounds <b>12g</b>, <b>13c</b>, <b>13i</b>, <b>13l</b>, and <b>13n</b> is shown in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. Treatment of <b>40</b> with MeNO<sub>2</sub> in the presence of ammonium acetate<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> gave nitrostyrene <b>41</b>, which was converted to carboxy derivative <b>44</b> in the same manner as described for <b>39</b>. Conversion of <b>44</b> to <i>N</i>-Cbz derivative <b>45</b> by a Curtius rearrangement and removal of the Cbz group by catalytic hydrogenation gave amino derivative <b>46</b>. Reaction of <b>44</b> with DPPA in the presence of triethylamine, followed by treatment with 4-fluoroaniline or 5-amino-2-methylphenol, gave <b>12g</b> and <b>13l</b>, respectively. Reaction of <b>46</b> with phenyl isocyanate or 2,4-difluorophenyl isocyanate gave <b>13c</b> and <b>13i</b>, respectively. Treatment of <b>46</b> with 2-chlorothiophene-5-carboxylic acid in the presence of DPPA and triethylamine gave <b>13n</b>.</div><figure id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Selected Compounds <b>12g</b>, <b>13c</b>, <b>13i</b>, <b>13l</b>, and <b>13n</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02101&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) MeNO<sub>2</sub>, ammonium acetate, AcOH, 95%; (b) dimethyl malonate, Ni(II)-bis[(<i>S</i>,<i>S</i>)-<i>N</i>,<i>N</i>′-dibenzylcyclohexane-1,2-diamine]bromide (3 mol %), toluene, 95%; (c) NaBH<sub>4</sub>, NiCl<sub>2</sub>·6H<sub>2</sub>O, MeOH, 55%; (d) 1 M NaOH aq, MeOH, 99%; (e) DPPA, Et<sub>3</sub>N, toluene then BnOH, 47%; (f) H<sub>2</sub>, 10% Pd–C, EtOH, 100%; (g) <b>44</b>, DPPA, Et<sub>3</sub>N, toluene then 4-fluoroaniline or 5-amino-2-methylphenol, 55% (for <b>12g</b>), 65% (for <b>13l</b>); (h) <b>46</b>, phenyl isocyanate or 3,4-difluorophenyl isocyanate, THF, 76% (for <b>13c</b>), 86% (for <b>13i</b>); (i) <b>46</b>, 2-chlorothiophene-5-carboxylic acid, DPPA, Et<sub>3</sub>N, toluene, 38% (for <b>13n</b>).</p></p></figure><div class="NLM_p last">Other analogs were synthesized using analogous chemistry, and details are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02101/suppl_file/jm9b02101_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46780" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46780" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Conformational restriction of a simple phenylethyl urea FPR2 agonist led to the discovery of a pyrrolidinone core, which was further optimized to produce potent FPR2 agonists with selectivity over FPR1. Evaluation of lead compounds in a lung LPS model and metabolic profilng assays led to the identification of compound <b>13c</b> (BMS-986235/LAR-1219) as a clinical candidate. Compound <b>13c</b> showed robust efficacy on both structure and function end points in a mouse myocardial infarction heart failure model after oral dosing for 28 days. These findings suggest that this selective, orally bioavailable small molecule FPR2 agonist could prevent adverse pathological remodeling that leads to heart failure.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15626" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15626" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Chemistry</h3><div class="NLM_p last">Melting points were measured on an OptiMelt automated melting point system MPA100 without correction. Infrared (IR) spectra were recorded with a ParkinElmer Spectrum 100 spectrometer. Measurements of mass spectra (MS) and high resolution MS (HRMS) were performed with a JEOL JMS SX-102A or a JEOL JMS-T100LP mass spectrometer. Proton nuclear magnetic resonance (<sup>1</sup>H NMR) spectra were measured with a JEOL JMN-EX400 (400 MHz) or a JEOL JMN-ECA-400 (400 MHz) spectrometer. The chemical shifts are expressed in parts per million (δ value) downfield from tetramethylsilane, using tetramethylsilane (δ = 0) and/or residual solvents such as chloroform (δ = 7.26) as an internal standard. Splitting patterns are indicated as follows: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br; broad peak. Specific optical rotations were measured on a JASCO P-1000 polarimeter. Purity data were collected by an Agilent 1100 HPLC with Agilent G1315B diode array detector. The column used was a RP-AQUA (50 mm × 2.1 mm i.d., 2.6 μm, ChromaNik Technologies Inc., Japan) with a temperature of 45 °C and a flow rate of 0.5 mL/min. Mobile phases A and B were a mixture of 0.05% formic acid in water, and 0.05% formic acid in MeCN, respectively. The ratio of mobile phase was increased linearly from 5% to 95% over 5 min, 95% over the next 3 min. The data for elemental analysis were within ±0.4% of the theoretical values and were determined by a Yanaco microcorder JM11. Column chromatography was carried out with silica gel [silica gel 60 (Kanto)] as an absorbent. Merck precoated thin layer chromatography (TLC) plates (silica gel 60 F<sub>254</sub>, 0.25 mm, Art 5715) were used for the TLC analysis. All purities for final compounds are ≥95.0% and were measured using HPLC.</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2-[1,2-Bis(4-methoxyphenyl)-4-oxoazetidin-3-yl]isoindoline-1,3-dione (<b>15</b>)</h3><div class="NLM_p last">A solution of 2-(1,3-dioxoisoindolin-2-yl)acetyl chloride (2.00 g, 8.94 mmol) in CH<sub>2</sub>Cl<sub>2</sub> was added dropwise to a mixture of <b>14</b> (1.44 g, 5.87 mmol), triethylamine (2.7 mL, 19 mmol), and CH<sub>2</sub>Cl<sub>2</sub> (65 mL) under cooling with NaCl–ice, and the mixture was stirred at room temperature for 38 h and concentrated in vacuo. Flash chromatography (hexane/AcOEt = 2:1) of the residue gave <b>15</b> (718 mg, 28%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 3.66 (s, 2.5H, OCH<sub>3</sub> of major isomer), 3.74 (s, 0.5H, OCH<sub>3</sub> of minor isomer), 3.75 (s, 0.5H, OCH<sub>3</sub> of minor isomer), 3.79 (s, 2.5H, OCH<sub>3</sub> of major isomer), 5.26 (d, <i>J</i> = 2.4 Hz, 0.2H, C-4H of minor isomer), 5.30 (d, <i>J</i> = 3.0 Hz, 0.2H, C-3H of minor isomer), 5.40 (d, <i>J</i> = 5.4 Hz, 0.8H, C-4H of major isomer), 5.62 (d, <i>J</i> = 5.4 Hz, 0.8H, C-3H of major isomer), 6.65 (d, <i>J</i> = 8.5 Hz, 0.3H, ArH of minor isomer), 6.70–6.76 (m, 1.7H, ArH of major isomer), 6.81 (d, <i>J</i> = 9.1 Hz, 0.3H, ArH of minor isomer), 6.86 (d, <i>J</i> = 9.1 Hz, 1.7H, ArH of major isomer), 6.91 (d, <i>J</i> = 8.5 Hz, 0.3H, ArH of minor isomer), 7.18 (d, <i>J</i> = 8.5 Hz, 1.7H, ArH of major isomer), 7.27–7.31 (m, 0.3H, ArH of minor isomer), 7.39 (d, <i>J</i> = 9.1 Hz, 1.7H, ArH of major isomer), 7.63–7.67 (m, 1.7H, ArH of major isomer), 7.69–7.72 (m, 1.7H, ArH of major isomer), 7.76 (dd, <i>J</i> = 5.5, 3.0 Hz, 0.3H, ArH of minor isomer), 7.88 (dd, <i>J</i> = 5.5, 3.0 Hz, 0.3H, ArH of minor isomer).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 2-[<i>cis</i>-2-(4-Methoxyphenyl)-4-oxoazetidin-3-yl]isoindoline-1,3-dione (<b>16</b>)</h3><div class="NLM_p last">A solution of ammonium cerium(IV) nitrate (2.33 g, 4.25 mmol) in water (14 mL) was added to a mixture of <b>15</b> (608 mg, 1.42 mmol), MeCN (28 mL), and THF (7 mL) under cooling with NaCl–ice, and the mixture was stirred at the same temperature for 2 h and then at room temperature for 2 h. After quenching the reaction addition of water, the mixture was extracted with AcOEt (3 × 40 mL). The combined extracts were washed with saturated aqueous NaHCO<sub>3</sub> solution, 10% aqueous NaHSO<sub>3</sub> solution, and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Flash chromatography (hexane/AcOEt = 2:1 → 1:2) of the residue gave <b>16</b> (283 mg, 62%) as a pale yellow amorphous solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 3.68 (s, 3H), 5.13 (d, <i>J</i> = 5.4 Hz, 1H), 5.56 (dd, <i>J</i> = 4.8, 1.8 Hz, 1H), 6.44 (br s, 1H), 6.75 (d, <i>J</i> = 8.5 Hz, 2H), 7.21 (d, <i>J</i> = 8.5 Hz, 2H), 7.63–7.66 (m, 2H), 7.68–7.72 (m, 2H). MS (FI<sup>+</sup>) <i>m</i>/<i>z</i>: 322 (M<sup>+</sup>). HRMS (FI<sup>+</sup>) for C<sub>18</sub>H<sub>14</sub>N<sub>2</sub>O<sub>4</sub> (M<sup>+</sup>): calcd, 322.09536; found, 322.09543. IR (ATR) cm<sup>–1</sup>: 3280, 1760, 1717.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>cis</i>-3-Amino-4-(4-methoxyphenyl)azetidin-2-one Hydrochloride (<b>17</b>)</h3><div class="NLM_p last">A solution of hydrazine monohydrate (0.050 mL, 1.0 mmol) in MeOH (0.3 mL) was added to a solution of <b>16</b> (250 mg, 0.776 mmol) in 1,4-dioxane (3.1 mL). The mixture was stirred at room temperature for 1 h and concentrated in vacuo. After addition of MeOH (3.0 mL) and 1 M HCl (1.5 mL) to the residue, the mixture was stirred at 40 °C for 2 h and concentrated in vacuo. After addition of water to the residue, the insoluble materials were filtered off, and then the filtrate was concentrated in vacuo. After addition of EtOH to the residue, the resulting precipitate was collected by filtration and washed with EtOH to give <b>17</b> (93.6 mg, 53%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.76 (s, 3H), 4.67 (dd, <i>J</i> = 5.5, 1.8 Hz, 1H), 4.94 (d, <i>J</i> = 5.4 Hz, 1H), 6.98 (d, <i>J</i> = 9.1 Hz, 2H), 7.33 (d, <i>J</i> = 8.5 Hz, 2H), 8.38 (br, 3H), 9.01 (s, 1H). MS (FI<sup>+</sup>) <i>m</i>/<i>z</i>: 192 (M<sup>+</sup>). HRMS (FI<sup>+</sup>) for C<sub>10</sub>H<sub>12</sub>N<sub>2</sub>O<sub>2</sub> (M<sup>+</sup>): calcd, 192.08988; found, 192.09032. IR (ATR) cm<sup>–1</sup>: 3078, 1752, 1728.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 1-(4-Chlorophenyl)-3-[<i>cis</i>-2-(4-methoxyphenyl)-4-oxoazetidin-3-yl]urea (<b>3</b>)</h3><div class="NLM_p last">To a mixture of <b>17</b> (89.0 mg, 0.389 mmol), AcOEt (1.6 mL), and saturated aqueous NaHCO<sub>3</sub> solution was added 4-chlorophenyl isocyanate (56.0 mg, 0.365 mmol) under cooling with ice, and the mixture was stirred at the same temperature for 2 h. After quenching the reaction by the addition of water, the mixture was extracted with AcOEt (2 × 10 mL). The combined extracts were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and then concentrated in vacuo. Trituration of the residue with AcOEt–Et<sub>2</sub>O gave <b>3</b> (85 mg, 63%) as a white powder. Mp: 184–186 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.73 (s, 3H), 4.86 (d, <i>J</i> = 4.8 Hz, 1H), 5.29 (dd, <i>J</i> = 9.7, 4.8 Hz, 1H), 6.27 (d, <i>J</i> = 9.7 Hz, 1H), 6.93–6.97 (m, 2H), 7.13–7.16 (m, 2H), 7.22–7.25 (m, 2H), 7.28–7.31 (m, 2H), 8.49 (s, 1H), 8.61 (s, 1H). MS (FD<sup>+</sup>) <i>m</i>/<i>z</i>: 345 (M<sup>+</sup>). HRMS (FD<sup>+</sup>) for C<sub>17</sub>H<sub>16</sub>ClN<sub>3</sub>O<sub>3</sub> (M<sup>+</sup>): calcd, 345.08802; found, 345.08767. IR (ATR) cm<sup>–1</sup>: 3278, 1771, 1627. HPLC purity: 98.1%.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>trans</i>-3-Azide-1,2-bis(4-methoxyphenyl)azetidin-2-one (<b>19</b>)</h3><div class="NLM_p last">To a mixture of <b>18</b> (530 mg, 1.77 mmol), triethylamine (0.37 mL, 2.7 mmol), and THF (8.9 mL) was added methanesulfonyl chloride (0.17 mL, 2.2 mmol) under cooling with ice; the mixture was stirred at the same temperature for 1.5 h. After quenching the reaction by the addition of ice–water, the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 20 mL). The combined extracts were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and then concentrated in vacuo. A mixture of the residue, NaN<sub>3</sub> (690 mg, 10.6 mmol), and DMF (8.9 mL) was stirred at 90 °C for 74 h. After quenching the reaction by the addition of ice–water, the mixture was extracted with AcOEt (2 × 20 mL). The combined extracts were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Flash chromatography (hexane/AcOEt = 3:1) of the residue gave <b>19</b> (510 mg, 89%) as a pale yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 3.74 (s, 3H), 3.81 (s, 3H), 4.46 (d, <i>J</i> = 1.8 Hz, 1H), 4.77 (d, <i>J</i> = 1.8 Hz, 1H), 6.76–6.80 (m, 2H), 6.90–6.93 (m, 2H), 7.19–7.23 (m, 2H), 7.24–7.28 (m, 2H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 325 (M<sup>+</sup> + H). HRMS (ESI<sup>+</sup>) for C<sub>17</sub>H<sub>17</sub>N<sub>4</sub>O<sub>3</sub> (M<sup>+</sup> + H): calcd, 325.13006; found, 325.12938. IR (ATR) cm<sup>–1</sup>: 2122, 1758.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>trans</i>-3-Azide-4-(4-methoxyphenyl)azetidin-2-one (<b>20</b>)</h3><div class="NLM_p last">Compound <b>20</b> (285 mg, 85%) was prepared from <b>19</b> (500 mg, 1.54 mmol) by the same method as that used for <b>16</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 3.83 (s, 3H), 4.36 (d, <i>J</i> = 1.8 Hz, 1H), 4.55 (d, <i>J</i> = 1.8 Hz, 1H), 6.13 (br s, 1H), 6.92–6.95 (m, 2H), 7.27–7.30 (m, 2H). MS (FD<sup>+</sup>) <i>m</i>/<i>z</i>: 218 (M<sup>+</sup>). HRMS (FD<sup>+</sup>) for C<sub>10</sub>H<sub>10</sub>N<sub>4</sub>O<sub>2</sub> (M<sup>+</sup>): calcd, 218.08038; found, 218.08038. IR (ATR) cm<sup>–1</sup>: 3079, 2101, 1772, 1733.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 1-(4-Chlorophenyl)-3-[<i>trans</i>-2-(4-methoxyphenyl)-4-oxoazetidin-3-yl]urea (<b>4</b>)</h3><div class="NLM_p last">To a mixture of <b>20</b> (100 mg, 0.46 mmol) and THF (4.6 mL) was added triphenylphosphine (136 mg, 0.519 mmol), and the mixture was stirred at room temperature for 100 min. After addition of water (0.04 mL) to the resulting mixture, the reaction mixture was stirred at 50 °C for 5 h. To the resulting mixture was added 4-chlorophenyl isocyanate (48.0 mg, 0.31 mmo), and the mixture was stirred at room temperature for 70 min. To the resulting mixture was added 4-chlorophenyl isocyanate (15.0 mg, 0.098 mmo), and the mixture was stirred at room temperature for 10 min. After quenching the reaction by the addition of water, the mixture was extracted with AcOEt (2 × 10 mL). The combined extracts were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Trituration of the residue with AcOEt–MeOH gave <b>4</b> (76.0 mg, 48%) as a white powder. Mp: 182–183 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.75 (s, 3H), 4.37 (dd, <i>J</i> = 7.9, 2.4 Hz, 1H), 4.56 (d, <i>J</i> = 2.4 Hz, 1H), 6.93–6.97 (m, 2H), 7.01 (d, <i>J</i> = 7.9 Hz, 1H), 7.26–7.34 (m, 4H), 7.41–7.45 (m, 2H), 8.53 (s, 1H), 8.88 (s, 1H). MS (FD<sup>+</sup>) <i>m</i>/<i>z</i>: 345 (M<sup>+</sup>). HRMS (FD<sup>+</sup>) for C<sub>17</sub>H<sub>16</sub>ClN<sub>3</sub>O<sub>3</sub> (M<sup>+</sup>): calcd, 345.08802; found, 345.08802. IR (ATR) cm<sup>–1</sup>: 3364, 1741, 1691. HPLC purity: 99.0%.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>tert</i>-Butyl 3-(4-Methoxyphenyl)-4-nitro-2-(2,2,2-trifluoroacetamido)butanoate (<b>22</b>)</h3><div class="NLM_p last">Lithium bis(trimethylsilyl)amide (1.6 M THF solution, 44 mL, 70 mmol) was added dropwise to a solution of <i>tert</i>-butyl (2,2,2-trifluoroacetyl)glycinate (6.33 g, 27.9 mmol) in THF (50 mL) at −78 °C, and the mixture was stirred at the same temperature for 30 min. To the resulting mixture was added dropwise a solution of <b>21</b> (5.00 g, 27.9 mmol) in THF (30 mL) at −78 °C, and then the mixture was stirred at room temperature for 30 min. After quenching the reaction by the addition of 1 M HCl, the mixture was extracted with AcOEt. The extract was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Flash chromatography of the residue (hexane/AcOEt = 4:1) gave <b>22</b> (10.0 g, 88%) as a pale yellow oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 1.38 and 1.47 [each s, total 9H, C(CH<sub>3</sub>)<sub>3</sub> of major and minor isomers), 3.79 and 3.80 (each s, total 3H, OCH<sub>3</sub> of major and minor isomers), 3.96 (q, <i>J</i> = 7.3 Hz, 0.7H, C-3H of major isomer), 4.20–4.26 (m, 0.3H, C-3H of minor isomer), 4.63–4.69 (m, 0.3H, C-2H of minor isomer), 4.76–4.87 [m, 2H (C-4H of major and minor isomers) + 0.7H (C-3H of major isomer)], 6.74–6.89 [m, 2H (ArH of major and minor isomers) + 1H (NH of major and minor isomers)], 7.05–7.10 (m, 2H, ArH of major and minor isomers).</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 3-(4-Methoxyphenyl)-4-nitro-2-(2,2,2-trifluoroacetamido)butanoic Acid (<b>23</b>)</h3><div class="NLM_p last">A mixture of <b>22</b> (10.0 g, 24.6 mmol) and trifluoroacetic acid (15 mL) was stirred at room temperature for 3 h and then concentrated in vacuo. A mixture of the resulting residue, AcOEt, and water was extracted with saturated aqueous NaHCO<sub>3</sub> solution. The aqueous layer was acidified with 1 M HCl, and then the mixture was extracted with AcOEt. The extract was washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and then concentrated in vacuo to obtain <b>23</b> (5.0 g, 58%). Compound <b>23</b> was used for the next step without further purification.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Methyl 3-(4-Methoxyphenyl)-4-nitro-2-(2,2,2-trifluoroacetamido)butanoate (<b>24</b>)</h3><div class="NLM_p last">To a solution of <b>23</b> (5.00 g, 14.3 mmol) in DMF (15 mL) were added KHCO<sub>3</sub> (2.86 g, 28.6 mmol) and iodomethane (1.78 mL, 28.6 mmol), and the mixture was stirred at 50 °C for 2 h. After quenching the reaction by the addition of water, the mixture was extracted with AcOEt. The extract was washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and then concentrated in vacuo. Flash chromatography (hexane/AcOEt = 4:1) of the residue gave <b>24</b> (4.8 g, 92%) as an off-white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 3.73 (s, 2H, OCH<sub>3</sub> of major isomer), 3.80 and 3.81 (each s, total 4H, OCH<sub>3</sub> of major and minor isomers), 4.00 (dd, <i>J</i> = 13.9, 7.9 Hz, 0.7H, C-3H of major isomer), 4.26–4.32 (m, 0.3H, C-3H of minor isomer), 4.68 (dd, <i>J</i> = 13.9, 8.5 Hz, 0.3H, C-4H of minor isomer), 4.85–4.94 [m, 2.1H (C-2H and C-4H of major isomer) + 0.3H (C-2H of minor isomer], 5.01–5.07 (m, 0.3H, C-4H of minor isomer), 6.68–6.80 (br, 1H, NH of major and minor isomers), 6.88 (d <i>J</i> = 9.1 Hz, 2H, ArH of major and minor isomers), 7.00–7.03 (m, 2H, ArH of major and minor isomers). MS (FI<sup>+</sup>) <i>m</i>/<i>z</i>: 364 (M<sup>+</sup>). HRMS (FI<sup>+</sup>) for C<sub>14</sub>H<sub>15</sub>F<sub>3</sub>N<sub>2</sub>O<sub>6</sub> (M<sup>+</sup>): calcd, 364.08822; found, 364.08839. IR (ATR) cm<sup>–1</sup>: 3266, 1734, 1706.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2,2,2-Trifluoro-<i>N</i>-[4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]acetamide (<b>25</b>)</h3><div class="NLM_p last">To a solution of <b>24</b> (4.78 g, 13.1 mmol) in MeOH (130 mL) were added a solution of NH<sub>4</sub>Cl (7.00 g, 131 mmol) in water (30 mL) and zinc powder (8.50 g, 131 mmol), and the mixture was stirred at room temperature for 30 min. The reaction mixture was diluted with AcOEt and the insoluble materials were filtered off. After addition of saturated aqueous NaHCO<sub>3</sub> solution to the filtrate, the mixture was extracted with AcOEt. The extract was washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and then concentrated in vacuo. To a solution of the residue in MeOH (65 mL) was added a solution of sodium acetate (13.0 g, 159 mmol) in water (43 mL) and 20% aqueous titanium(III) chloride solution (17 mL), and then the mixture was stirred at room temperature for 2 h. After quenching the reaction by additioon of water, the mixture was extracted with AcOEt. The extract was washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and then concentrated in vacuo. Flash chromatography (hexane/AcOEt = 1:2) of the residue gave <b>25</b> (2.5 g, 63%) as a pale yellow oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 3.43 (t, <i>J</i> = 9.7 Hz, 0.3H, C-5H of minor isomer), 3.61–3.68 (m, 1H, C-5H of major and minor isomers), 3.73 (t, <i>J</i> = 9.7 Hz, 0.3H, C-4H of minor isomer), 3.79 and 3.81 (each s, total 3H, OCH<sub>3</sub> of major and minor isomers), 3.93 (dd, <i>J</i> = 10.3, 6.7 Hz, 0.7H, C-5H of major isomer), 4.04 (t, <i>J</i> = 6.7 Hz, 0.7H, C-4H of major isomer), 4.72 (dd, <i>J</i> = 10.9, 8.5 Hz, 0.3H, C-3H of minor isomer), 4.77 (t, <i>J</i> = 6.7 Hz, 0.7H, C-3H of major isomer), 6.31 (br s, 1H, NH of major and minor isomers), 6.34–6.42 (br, 0.7H, NH of major isomer), 6.84 (d, <i>J</i> = 9.1 Hz, 1.3H, ArH of major isomer), 6.91 (d, <i>J</i> = 8.5 Hz, 0.7H, ArH of minor isomer), 7.00 (d, <i>J</i> = 7.9 Hz, 0.3H, NH of minor isomer), 7.07 (d, <i>J</i> = 8.5 Hz, 1.3H, ArH of major isomer), 7.22 (d, <i>J</i> = 8.5 Hz, 0.7H, ArH of minor isomer). MS (FI<sup>+</sup>) <i>m</i>/<i>z</i>: 302 (M<sup>+</sup>). HRMS (FI<sup>+</sup>) for C<sub>13</sub>H<sub>13</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> (M<sup>+</sup>): calcd, 302.08783; found, 302.08781. IR (ATR) cm<sup>–1</sup>: 3296, 3235, 1722, 1696, 1674.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-(4-Chlorophenyl)-3-[<i>cis</i>-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]urea (<b>5</b>) and 1-(4-Chlorophenyl)-3-[<i>trans</i>-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]urea (<b>6</b>)</h3><div class="NLM_p">To a solution of <b>25</b> (60.0 mg, 0.199 mmol) in MeOH (3.0 mL) was added 1 M aqueous NaOH solution (0.5 mL), and the mixture was stirred at 70 °C for 2 h. After neutralization (pH 7) of the reaction mixture by addition of 1 M HCl, the mixture was concentrated in vacuo. To the mixture of residue (<b>26</b>) and AcOEt (3.0 mL), 4-chlorophenyl isocyanate (30.0 mg, 0.195 mmol) was added, and the mixture was stirred at room temperature for 10 min. After dilution of the reaction mixture with AcOEt, the mixture was washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Flash chromatography (hexne/AcOEt → AcOEt → AcOEt/MeOH) of the residue gave <b>5</b> (3.00 mg, 4.2%) and <b>6</b> (31.0 mg, 44%).</div><div class="NLM_p"><b>26</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 3.20–3.27 (m, 1H), 3.36 (d, <i>J</i> = 9.7 Hz, 1H), 3.58–3.74 (m, 2H), 3.81 (s, 3H), 5.91 (br s, 1H), 6.86–6.92 (m, 2H), 7.17–7.24 (m, 2H). MS (FI<sup>+</sup>) <i>m</i>/<i>z</i>: 206 (M<sup>+</sup>). HRMS (FI<sup>+</sup>) for C<sub>11</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub> (M<sup>+</sup>): calcd, 206.10553; found, 206.10598.</div><div class="NLM_p"><b>5</b>. White powder. Mp: 211–213 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.25–3.30 (m, 1H), 3.68–3.72 (m, 5H), 4.59 (t, <i>J</i> = 7.3 Hz, 1H), 5.80 (d, <i>J</i> = 7.3 Hz, 1H), 6.83–6.87 (m, 2H), 7.03–7.06 (m, 2H), 7.21–7.25 (m, 2H), 7.30–7.34 (m, 2H), 8.10 (s, 1H), 8.73 (s, 1H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 360 (M<sup>+</sup> + H). HRMS (ESI<sup>+</sup>) for C<sub>18</sub>H<sub>19</sub>ClN<sub>3</sub>O<sub>3</sub> (M<sup>+</sup> + H): calcd, 360.11149; found, 360.11120. IR (ATR) cm<sup>–1</sup>: 3303, 1699. HPLC purity: 99.0%.</div><div class="NLM_p last"><b>6</b>. White powder. Mp: 151–154 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.13–3.20 (m, 1H), 3.43–3.50 (m, 2H), 3.72 (s, 3H), 4.48 (dd, <i>J</i> = 10.9, 9.1 Hz, 1H), 6.47 (d, <i>J</i> = 8.5 Hz, 1H), 6.86–6.90 (m, 2H), 7.22–7.26 (m, 2H), 7.28–7.32 (m, 2H), 7.37–7.41 (m, 2H), 7.92 (s, 1H), 8.68 (s, 1H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 360 (M<sup>+</sup> + H). HRMS (ESI<sup>+</sup>) for C<sub>18</sub>H<sub>19</sub>ClN<sub>3</sub>O<sub>3</sub> (M<sup>+</sup> + H): calcd, 360.11149; found, 360.11142. IR (ATR) cm<sup>–1</sup>: 3387, 1729, 1660. HPLC purity: 99.0%.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Dimethyl 2-[2-Cyano-1-(4-methoxyphenyl)ethyl]malonate (<b>28</b>)</h3><div class="NLM_p last">To a 1 M soluion of sodium methoxide in MeOH [prepared from sodium (460 mg, 20.0 mmol) and MeOH (20 mL)] was added dimethyl malonate (3.00 mL, 26.3 mmol), and the mixture was stirred at room temperature for 10 min. To the reaction mixture was added <b>27</b> (2.90 mL, 20.0 mmol), and the mixture was heated under reflux for 18 h. After quenching the reaction by the addition of 1 M HCl (50 mL) under ice cooling, the mixture was extracted with AcOEt (2 × 100 mL). The combined extracts were washed with brine (2 × 50 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. After suspension of the residue in MeOH (50 mL), the insoluble materials were filtered off, and the filtrate was concentrated in vacuo. Flash chromatography (hexane/AcOEt = 10:1 → 1:2) of the residue gave <b>28</b> (1.43 g, 24%) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 2.83 (dd, <i>J</i> = 17.0, 4.8 Hz, 1H), 2.89 (dd, <i>J</i> = 16.3, 7.3 Hz, 1H), 3.53 (s, 3H), 3.67–3.73 (m, 1H), 3.786 (s, 3H), 3.795 (s, 3H), 3.85 (d, <i>J</i> = 9.7 Hz, 1H), 6.85–6.89 (m, 2H), 7.18–7.22 (m, 2H). MS (EI<sup>+</sup>) <i>m</i>/<i>z</i>: 291 (M<sup>+</sup>). IR (ATR) cm<sup>–1</sup>: 2248, 1750, 1734.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Methyl 4-(4-Methoxyphenyl)-2-oxopiperidine-3-carboxylate (<b>29</b>)</h3><div class="NLM_p last">To a mixture of <b>28</b> (1.31 g, 4.50 mmol) and nickel(II) chloride hexahydrate (1.07 g, 4.50 mmol) in MeOH (45 mL) was added portionwise NaBH<sub>4</sub> (1.02 g, 27.0 mmol) under cooling with ice, and the mixture was stirred at room temperature for 1 h. After quenching the reaction by adding 1 M HCl (30 mL), the mixture was extracted with AcOEt (2 × 100 mL). The combined extracts were washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Flash chromatography (hexane/AcOEt = 1:2) of the residue gave <b>29</b> (765 mg, 65%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 1.80 (br d, <i>J</i> = 13.5 Hz, 1H), 1.97 (dq, <i>J</i> = 12.7, 5.5 Hz, 1H), 3.14–3.31 (m, 3H), 3.44 (s, 3H), 3.52 (d, <i>J</i> = 11.5 Hz, 1H), 3.72 (s, 3H), 6.84–6.87 (m, 2H), 7.16–7.19 (m, 2H), 7.89 (d, <i>J</i> = 2.4 Hz, 1H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 264 (M<sup>+</sup> + H). IR (ATR) cm<sup>–1</sup>: 3191, 1740, 1656.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 4-(4-Methoxyphenyl)-2-oxopiperidine-3-carboxylic Acid (<b>30</b>)</h3><div class="NLM_p last">To a solution of <b>29</b> (710 mg, 2.70 mmol) in MeOH (5.4 mL) was added 1 M aqueous NaOH solution (5.40 mL, 5.40 mmol), and then the mixture was stirred at 50 °C for 1 h. After removal of MeOH in vacuo, the resulting mixture was adjusted to pH 1 by addition of 1 M HCl under cooling with ice, and the resulting precipitate was collected by filtration. The filtered precipitate was washed with water and hexane and dried in vacuo to give <b>30</b> (618 mg, 92%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 1.79 (br d, <i>J</i> = 13.3 Hz, 1H), 1.92 (dq, <i>J</i> = 12.7, 5.5 Hz, 1H), 3.11–3.30 (m, 3H), 3.36 (d, <i>J</i> = 11.5 Hz, 1H), 3.72 (s, 3H), 6.84–6.68 (m, 2H), 7.17–7.21 (m, 2H), 7.80 (d, <i>J</i> = 3.0 Hz, 1H), 12.2 (br s, 1H). MS (FD<sup>+</sup>) <i>m</i>/<i>z</i>: 249 (M<sup>+</sup>). IR (ATR) cm<sup>–1</sup>: 3305, 1740.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 1-(4-Chlorophenyl)-3-[<i>trans</i>-4-(4-methoxyphenyl)-2-oxopiperidin-3-yl]urea (<b>7</b>)</h3><div class="NLM_p last">Diphenylphosphoryl azide (0.17 mL, 0.760 mmol) and triethylamine (0.11 mL, 0.789 mmol) were added to a mixture of <b>30</b> (150 mg, 0.602 mmol) in toluene (3.0 mL) and MeCN (0.3 mL). The mixture was stirred at room temperature for 1 h and then at 100 °C for 1 h. To the reaction mixture was added 4-chloroaniline (155 mg, 1.22 mmol). The mixture was stirred at 100 °C for 6.5 h and concentrated in vacuo. Flash chromatography (AcOEt → AcOEt/MeOH = 4:1) of the residue gave <b>7</b> (14.6 mg, 6.5%) as a white powder. Mp: 254–260 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 1.85 (br d, <i>J</i> = 12.1 Hz, 1H), 2.01 (dq, <i>J</i> = 12.1, 5.5 Hz, 1H), 3.12–3.21 (m, 2H), 3.26 (dt, <i>J</i> = 11.5, 4.2 Hz, 1H), 3.69 (s, 3H), 4.13 (dd, <i>J</i> = 11.5, 9.1 Hz, 1H), 6.24 (d, <i>J</i> = 9.1 Hz, 1H), 6.82 (d, <i>J</i> = 8.5 Hz, 2H), 7.17 (d, <i>J</i> = 8.5 Hz, 2H), 7.20 (d, <i>J</i> = 9.1 Hz, 2H), 7.34 (d, <i>J</i> = 9.1 Hz, 2H), 7.61 (s, 1H), 8.59 (s, 1H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 374 (M<sup>+</sup> + H). HRMS (ESI<sup>+</sup>) for C<sub>19</sub>H<sub>21</sub>ClN<sub>3</sub>O<sub>3</sub> (M<sup>+</sup> + H): calcd, 374.12714; found, 374.12805. IR (ATR) cm<sup>–1</sup>: 3322, 1678, 1647. Anal. Calcd for C<sub>19</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>3</sub>·0.8H<sub>2</sub>O: C, 58.78; H, 5.61; N, 10.82. Found: C, 58.84; H, 5.34; N, 10.74.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Ethyl 2-[(<i>tert</i>-butoxycarbonyl)amino]-3-(4-methoxyphenyl)-4-nitrobutanoate (<b>31</b>)</h3><div class="NLM_p last">Lithium diisopropylamide (1.09 M THF solution, 18.3 mL, 20.0 mmol) was added dropwise to a solution of ethyl 2-[(diphenylmethylene)amino]acetate (5.35 g, 20.0 mmol) in THF (56 mL) at −78 °C, and the mixture was stirred at −78 °C for 1 h. To the reaction mixture was added dropwise a solution of <b>21</b> (3.00 g, 16.7 mmol) in THF (16 mL) at −78 °C, and the mixture was stirred for 4.5 h with gradual warming to room temperature. The reaction mixture was poured into saturated aqueous NH<sub>4</sub>Cl solution (150 mL), and the resulting mixture was extracted with AcOEt (2 × 30 mL). The combined extracts were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and then concentrated in vacuo. Flash chromatography (hexane/AcOEt = 4:1) of the residue gave ethyl 2-[(diphenylmethylene)amino]-3-(4-methoxyphenyl)-4-nitrobutanoate (8.47 g). A mixture of the compound obtained (8.47 g), acetic acid (45 mL), and water (9 mL) was stirred at 45 °C for 4 h and then at 50 °C for 2 h. After addition of 0.5 M HCl (70 mL) and diethyl ether (20 mL) to the reaction mixture, the aqueous layer was separated and washed with diethyl ether (2 × 20 mL). The resulting mixture was neutralized with saturated aqueous NaHCO<sub>3</sub> solution and extracted with AcOEt (2 × 50 mL). The combined extracts were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Di-<i>tert</i>-butyl dicarbonate (4.02 g, 18.4 mmol) and THF (42 mL) were added to the residue, and the reaction mixture was stirred at room temperature for 6 h. To the reaction mixture were added AcOEt (30 mL) and water (100 mL). The organic layer was separated, and the aqueous layer was extracted with AcOEt (2 × 20 mL). The combined extracts were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Flash chromatography (hexane/AcOEt = 95:5 → 4:1) of the residue gave <b>31</b> (4.00 g, 63%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 1.08 (br, 3H), 1.46 (s, 9H), 3.78 (s, 3H), 3.79–3.85 (m, 1H), 4.01 (d, <i>J</i> = 6.7 Hz, 2H), 4.53–4.57 (m, 1H), 4.77 (dd, <i>J</i> = 13.4 Hz, 9.2 Hz, 1H), 4.85 (dd, <i>J</i> = 13.4 Hz, 5.5 Hz, 1H), 5.11 (br, 1H), 6.85 (d, <i>J</i> = 8.6 Hz, 2H), 7.10 (d, <i>J</i> = 8.6 Hz, 2H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 383 (M<sup>+</sup> + H). HRMS (ESI<sup>+</sup>) for C<sub>18</sub>H<sub>27</sub>N<sub>2</sub>O<sub>7</sub> (M<sup>+</sup> + H): calcd, 383.18183; found, 383.18131. IR (ATR) cm<sup>–1</sup>: 3401, 1732, 1697.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (−)-<i>tert</i>-Butyl [4-(4-Methoxyphenyl)-2-oxopyrrolidin-3-yl]carbamate (<b>32</b>) and (+)-<i>tert</i>-Butyl [4-(4-Methoxyphenyl)-2-oxopyrrolidin-3-yl]carbamate (<b>33</b>)</h3><div class="NLM_p">To a mixture of <b>31</b> (4.00 g, 10.5 mmol) and nickel(II) chloride hexahydrate (2.50 g, 10.5 mmol) in MeOH (210 mL) was added portionwise NaBH<sub>4</sub> (2.38 g, 63.0 mmol) under cooling with ice. The mixture was stirred at room temperature for 45 min and then at 40 °C for 2 h. The reaction mixture was poured into saturated aqueous NH<sub>4</sub>Cl solution, and the resulting mixture was extracted with AcOEt (500 mL). The extract was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and then concentrated in vacuo. Flash chromatography (hexane/AcOEt = 3:2) of the residue gave the racematic <i>tert</i>-butyl [4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]carbamate (2.68 g). Chiral separation of the racemate by HPLC using CHIRALPAK AD column (hexane/EtOH/<i>tert</i>-butyl methyl ether = 45:30:25) gave <b>32</b> (1.14 g, 35%) and <b>33</b> (1.40 g, 43%).</div><div class="NLM_p"><b>32</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.37 (s, 9H), 3.55 (d, <i>J</i> = 9.8 Hz, 1H), 3.80 (s, 3H), 3.82–3.92 (m, 2H), 4.58 (br s, 2H), 5.75 (br s, 1H), 6.83 (d, <i>J</i> = 8.6 Hz, 2H), 7.10 (d, <i>J</i> = 8.6 Hz, 2H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 307 (M<sup>+</sup> + H). HRMS (ESI<sup>+</sup>) for C<sub>16</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub> (M<sup>+</sup> + H): calcd, 307.16578; found, 307.16561. IR (ATR) cm<sup>–1</sup>: 3363, 3287, 1708, 1684. [α]<sup>22</sup><sub>D</sub> −88.2 (<i>c</i> 0.104, EtOH).</div><div class="NLM_p last"><b>33</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.37 (s, 9H), 3.56 (d, <i>J</i> = 9.8 Hz, 1H), 3.80 (s, 3H), 3.82–3.97 (m, 2H), 4.58 (br s, 2H), 5.73 (br s, 1H), 6.83 (d, <i>J</i> = 8.6 Hz, 2H), 7.10 (d, <i>J</i> = 8.6 Hz, 2H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 307 (M<sup>+</sup> + H). HRMS (ESI<sup>+</sup>) for C<sub>16</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub> (M<sup>+</sup> + H): calcd, 307.16578; found, 307.16615. IR (ATR) cm<sup>–1</sup>: 3363, 3287, 1708, 1684. [α]<sup>22</sup><sub>D</sub> +98.4 (<i>c</i> 0.101, EtOH).</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (−)-1-(4-Chlorophenyl)-3-[<i>cis</i>-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]urea (<b>8</b>)</h3><div class="NLM_p last">Trifluoroacetic acid (0.5 mL) was added to a solution of <b>32</b> (42.9 mg, 0.140 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) at 0 °C, and the mixture was stirred at room temperature for 75 min. After concentration of the reaction mixture in vacuo, a mixture of the residue, saturated aqueous NaHCO<sub>3</sub>, THF (1 mL), and 4-chlorophenyl isocyanate (23.6 mg, 0.154 mmol) was stirred at room temperature for 1 h. To the reaction mixture was added 4-chlorophenyl isocyanate (11 mg, 0.070 mmol), and the mixture was stirred at room temperature for 40 min and concentrated in vacuo. Flash chromatography of the residue (CHCl<sub>3</sub>/MeOH = 10:1) gave <b>8</b> (28.0 mg, 56%) as a white powder. Mp: 212–214 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.25–3.31 (m, 1H), 3.68–3.72 (m, 5H), 4.59 (t, <i>J</i> = 7.3 Hz, 1H), 5.81 (d, <i>J</i> = 6.7 Hz, 1H), 6.83–6.87 (m, 2H), 7.03–7.06 (m, 2H), 7.21–7.25 (m, 2H), 7.30–7.34 (m, 2H), 8.10 (s, 1H), 8.74 (s, 1H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 360 (M<sup>+</sup> + H). HRMS (ESI<sup>+</sup>) for C<sub>18</sub>H<sub>19</sub>ClN<sub>3</sub>O<sub>3</sub> (M<sup>+</sup> + H): calcd, 360.11149; found, 360.11194. IR (ATR) cm<sup>–1</sup>: 3301, 1664. Enantiomeric excess was determined by HPLC analysis with CHIRALPAK ID column (30:70 hexane:EtOH, 1.0 mL/mim, 254 nm); major enantiomer <i>t</i><sub>r</sub> = 11.2 min; 100% ee; [α]<sup>25</sup><sub>D</sub> −260 (<i>c</i> 0.101, EtOH). HPLC purity 100%</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (+)-1-(4-Chlorophenyl)-3-[<i>cis</i>-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]urea (<b>9</b>)</h3><div class="NLM_p last">Compound <b>9</b> (26.6 mg, 56%) was prepared from <b>33</b> (40.3 mg, 0.132 mmol) by the same method as that used for <b>8</b>. White powder. Mp: 211–214 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.25–3.31 (m, 1H), 3.68–3.72 (m, 5H), 4.59 (t, <i>J</i> = 7.3 Hz, 1H), 5.81 (d, <i>J</i> = 7.3 Hz, 1H), 6.83–6.87 (m, 2H), 7.03–7.06 (m, 2H), 7.21–7.25 (m, 2H), 7.30–7.34 (m, 2H), 8.10 (s, 1H), 8.74 (s, 1H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 360 (M<sup>+</sup> + H). HRMS (ESI<sup>+</sup>) for C<sub>18</sub>H<sub>19</sub>ClN<sub>3</sub>O<sub>3</sub> (M<sup>+</sup> + H): calcd, 360.11149; found, 360.11186. IR (ATR) cm<sup>–1</sup>: 3304, 1684, 1666. Enantiomeric excess was determined by HPLC analysis with CHIRALPAK ID column (30:70 hexane:EtOH, 1.0 mL/mim, 254 nm); major enantiomer <i>t</i><sub>r</sub> = 12.5 min; 100% ee; [α]<sup>25</sup><sub>D</sub> +235 (<i>c</i> 0.104, EtOH). HPLC purity 99.9%.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Methyl (3<i>R</i>,4<i>S</i>)-4-(4-Methoxyphenyl)-2-oxopyrrolidine-3-carboxylate (<b>35</b>)</h3><div class="NLM_p">To a solution of <b>21</b> (12.0 g, 64.3 mmol) in toluene (64 mL) was added dimethyl malonate (7.50 mL, 64.3 mmol) and nickel(II)-bis[(<i>R</i>,<i>R</i>)-<i>N</i>,<i>N</i>′-dibenzylcyclohexan-1,2-diamine]bromide (1.56 g, 1.93 mmol), and the mixture was stirred at room temperature for 28 h. The reaction mixture was washed with 0.1 M HCl (50 mL) and water (50 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and then concentrated in vacuo to give dimethyl (<i>S</i>)-2-[1-(4-methoxyphenyl)-2-nitroethyl]malonate (<b>34</b>) as a white solid. To a mixture of crude <b>34</b> and nickel(II) chloride hexahydrate (17.2 g, 70.7 mmol) in MeOH (322 mL) was added portionwise NaBH<sub>4</sub> (14.9 g, 386 mmol) under cooling with ice, and then the mixture was stirred at room temperature for 2.5 h. To the reaction mixture was added saturated aqueous NH<sub>4</sub>Cl (800 mL) and AcOEt (1200 mL) under cooling with ice, and the mixture was stirred at room temperature for 2 h, and then the organic layer was separated. The organic layer was washed with saturated aqueous NH<sub>4</sub>Cl (500 mL), water (500 mL), and brine (500 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Trituration of the residue with EtOH–diisopropyl ether gave <b>35</b> (11.6 g, 73%) as a white solid.</div><div class="NLM_p"><b>34</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 3.58 (s, 3H), 3.76 (s, 3H), 3.78 (s, 3H), 3.83 (d, <i>J</i> = 9.1 Hz, 1H), 4.19 (dt, <i>J</i> = 9.1, 4.8 Hz, 1H), 4.83 (dd, <i>J</i> = 12.7, 9.1 Hz, 1H), 4.89(dd, <i>J</i> = 12.7, 4.8 Hz, 1H), 6.82–6.86 (m, 2H), 7.13–7.16 (m, 2H). Enantiomeric excess was determined by HPLC analysis with CHIRALPAK ID column (90:10 hexane:EtOH, 1.0 mL/mim, 254 nm); minor enantiomer <i>t</i><sub>r</sub> = 21.5 min, major enantiomer <i>t</i><sub>r</sub> = 19.8 min; 92.4% ee; [α]<sup>25</sup><sub>D</sub> +5.33 (<i>c</i> 1.121, CHCl<sub>3</sub>).</div><div class="NLM_p last"><b>35</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 3.40 (t, <i>J</i> = 8.5 Hz, 1H), 3.54 (d, <i>J</i> = 9.7 Hz, 1H), 3.71–3.74 (m, 1H), 3.78 (s, 3H), 3.80 (s, 3H), 4.09 (q, <i>J</i> = 8.5 Hz, 1H), 5,72 (br s, 1H), 6.86–6.90 (m, 2H), 7.17–7.20 (m, 2H). MS (FI<sup>+</sup>) <i>m</i>/<i>z</i>: 249 (M<sup>+</sup>). HRMS (FI<sup>+</sup>) for C<sub>13</sub>H<sub>15</sub>NO<sub>4</sub> (M<sup>+</sup>): calcd, 249.10011; found, 249.10051. IR (ATR) cm<sup>–1</sup>: 3226, 1718, 1693. Enantiomeric excess was determined by HPLC analysis with CHIRALPAK ID column (80:20 hexane:EtOH, 1.0 mL/mim, 254 nm); minor enantiomer <i>t</i><sub>r</sub> = 14.4 min, major enantiomer <i>t</i><sub>r</sub> = 17.0 min; 99.1% ee; [α]<sup>25</sup><sub>D</sub> +154 (<i>c</i> 0.164, EtOH).</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (3<i>R</i>,4<i>S</i>)-4-(4-Methoxyphenyl)-2-oxopyrrolidine-3-carboxylic Acid (<b>36</b>)</h3><div class="NLM_p last">To a solution of <b>35</b> (200 mg, 0.802 mmol) in MeOH (4.0 mL) was added 2 M NaOH solution (0.80 mL, 1.6 mmol), and the mixture was stirred at 60 °C for 1.5 h. After addition of 1 M HCl (1.8 mL) to the reaction mixture, water (25 mL) was added, and the mixture was extracted with AcOEt (2 × 35 mL). The combined extracts were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to give <b>36</b> (166 mg, 88%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.16 (t, <i>J</i> = 9.1 Hz, 1H), 3.41 (br d, 1H), 3.55 (t, <i>J</i> = 8.5 Hz, 1H), 3.72 (s, 3H), 3.79 (q, <i>J</i> = 8.5 Hz, 1H), 6.88 (d, <i>J</i> = 8.5 Hz, 2H), 7.24 (d, <i>J</i> = 8.5 Hz, 2H), 8.01 (s, 1H), 12.6 (br s, 1H). MS (FD<sup>+</sup>) <i>m</i>/<i>z</i>: 235 (M<sup>+</sup>). HRMS (FD<sup>+</sup>) for C<sub>12</sub>H<sub>13</sub>NO<sub>4</sub> (M<sup>+</sup>): calcd, 235.08446; found, 235.08379. IR (ATR) cm<sup>–1</sup>: 3239, 1686. [α]<sup>25</sup><sub>D</sub> +146 (<i>c</i> 0.192, EtOH).</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 1-(4-Chlorophenyl)-3-[(3<i>R</i>,4<i>S</i>)-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]urea (<b>10</b>)</h3><div class="NLM_p last">To a mixture of <b>36</b> (80.0 mg, 0.340 mmol) in toluene (1.7 mL) were added triethylamine (61.9 μL, 0.442 mmol) and diphenyphosphoryl azide (80.6 μL, 0.374 mmol), and the mixture was stirred at room temperature for 4.5 h and then at 60 °C for 45 min. To the reaction mixture was added 4-chloroaniline (87.6 μL, 0.680 mmol), and the mixture was stirred at 90 °C for 2.5 h. AcOEt (3.0 mL) and 1 mol/L HCl (2.0 mL) were added to the reaction mixture, and the organic layer was separated. The organic layer was washed with 1 M HCl, saturated aqueous NaHCO<sub>3</sub> solution, and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Flash chromatography (AcOEt → AcOEt/MeOH = 20:1) of the residue gave <b>10</b> (65 mg, 53%) as a white powder. Mp: 191–193 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.13–3.20 (m, 1H), 3.42–3.50 (m, 2H), 3.72 (s, 3H), 4.47 (dd, <i>J</i> = 10.9, 9.1 Hz, 1H), 6.49 (d, <i>J</i> = 9.1 Hz, 1H), 6.86–6.90 (m, 2H), 7.22–7.26 (m, 2H), 7.28–7.32 (m, 2H), 7.37–7.41 (m, 2H), 7.92 (s, 1H), 8.70 (s, 1H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 360 (M<sup>+</sup> + H). HRMS (ESI<sup>+</sup>) for C<sub>18</sub>H<sub>19</sub>ClN<sub>3</sub>O<sub>3</sub> (M<sup>+</sup> + H): calcd, 360.11149; found, 360.11120. IR (ATR) cm<sup>–1</sup>: 3303, 1664. Enantiomeric excess was determined by HPLC analysis with CHIRALPAK ID column (50:50 hexane:EtOH, 1.0 mL/mim, 254 nm); minor enantiomer <i>t</i><sub>r</sub> = 7.1 min, major enantiomer <i>t</i><sub>r</sub> = 11.0 min; 99.9% ee; [α]<sup>25</sup><sub>D</sub> +145 (<i>c</i> 0.298, EtOH). HPLC purity 99.5%.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Methyl (3<i>S</i>,4<i>R</i>)-4-(4-Methoxyphenyl)-2-oxopyrrolidine-3-carboxylate (<b>38</b>)</h3><div class="NLM_p">Compound <b>38</b> (19.2 g, 68%) was prepared from <b>21</b> (20.0 g, 112 mmol) and nickel(II)-bis[(<i>S</i>,<i>S</i>)-<i>N</i>,<i>N</i>′-dibenzylcyclohexan-1,2-diamine]bromide (2.56 g, 3.28 mmol) by the same method as that used for <b>35</b>.</div><div class="NLM_p"><b>37</b>. White solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 3.57 (s, 3H), 3.76 (s, 3H), 3.78 (s, 3H), 3.83 (d, <i>J</i> = 9.1 Hz, 1H), 4.19 (d t, <i>J</i> = 9.1, 5.4 Hz, 1H), 4.82 (dd, <i>J</i> = 13.3, 9.1 Hz, 1H), 4.89 (dd, <i>J</i> = 13.3, 5.5 Hz, 1H), 6.82–6.86 (m, 2H), 7.12–7.16 (m, 2H). Enantiomeric excess was determined by HPLC analysis with CHIRALPAK ID column (90:10 hexane:EtOH, 1.0 mL/mim, 254 nm); minor enantiomer <i>t</i><sub>r</sub> = 20.4 min, major enantiomer <i>t</i><sub>r</sub> = 21.9 min; 92.5% ee; [α]<sup>25</sup><sub>D</sub> −7.25 (<i>c</i> 1.230, CHCl<sub>3</sub>).</div><div class="NLM_p last"><b>38</b>. Pale brown solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 3.40 (t, <i>J</i> = 9.1 Hz, 1H), 3.54 (d, <i>J</i> = 10.3 Hz, 1H), 3.76–3.80 (s × 2 + m, total 7H), 4.09 (q, <i>J</i> = 8.5 Hz, 1H), 5,75 (br s, 1H), 6.86–6.90 (m, 2H), 7.17–7.20 (m, 2H). MS (FI<sup>+</sup>) <i>m</i>/<i>z</i>: 249 (M<sup>+</sup>). HRMS (FI<sup>+</sup>) for C<sub>13</sub>H<sub>15</sub>NO<sub>4</sub> (M<sup>+</sup>): calcd, 249.10011; found, 249.09991. IR (ATR) cm<sup>–1</sup>: 3226, 1738, 1718, 1692. Enantiomeric excess was determined by HPLC analysis with CHIRALPAK ID column (80:20 hexane:EtOH, 1.0 mL/mim, 254 nm); minor enantiomer <i>t</i><sub>r</sub> = 16.3 min, major enantiomer <i>t</i><sub>r</sub> = 13.6 min; 99.1% ee; [α]<sup>25</sup><sub>D</sub> −145 (<i>c</i> 0.187, EtOH).</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (3<i>S</i>,4<i>R</i>)-4-(4-Methoxyphenyl)-2-oxopyrrolidine-3-carboxylic Acid (<b>39</b>)</h3><div class="NLM_p last">Compound <b>39</b> (1.85 g, 98%) was prepared from <b>38</b> (2.00 g, 8.02 mmol) by the same method as that used for <b>36</b>. Pale brown solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.16 (t, <i>J</i> = 9.1 Hz, 1H), 3.42 (d, <i>J</i> = 10.9 Hz, 1H), 3.55 (t, <i>J</i> = 8.5 Hz, 1H), 3.72 (s, 3H), 3.79 (q, <i>J</i> = 9.1 Hz, 1H), 6.88 (d, <i>J</i> = 8.5 Hz, 2H), 7.24 (d, <i>J</i> = 9.1 Hz, 2H), 8.03 (s, 1H), 12.5 (br s, 1H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 236 (M<sup>+</sup> + H). HRMS (ESI<sup>+</sup>) for C<sub>12</sub>H<sub>14</sub>NO<sub>4</sub> (M<sup>+</sup> + H): calcd, 236.09228; found, 236.09242. IR (ATR) cm<sup>–1</sup>: 3240, 1686. [α]<sup>26</sup><sub>D</sub> −139 (<i>c</i> 0.148, EtOH).</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 1-(4-Chlorophenyl)-3-[(3<i>S</i>,4<i>R</i>)-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]urea (<b>11a</b>)</h3><div class="NLM_p last">Compound <b>11a</b> (40 mg, 24%) was prepared from <b>39</b> (110 mg, 0.47 mmol) by the same method as that used for <b>10</b>. White powder. Mp: 192–195 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.13–3.20 (m, 1H), 3.43–3.50 (m, 2H), 3.72 (s, 3H), 4.48 (dd, <i>J</i> = 10.9, 9.1 Hz, 1H), 6.47 (d, <i>J</i> = 9.1 Hz, 1H), 6.86–6.90 (m, 2H), 7.22–7.26 (m, 2H), 7.28–7.32 (m, 2H), 7.37–7.41 (m, 2H), 7.92 (s, 1H), 8.68 (s, 1H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 360 (M<sup>+</sup> + H). HRMS (ESI<sup>+</sup>) for C<sub>18</sub>H<sub>19</sub>ClN<sub>3</sub>O<sub>3</sub> (M<sup>+</sup> + H): calcd, 360.11149; found, 360.11076. IR (ATR) cm<sup>–1</sup>: 3333, 1669. Enantiomeric excess was determined by HPLC analysis with CHIRALPAK ID column (50:50 hexane:EtOH, 1.0 mL/mim, 254 nm); minor enantiomer <i>t</i><sub>r</sub> = 11.1 min, major enantiomer <i>t</i><sub>r</sub> = 7.1 min; 99.7% ee; [α]<sup>28</sup><sub>D</sub> −130 (<i>c</i> 0.101, EtOH). HPLC purity 97.4%.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 1-(4-Fluorophenyl)-3-[(3<i>S</i>,4<i>R</i>)-4-(4-methoxyphenyl)-2-oxopyrrolidin-3-yl]urea (<b>11b</b>)</h3><div class="NLM_p last">Compound <b>11b</b> (44 mg, 18%) was prepared from <b>39</b> (170 mg, 0.773 mmol) and 4-fluoroaniline (140 μL, 1.45 mmol) by the same method as that used for <b>10</b>. White powder. Mp: 203–204 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.13–3.20 (m, 1H), 3.42–3.50 (m, 2H), 3.72 (s, 3H), 4.47 (dd, <i>J</i> = 10.9, 9.1 Hz, 1H), 6.41 (d, <i>J</i> = 8.5 Hz, 1H), 6.86–6.90 (m, 2H), 7.01–7.07 (m, 2H), 7.28–7.32 (m, 2H), 7.33–7.39 (m, 2H), 7.91 (s, 1H), 8.55 (s, 1H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 344 (M<sup>+</sup> + H). HRMS (ESI<sup>+</sup>) for C<sub>18</sub>H<sub>19</sub>FN<sub>3</sub>O<sub>3</sub> (M<sup>+</sup> + H): calcd, 344.14104; found, 344.14061. IR (ATR) cm<sup>–1</sup>: 3345, 1673. [α]<sup>28</sup><sub>D</sub> −156 (<i>c</i> 0.100, EtOH). HPLC purity: 99.6%.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (<i>E</i>)-2.6-Difluoro-4-methoxyl-(2-nitrovinyl)benzene (<b>41</b>)</h3><div class="NLM_p last">Ammonium acetate (11.2 g, 145 mmol) and nitromethane (22.9 mL, 427 mmol) were added to a solution of <b>40</b> (14.7 g, 85.4 mmol) in acetic acid (85 mL). The mixture was stirred at 100 °C for 6 h and concentrated in vacuo. Water (50 mL) was added to the residue, and the resulting precipitates were collected by filtration. The precipitates were washed with water and dried in vacuo to give <b>41</b> (17.5 g, 95%) as a yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 3.87 (s, 3H), 6.56 (d, <i>J</i> = 10.3 Hz, 2H), 7.77 (d, <i>J</i> = 13.9 Hz, 1H), 8.11 (d, <i>J</i> = 13.9 Hz, 1H). MS (EI<sup>+</sup>) <i>m</i>/<i>z</i>: 215 (M<sup>+</sup>). HRMS (EI<sup>+</sup>) for C<sub>9</sub>H<sub>7</sub>F<sub>2</sub>NO<sub>3</sub> (M<sup>+</sup>): calcd, 215.03940; found, 215.03889. IR (ATR) cm<sup>–1</sup>: 1624, 1571, 1509.</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Dimethyl (<i>R</i>)-[1-(2,6-Difluoro-4-methoxyphenyl)-2-nitroethyl]malonate (<b>42</b>)</h3><div class="NLM_p last">Compound <b>42</b> (22.5 g, 95%) was prepared from <b>41</b> (14.7 g, 68.3 mmol) by the same method as that used for <b>37</b>. White solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 3.57 (s, 3H), 3.77 (s, 3H), 3.80 (s, 3H), 3.92 (d, <i>J</i> = 10.4 Hz, 1H), 4.66 (dt, <i>J</i> = 9.8, 4.9 Hz, 1H), 4.81 (dd, <i>J</i> = 12.8, 9.8 Hz, 1H), 4.91 (dd, <i>J</i> = 12.8, 4.9 Hz, 1H), 6.41–6.47 (m, 2H). MS (FI<sup>+</sup>) <i>m</i>/<i>z</i>: 347 (M<sup>+</sup>). HRMS (FI<sup>+</sup>) for C<sub>14</sub>H<sub>15</sub>F<sub>2</sub>NO<sub>7</sub> (M<sup>+</sup>): calcd, 347.08166; found, 347.082160. IR (ATR) cm<sup>–1</sup>: 1726, 1551. [α]<sup>24</sup><sub>D</sub> −25.0 (<i>c</i> 0.106, EtOH).</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Methyl (3<i>S</i>,4<i>R</i>)-4-(2.6-Difluoro-4-methoxyphenyl)-2-oxopyrrolidine-3-carboxylate (<b>43</b>)</h3><div class="NLM_p last">Compound <b>43</b> (10.5 g, 55%) was prepared from <b>42</b> (23.3 g, 67.0 mmol) by the same method as that used for <b>38</b>. White solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 3.51 (t, <i>J</i> = 9.2 Hz, 1H), 3.67 (dt, <i>J</i> = 9.2, 1.2 Hz, 1H), 3.78–3.81 (m, 7H), 4.46 (q, <i>J</i> = 9.2 Hz, 1H), 6.24 (br, 1H), 6.47 (d, <i>J</i> = 10.4 Hz, 2H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 286 (M<sup>+</sup> + H). HRMS (ESI<sup>+</sup>) for C<sub>13</sub>H<sub>14</sub>F<sub>2</sub>NO<sub>4</sub> (M<sup>+</sup> + H): calcd, 286.08909; found, 286.08922. IR (ATR) cm<sup>–1</sup>: 3219, 1742, 1706. [α]<sup>24</sup><sub>D</sub> −120 (<i>c</i> 0.106, EtOH).</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (3<i>S</i>,4<i>R</i>)-4-(2,6-Difluoro-4-methoxyphenyl)-2-oxopyrrolidine-3-carboxylic Acid (<b>44</b>)</h3><div class="NLM_p last">Compound <b>44</b> (9.85 g, 100%) was prepared from <b>43</b> (10.4 g, 36.4 mmol) by the same method as that used for <b>39</b>. White solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.25 (t, <i>J</i> = 9.2 Hz, 1H), 3.43 (d, <i>J</i> = 10.4 Hz, 1H), 3.56 (t, <i>J</i> = 9.2 Hz, 1H), 3.76 (s, 3H), 4.14 (q, <i>J</i> = 9.2 Hz, 1H), 6.73–6.79 (m, 2H), 8.20 (s, 1H), 12.8 (br, 1H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 272 (M<sup>+</sup> + H). HRMS (ESI<sup>+</sup>) for C<sub>12</sub>H<sub>12</sub>F<sub>2</sub>NO<sub>4</sub> (M<sup>+</sup> + H): calcd, 272.07344; found, 272.07428. IR (ATR) cm<sup>–1</sup>: 3263, 1726, 1638. [α]<sup>23</sup><sub>D</sub> −121 (<i>c</i> 0.100, EtOH).</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Benzyl [(3<i>S</i>,4<i>R</i>)-4-(2,6-Difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]carbamate (<b>45</b>)</h3><div class="NLM_p last">To a solution of <b>44</b> (3.00 g, 11.1 mmol) in toluene (157 mL) and MeCN (42 mL) were added triethylamine (1.70 mL, 12.2 mmol) and diphenylphosphoryl azide (3.00 mL, 13.4 mmol), and the mixture was stirred at room temperature for 2 h. Benzyl alcohol (5.70 mL, 55.1 mmol) was added to the reaction mixture, and the mixture was stirred at 80 °C for 30 min and then 110 °C for 2 h. After removal of MeCN in vacuo, the resulting mixture was washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. A mixture of the residue and benzyl alcohol (11.3 mL, 109 mmol) was stirred at 110 °C for 23 h. Flash chromatography (hexane/AcOEt = 4:1 → 1:1 → AcOEt) of the resulting mixture gave <b>45</b> (1.93 g, 47%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 3.48–3.62 (m, 2H), 3.79 (s, 3H), 3.80–3.96 (m, 1H), 4.67–4.75 (m, 1H), 5.05 (s, 2H), 5.37 (br d, 1H), 6.46 (br d, 2H), 6.60 (s, 1H), 7.26–7.36 (m, 5H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 377 (M<sup>+</sup> + H). HRMS (ESI<sup>+</sup>) for C<sub>19</sub>H<sub>19</sub>F<sub>2</sub>N<sub>2</sub>O<sub>4</sub> (M<sup>+</sup> + H): calcd, 377.13129; found, 377.13184. [α]<sup>24</sup><sub>D</sub> −107 (<i>c</i> 0.102, EtOH).</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (3<i>S</i>,4<i>R</i>)-3-Amino-4-(2,6-difluoro-4-methoxyphenyl)pyrrolidin-2-one (<b>46</b>)</h3><div class="NLM_p last">A suspension of <b>45</b> (811 mg, 2.15 mmol) and 10% Pd–C (wetted with ∼55% water, 81.0 mg) in EtOH (30 mL) was stirred at room temperature for 2 h under H<sub>2</sub> atmosphere. After the insoluble materials were filtered off, the filtrate was concentrated in vacuo. Flash chromatography (hexane/AcOEt = 1:1 → AcOEt → AcOEt/MeOH = 5:1) of the residue gave <b>46</b> (525 mg, 100%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 1.78 (br s, 2H), 3.22 (t, <i>J</i> = 8.6 Hz, 1H), 3.34–3.48 (m, 3H), 3.76 (s, 3H), 6.74 (d, <i>J</i> = 11.0 Hz, 2H), 7.88 (br s, 1H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 243 (M<sup>+</sup> + H). HRMS (ESI<sup>+</sup>) for C<sub>11</sub>H<sub>13</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (M<sup>+</sup> + H): calcd, 243.09451; found, 243.09492. [α]<sup>24</sup><sub>D</sub> −90.1 (<i>c</i> 0.110, EtOH).</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 1-[(3<i>S</i>,4<i>R</i>)-4-(2,6-Difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-3-(4-fluorophenyl)urea (<b>12g</b>)</h3><div class="NLM_p last">To a mixture of <b>44</b> (3.00 g, 11.1 mmol), toluene (110 mL), and MeCN (30 mL) were added triethylamine (1.69 mL, 12.2 mmol) and diphenyphosphoryl azide (2.72 mL, 12.2 mmol), and the mixture was stirred at room temperature for 1 h and then at 80 °C for 30 min. To the reaction mixture was added 4-fluoroaniline (2.11 mL, 22.0 mmol), and the mixture was stirred at 110 °C for 2 h. After cooling to room temperature, the reaction mixture was concentrated in vacuo. To the residue was added 1 M HCl, and the mixture was extracted with AcOEt. The extract was washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Flash chromatography (hexane/AcOEt = 1:1 → AcOEt → AcOEt/MeOH = 95:5) of the residue gave <b>12g</b> (2.29 g, 55%) as a white powder. Mp: 194–197 °C <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.31 (t, <i>J</i> = 9.7 Hz, 1H), 3.45 (t, <i>J</i> = 9.1 Hz, 1H), 3.76 (s, 3H), 3.80 (q, <i>J</i> = 10.9 Hz, 1H), 4.58 (dd, <i>J</i> = 10.9 8.5 Hz, 1H), 6.47 (d, <i>J</i> = 7.9 Hz, 1H), 6.75 (d, <i>J</i> = 10.3 Hz, 2H), 6.99–7.06 (m, 2H), 7.31–7.37 (m, 2H), 8.07 (s, 1H), 8.68 (s, 1H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 380 (M<sup>+</sup> + H). HRMS (ESI<sup>+</sup>) for C<sub>18</sub>H<sub>17</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub> (M<sup>+</sup> + H): calcd, 380.12220; found, 380.12171. IR (ATR) cm<sup>–1</sup>: 3316, 1711, 1638. [α]<sup>28</sup><sub>D</sub> −156 (<i>c</i> 0.101, EtOH). HPLC purity 99.4%.</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 1-[(3<i>S</i>,4<i>R</i>)-4-(2,6-Difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-3-phenylurea (<b>13c</b>)</h3><div class="NLM_p last">A mixture of <b>46</b> (74.3 mg, 0.306 mmol) and phenyl isocyanate (33.0 μL, 0.306 mmol) in THF (3.1 mL) was stirred at room temperature for 15 min and concentrated in vacuo. Flash chromatography (hexane/AcOEt = 4:1 → AcOEt) of the residue gave <b>13c</b> (83.8 mg, 76%) as a white powder. Mp: 211–213 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.31 (t, <i>J</i> = 9.1 Hz 1H), 3.46 (t, <i>J</i> = 9.1 Hz, 1H), 3.76 (s, 3H), 3.80 (q, <i>J</i> = 9.1 Hz, 1H), 4.58 (dd, <i>J</i> = 10.9, 8.5 Hz, 1H), 6.47 (d, <i>J</i> = 8.5 Hz, 1H), 6.75 (d, <i>J</i> = 10.9 Hz, 2H), 6.85–6.89 (m, 1H), 7.16–7.27 (m, 2H), 7.31–7.35 (m, 2H), 8.07 (s, 1H), 8.63 (s, 1H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 362 (M<sup>+</sup> + H). HRMS (ESI<sup>+</sup>) for C<sub>18</sub>H<sub>18</sub>F<sub>2</sub>N<sub>3</sub>O<sub>3</sub> (M<sup>+</sup> + H): calcd, 362.13162; found, 362.13145. IR (ATR) cm<sup>–1</sup>: 3315, 1709, 1638. [α]<sup>27</sup><sub>D</sub> −162 (<i>c</i> 0.103, EtOH). HPLC purity 98.1%.</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 1-[(3<i>S</i>,4<i>R</i>)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-3-(3,4-difluorophenyl)urea (<b>13i</b>)</h3><div class="NLM_p last">Compound <b>13i</b> (56.6 mg, 86%) was prepared from <b>46</b> (40.0 mg, 0.165 mmol) and 3,4-difluorophenyl isocyanate (20.0 μL, 0.165 mmol) by the same method as that used for <b>13c</b>. White amorphous solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.31 (t, <i>J</i> = 9.7 Hz, 1H), 3.46 (t, <i>J</i> = 9.1 Hz, 1H), 3.76 (s, 3H), 3.82 (q, <i>J</i> = 9.7 Hz, 1H), 4.57 (dd, <i>J</i> = 10.9, 8.5 Hz, 1H), 6.59 (d, <i>J</i> = 8.5 Hz, 1H), 6.75 (d, <i>J</i> = 10.9 Hz, 2H), 6.99–7.04 (m, 1H), 7.22–7.29 (m, 1H), 7.54 (ddd, <i>J</i> = 10.3, 7.9, 3.0 Hz, 1H), 8.08 (s, 1H), 8.90 (s, 1H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 398 (M<sup>+</sup> + H). HRMS (ESI<sup>+</sup>) for C<sub>18</sub>H<sub>16</sub>F<sub>4</sub>N<sub>3</sub>O<sub>3</sub> (M<sup>+</sup> + H): calcd, 398.11278; found, 398.11214. IR (ATR) cm<sup>–1</sup>: 3303, 1666, 1638. [α]<sup>27</sup><sub>D</sub> −138 (<i>c</i> 0.100, EtOH). HPLC purity 99.5%.</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 1-[(3<i>S</i>,4<i>R</i>)-4-(2,6-Difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-3-(3-hydroxy-4-methylphenyl)urea (<b>13l</b>)</h3><div class="NLM_p last">Compound <b>13l</b> (105 mg, 65%) was prepared from <b>44</b> (130 mg, 0.387 mmol) and 5-amino-2-methylphenol (95.0 mg, 0.771 mmol) by the same method as that used for <b>12g</b>. White amorphous solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 1.99 (s, 3H), 3.30 (t, <i>J</i> = 9.7 Hz, 1H), 3.45 (t, <i>J</i> = 9.7 Hz, 1H), 3.72–3.80 (m, 4H), 4.58 (dd, <i>J</i> = 10.9, 8.5 Hz, 1H), 6.32 (d, <i>J</i> = 8.5 Hz, 1H), 6.56 (dd, <i>J</i> = 7.9, 2.4 Hz, 1H), 6.74 (d, <i>J</i> = 10.9 Hz, 2H), 6.83 (d, <i>J</i> = 8.5 Hz, 1H), 6.99 (d, <i>J</i> = 2.4 Hz, 1H), 8.07 (s, 1H), 8.41 (s, 1H), 9.10 (s, 1H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 392 (M<sup>+</sup> + H). HRMS (ESI<sup>+</sup>) for C<sub>19</sub>H<sub>20</sub>F<sub>2</sub>N<sub>3</sub>O<sub>4</sub> (M<sup>+</sup> + H): calcd, 392.14219; found, 392.14299. IR (ATR) cm<sup>–1</sup>: 3302, 1638. [α] <sup>25</sup><sub>D</sub> −151 (<i>c</i> 0.151, EtOH). HPLC purity 97.9%.</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 1-(5-Chlorothiophen-2-yl)-3-[(3<i>S</i>,4<i>R</i>)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]urea (<b>13n</b>)</h3><div class="NLM_p last">To a mixture of 2-chlorothiophene-5-carboxylic acid (60.0 mg, 0.369 mmol) and triethylamine (51.0 μL, 0.369 mmol) in toluene (3.7 mL) was added diphenylphosphoryl azide (83.0 μL, 0.369 mmol), and the mixture was stirred at 40 °C for 1 h, 50 °C for 1 h, and then at 100 °C for 1 h. After addition of <b>46</b> (44.8 mg, 0.185 mmol), the mixture was stirred at 100 °C for 15 min. After addition of <b>46</b> (26.6 mg, 0.110 mmol), the mixture was stirred at 100 °C for 3 h and concentrated in vacuo. Flash chromatography (hexane/AcOEt = 3:1 → AcOEt) of the residue gave <b>13n</b> (45.0 mg, 38%) as a white powder. Mp: 180–183 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.31 (t, <i>J</i> = 9.7 Hz, 1H), 3.46 (t, <i>J</i> = 9.1 Hz, 1H), 3.76 (s, 3H), 3.86 (q, <i>J</i> = 9.7 Hz, 1H), 4.54 (dd, <i>J</i> = 10.9, 8.5 Hz, 1H), 6.22 (d, <i>J</i> = 4.2 Hz, 1H), 6.72–6.79 (m, 4H), 8.08 (s, 1H), 9.95 (s, 1H). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i>: 402 (M<sup>+</sup> + H). HRMS (ESI<sup>+</sup>) for C<sub>16</sub>H<sub>15</sub>ClF<sub>2</sub>N<sub>3</sub>O<sub>3</sub>S (M<sup>+</sup> + H): calcd, 402.04907; found, 402.04877. IR (ATR) cm<sup>–1</sup>: 3275, 1713, 1664, 1638. [α]<sup>27</sup><sub>D</sub> −135 (<i>c</i> 0.105, EtOH). HPLC purity 99.8%.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Pharmacology and Biology</h3><div class="NLM_p last">Animal studies were carried out in accordance with American Association for Accreditation of Laboratory Animal Care guidelines, and protocols were approved by Bristol-Myers Squibb and University of California San Diego Animal Care and Use committees.</div></div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Calcium Mobilization Assays</h3><div class="NLM_p last">HEK293 cells were obtained from NIHS (JCRB; cell number JCRB9068) and maintained in Dulbecco’s modified Eagle medium (Thermo Fisher Scientific, Waltham, MA) supplemented with 10% heat-inactivated fetal bovine serum and 100 U/mL penicillin/streptomycin at 37 °C under 5% CO<sub>2</sub>. HEK293 cells were transfected with plasmids encoding human FPR1, human FPR2, or mouse FPR2 together with Gα15 using Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer’s protocol. After 24 h incubation, the HEK293 cells expressing FPRs/Gα15 were reseeded in Biocoat poly-<span class="smallcaps smallerCapital">d</span>-lysine 96-well plates (7 × 10<sup>4</sup> cells/well) and further incubated for an additional day. Changes in intracellular Ca<sup>2+</sup> were measured with a FlexStation III scanning fluorometer (Molecular Devices Co., Ltd.) using a Fluo-4 NW calcium assay kit (Invitrogen). Briefly, the cell culture medium was replaced with dye loading solution (90 μL/well) and incubated for 45 min at 37 °C under 5% CO<sub>2</sub>. After removal of the dye loading solution, 90 μL/well of assay buffer was added to each well, and plates were mounted in the FlexStation III. The fluorescence intensity (excitation at 485 nm and emission at 525 nm) was measured for 80 s at 1.5 s interval after adding the assay solutions including test compounds (10 μL/well) to cells. The value was quantified as the maximal peak height, which was calculated automatically by subtracting the basal value from the maximal value during each measurement. Curve fitting and calculation of EC<sub>50</sub> were performed by nonlinear regression analysis of the dose–response curves generated using Prism 4 (GraphPad Software, Inc., San Diego, CA). Compound <b>43</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) was used as an internal standard: hFPR2 EC<sub>50</sub> = 8.4 nM (SD = 7.4, <i>n</i> = 173), hFPR1 EC<sub>50</sub> = 9.0 nM (SD = 7.1, <i>n</i> = 75).</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays</h3><div class="NLM_p last">A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) was added to 384-well Proxiplates (PerkinElmer) predotted with test compounds in DMSO (1% final) at final concentrations in the range of 1.7 nM to 100 μM. Chinese hamster ovary cells (CHO) overexpressing human FPR1 or human FPR2 receptors were cultured in F-12 (Ham’s) medium supplemented with 10% qualified FBS, 250 μg/mL zeocin, and 300 μg/mL hygromycin (Life Technologies). Reactions were initiated by adding 2000 human FPR2 cells per well or 4000 human FPR1 cells per well in Dulbecco’s PBS (with calcium and magnesium) (Life Technologies) supplemented with 0.1% BSA (PerkinElmer). The reaction mixtures were incubated for 30 min at room temperature. The level of intracellular cAMP was determined using the HTRF HiRange cAMP assay reagent kit (Cisbio) according to the manufacturer’s instruction. Solutions of cryptate conjugated anti-cAMP and d2 fluororophore-labeled cAMP were made in a supplied lysis buffer separately. Upon completion of the reaction, the cells were lysed with equal volume of the d2-cAMP solution and anti-cAMP solution. After a 1 h room temperature incubation, time-resolved fluorescence intensity was measured using the Envision (PerkinElmer) at 400 nm excitation and dual emission at 590 and 665 nm. A calibration curve was constructed with an external cAMP standard at concentrations ranging from 1 μM to 0.1 pM by plotting the fluorescent intensity ratio from 665 nm emission to the intensity from the 590 nm emission against cAMP concentrations. The potency and activity of a compound to inhibit cAMP production were then determined by fitting to a four-parametric logistic equation from a plot of cAMP level versus compound concentrations. Values are an average of at least two test occasions.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Chemotaxis Assay</h3><div class="NLM_p last">HL-60 cells were differentiated for 5 days in 1.2% DMSO. Assay medium was phenol red free RPMI with 0.2% fatty acid free BSA. Approximately 1 × 10<sup>6</sup> cells were added to the upper chamber of a Transwell plate (Corning no. 3387). Migration was induced by placing chemoattractant in the bottom chamber and the dHL-60 cells in the top chamber. Following migration, dHL-60 cells in the lower chamber (migrated fraction) were quantitated using a luminescence cell viability assay (Promega, G7571).</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Phagocytosis</h3><div class="NLM_p last">Mice were injected ip with 1 mL of 2% BioGel P100 solution (BioRad, Inc.). After 4 days, the peritoneum was lavaged with PBS/2 mM EDTA. Residual BioGel particles were removed by passing the exudate through a 40 μm strainer. Cells were washed with PBS and then seeded into 96-well plates (Costar 3904) at a density of 1.2 × 10<sup>5</sup> cells/well. After 90 min, nonadherent cells were removed by washing with PBS and the macrophages were incubated overnight in Macrophage-SFM media (ThermoFisher, Inc.). Macrophages were treated with test compound for 15 min and then fed opsonized FITC labeled zymosan (1:8 ratio of cells:zymosan) for 45 min at 37 °C. Cells were washed, and extracellular fluorescence was quenched with 0.025% Trypan Blue. Phagocytosis was measured using a SpectraMAX Gemini EM plate reader (Molecular Devices, Inc.).</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Pharmacokinetic Study in Animals</h3><div class="NLM_p">Male mice (BALB/cCrSlc for oral administration, Crl:CD1(ICR) for intravenous administration), male rats (Crl:CD(SD)), male dogs (beagle), and male monkeys (cynomolgus) were used. The <b>13c</b> suspensions in 0.5% MC were orally administered. The <b>13c</b> solution in DMSO/PEG400/saline (5/47.5/47.5) was administered from the vein. The blood was collected to a microhematocrit capillary tube (EDTA 2K). After the centrifugation, the plasma samples were stored in a freezer until analysis. The plasma samples were mixed with methanol/acetonitrile (1:1) and the internal standard solution. After the centrifugation, the supernatant was mixed with purified water. The concentration of <b>13c</b> was determined by a liquid chromatography–tandem mass spectrometry (LC–MS/MS) method.</div><div class="NLM_p last">The area under the plasma concentration curve from 0 to infinity was calculated using the trapezoidal rule. Extrapolation to infinity was accomplished using the elimination rate constant (<i>k</i><sub>el</sub>) calculated from the terminal phase of the plasma concentration–time curve. The half-life (<i>t</i><sub>1/2</sub>) was calculated as ln 2/<i>k</i><sub>el</sub>. The bioavailability (BA) was determined using the equation BA = [(AUC<sub>0–inf,po</sub>/dose<sub>po</sub>)/(AUC<sub>0–-inf,iv</sub>/dose<sub>iv</sub>)] × 100.</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Metabolic Stability of <b>13c</b> in Human and Animal Liver Microsomes</h3><div class="NLM_p last">The suspension of liver microsomes with NADPH regenerating systems was preincubated at 37 °C for 5 min. By addition of <b>13c</b> standard solution, the metabolic reaction was initiated. Final concentrations of <b>13c</b> and microsomal protein were 0.1 μmol/L and 1 mg protein/mL, respectively. After the incubation at 37 °C for 0, 2, 5, 10, 15, 20, 30, and 60 min, an aliquot of the reaction mixture was mixed with methanol/acetonitrile (1/1) and the internal standard solution, followed by the centrifugation. The supernatant was diluted with purified water. An aliquot of the diluted supernatant was injected into the LC–MS/MS system to determine <b>13c</b> concentration. All procedures were run in triplicate. The elimination rate constant (<i>k</i><sub>el</sub>) was calculated from the residual ratio–time curve using five time points from 5 to 30 min. Intrinsic hepatic clearance (CL<sub>int,in vitro</sub>) was calculated using the equation CL<sub>int,in vitro</sub> ((mL/min)/mg protein) = <i>k</i><sub>el</sub> (min<sup>–1</sup>)/microsomal protein concentration (mg protein/mL).</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Metabolic Stability of <b>13c</b> in Human and Animal Hepatocytes</h3><div class="NLM_p">The suspension of hepatocytes (1 × 10<sup>6</sup> cells/mL) in Krebs–Henseleit buffer modified was preincubated at 37 °C for 5 min. By addition of <b>13c</b> standard solution to the mixture and gentle mixing, the metabolic reaction was initiated. Final concentration of <b>13c</b> was 0.1 μmol/L. After the incubation at 37 °C for 0, 1, 2, 4, and 6 h, an aliquot of the reaction mixture was mixed with methanol/acetonitrile (1/1), followed by the centrifugation. The supernatant was mixed with internal standard solution and purified water. An aliquot of the mixture was injected into the LC–MS/MS system to determine <b>13c</b> concentration. All procedures were run in duplicate.</div><div class="NLM_p last">The elimination rate constant (<i>k</i><sub>el</sub>) was calculated from the residual ratio–time curve using three time points from 0 to 2 h. Intrinsic hepatic clearance (CL<sub>int,in vitro</sub>) was calculated using the equation of CL<sub>int,in vitro</sub> (mL min<sup>–1</sup> kg<sup>–1</sup>) = <i>k</i><sub>el</sub> (h<sup>–1</sup>)/60/(hepatocytes concentration (cells/mL)/hepatocellularity numbers (cells/g liver)/liver weight (g liver/kg)).</div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Mouse Myocardial Infarction Studies</h3><div class="NLM_p last">Male C57BL/6 mice were purchased from the Jackson Laboratory and were 10–12 weeks of age at the time of surgery. Myocardial infarction was induced by permanent ligation of the left anterior descending coronary artery (LAD) using two procedures. For 28-day studies mice were anesthetized with a mixture of ketamine (100 mg/kg) and xylazine (8 mg/kg) given via the intraperitoneal route followed by oral intubation with a modified endotracheal tube. Mice were placed in a right lateral position on a circulating-water heating pad for maintenance of normal body temperature and mechanically ventilated at a tidal volume of ∼0.5 mL and ∼105 respirations per min. The neck and chest areas were shaved and prepped with a 70% isopropyl alcohol followed by betadine solution. Following draping for aseptic surgery the heart was exposed via a left thoracotomy in the fourth intercostal space, and the pericardium was incised. The descending left coronary artery was regionally located (<i>ramus interventricularis paraconalis</i>). Animals were randomized into treatment groups. The coronary artery was permanently ligated with a silk suture with a tapered curved 6 mm needle. Complete coronary occlusion was confirmed visually by noting the prompt and sustained pallor of the anterior wall distal to the ligation site. For animals designated as Sham, the snare was placed but not tightened. The chest was closed in layers, and the pneumothorax was evacuated. For pain management a local anesthetic (bupivacaine) was infiltrated subcutaneously along the edges of the incision sites, and buprenorphine (0.05–0.1 mg/kg) was administered immediately postoperatively. Animals were returned to their cage, given water and standard rodent chow ad libitum, and monitored daily until the terminal procedure. Mice were dosed daily (QD) with compound <b>13c</b>, captopril or with vehicle for 28 days. Dosing was initiated 24 h after MI. Dosing route with compound <b>13c</b> and vehicle was oral (po) via gavage at a dose volume of 5 mL/kg. Treatment with the angiotensin converting enzyme inhibitor captopril was provided in the drinking water (∼100 mg kg<sup>–1</sup> day<sup>–1</sup>).</div></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Ex Vivo Passive Mechanics</h3><div class="NLM_p last">Following exposure of the heart via thoracotomy, the heart was arrested in diastole by rapid intracardiac infusion of ice-cold cardioplegic solution containing high potassium and 2,3-butanedione monoxime. The heart was excised, the aorta cannulated, and the heart perfused with cardioplegia to flush out residual blood. The atrial appendages were trimmed, the hearts were weighed, and a cardiac balloon was inserted into the left ventricle (LV) across the mitral valve. The hearts were mounted onto a pressure–volume (<i>P</i>–<i>V</i>) measurement stand and multiple epicardial surface markers placed onto the anterior wall. A digital camera was positioned to enable capture of video images of the anterior surface of the heart. <i>P</i>–<i>V</i> curves were obtained by digitally acquiring left ventricular pressure and volume during balloon inflations. There were two to three conditioning runs followed by two to three data acquisition runs with maximal LV pressure of ∼50 mmHg. Synchronized video images were obtained during each data run. Following acquisition of the PV data, the hearts were perfusion-fixed for 5–10 min by infusion of 10% formalin into the aortic cannula while maintaining LV balloon pressure at 10–15 mmHg. Hearts were stored in 10% formalin at room temperature for subsequent histologic processing</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70"><a href="/doi/suppl/10.1021/acs.jmedchem.9b02101" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77270" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77270" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b02101?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02101</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental procedures for compounds <b>2a</b>–<b>d</b>, <b>12a</b>–<b>f</b>,<b>h</b>–<b>l</b>, <b>13a</b>,<b>b</b>,<b>d</b>–<b>h</b>,<b>j</b>,<b>k</b>,<b>m</b>,<b>o</b>–<b>q</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02101/suppl_file/jm9b02101_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings for all compound included in the article and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02101/suppl_file/jm9b02101_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02101/suppl_file/jm9b02101_si_001.pdf">jm9b02101_si_001.pdf (1.2 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02101/suppl_file/jm9b02101_si_002.csv">jm9b02101_si_002.csv (4.86 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b02101" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40301" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40301" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yoshikazu Asahina</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratories, Kyorin Pharmaceutical
Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#730a1c001b1a181209065d1200121b1a1d12331e115d180a1c011a1d5e031b12011e5d101c5d1903"><span class="__cf_email__" data-cfemail="dca5b3afb4b5b7bda6a9f2bdafbdb4b5b2bd9cb1bef2b7a5b3aeb5b2f1acb4bdaeb1f2bfb3f2b6ac">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas R. Wurtz</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2574-9440" title="Orcid link">http://orcid.org/0000-0003-2574-9440</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#137d7a707b7c7f72603d646661676953717e603d707c7e"><span class="__cf_email__" data-cfemail="fb9592989394979a88d58c8e898f81bb999688d5989496">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kazuto Arakawa</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratories, Kyorin Pharmaceutical
Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nancy Carson</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kiyoshi Fujii</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratories, Kyorin Pharmaceutical
Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kazunori Fukuchi</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratories, Kyorin Pharmaceutical
Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ricardo Garcia</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mei-Yin Hsu</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Junichi Ishiyama</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratories, Kyorin Pharmaceutical
Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce Ito</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicine, University of California, San
Diego, 9500 Gilman Drive, La Jolla, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ellen Kick</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3498-4194" title="Orcid link">http://orcid.org/0000-0003-3498-4194</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Lupisella</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shingo Matsushima</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratories, Kyorin Pharmaceutical
Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kohei Ohata</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratories, Kyorin Pharmaceutical
Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacek Ostrowski</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yoshifumi Saito</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratories, Kyorin Pharmaceutical
Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kosuke Tsuda</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratories, Kyorin Pharmaceutical
Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francisco Villarreal</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicine, University of California, San
Diego, 9500 Gilman Drive, La Jolla, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hitomi Yamada</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratories, Kyorin Pharmaceutical
Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Toshikazu Yamaoka</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratories, Kyorin Pharmaceutical
Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruth Wexler</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Gordon</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yasushi Kohno</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratories, Kyorin Pharmaceutical
Co. Ltd., 2399-1, Nogi, Nogi-Machi, Shimotsuga-Gun, Tochigi 329-0114, Japan</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ACEi</td><td class="NLM_def"><p class="first last">angiotensin-converting enzyme inhibitor</p></td></tr><tr><td class="NLM_term">BALF</td><td class="NLM_def"><p class="first last">bronchoalveolar lavage fluid</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P</p></td></tr><tr><td class="NLM_term">DPPA</td><td class="NLM_def"><p class="first last">diphenyl phosphorylazide</p></td></tr><tr><td class="NLM_term">fMLP aka fMPF</td><td class="NLM_def"><p class="first last"><i>N</i>-formyl-methionyl-leucyl-phenylalanine</p></td></tr><tr><td class="NLM_term">FPR</td><td class="NLM_def"><p class="first last">formyl peptide receptor</p></td></tr><tr><td class="NLM_term">IL</td><td class="NLM_def"><p class="first last">interleukin</p></td></tr><tr><td class="NLM_term">LAD</td><td class="NLM_def"><p class="first last">left anterior descending artery</p></td></tr><tr><td class="NLM_term">LV</td><td class="NLM_def"><p class="first last">left ventricle</p></td></tr><tr><td class="NLM_term">MI</td><td class="NLM_def"><p class="first last">myocardial infarction</p></td></tr><tr><td class="NLM_term"><i>P</i>–<i>V</i></td><td class="NLM_def"><p class="first last">pressure–volume</p></td></tr><tr><td class="NLM_term">SAA</td><td class="NLM_def"><p class="first last">serum amyloid A</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i73">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53822" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53822" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 30 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boulay, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmentier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serhan, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, P. M.</span></span> <span> </span><span class="NLM_article-title">International union of basic and clinical pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1124/pr.109.001578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1124%2Fpr.109.001578" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=19498085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWmu7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2009&pages=119-161&author=R.+D.+Yeauthor=F.+Boulayauthor=J.+M.+Wangauthor=C.+Dahlgrenauthor=C.+Gerardauthor=M.+Parmentierauthor=C.+N.+Serhanauthor=P.+M.+Murphy&title=International+union+of+basic+and+clinical+pharmacology.+LXXIII.+Nomenclature+for+the+formyl+peptide+receptor+%28FPR%29+family&doi=10.1124%2Fpr.109.001578"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">International union of basic and clinical pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family</span></div><div class="casAuthors">Ye, Richard D.; Boulay, Francois; Wang, Ji Ming; Dahlgren, Claes; Gerard, Craig; Parmentier, Marc; Serhan, Charles N.; Murphy, Philip M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-161</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Formyl peptide receptors (FPRs) are a small group of seven-transmembrane domain, G protein-coupled receptors that are expressed mainly by mammalian phagocytic leukocytes and are known to be important in host defense and inflammation.  The three human FPRs (FPR1, FPR2/ALX, and FPR3) share significant sequence homol. and are encoded by clustered genes.  Collectively, these receptors bind an extraordinarily numerous and structurally diverse group of agonistic ligands, including N-formyl and nonformyl peptides of different compn., that chemoattract and activate phagocytes.  N-formyl peptides, which are encoded in nature only by bacterial and mitochondrial genes and result from obligatory initiation of bacterial and mitochondrial protein synthesis with N-formylmethionine, is the only ligand class common to all three human receptors.  Surprisingly, the endogenous anti-inflammatory peptide annexin 1 and its N-terminal fragments also bind human FPR1 and FPR2/ALX, and the anti-inflammatory eicosanoid lipoxin A4 is an agonist at FPR2/ALX.  In comparison, fewer agonists have been identified for FPR3, the third member in this receptor family.  Structural and functional studies of the FPRs have produced important information for understanding the general pharmacol. principles governing all leukocyte chemoattractant receptors.  This article aims to provide an overview of the discovery and pharmacol. characterization of FPRs, to introduce an International Union of Basic and Clin. Pharmacol. (IUPHAR)-recommended nomenclature, and to discuss unmet challenges, including the mechanisms used by these receptors to bind diverse ligands and mediate different biol. functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK2C5MK1gTQrVg90H21EOLACvtfcHk0lij4FnQJLxDCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWmu7jO&md5=b4c8b0c6642881d9c19c885301fd9c0a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1124%2Fpr.109.001578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.109.001578%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DR.%2BD.%26aulast%3DBoulay%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DJ.%2BM.%26aulast%3DDahlgren%26aufirst%3DC.%26aulast%3DGerard%26aufirst%3DC.%26aulast%3DParmentier%26aufirst%3DM.%26aulast%3DSerhan%26aufirst%3DC.%2BN.%26aulast%3DMurphy%26aufirst%3DP.%2BM.%26atitle%3DInternational%2520union%2520of%2520basic%2520and%2520clinical%2520pharmacology.%2520LXXIII.%2520Nomenclature%2520for%2520the%2520formyl%2520peptide%2520receptor%2520%2528FPR%2529%2520family%26jtitle%3DPharmacol.%2520Rev.%26date%3D2009%26volume%3D61%26spage%3D119%26epage%3D161%26doi%3D10.1124%2Fpr.109.001578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerard, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eddy, R. L.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shows, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerard, C.</span></span> <span> </span><span class="NLM_article-title">Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19</span>. <i>Genomics</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">440</span>, <span class="refDoi"> DOI: 10.1016/0888-7543(92)90265-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1016%2F0888-7543%2892%2990265-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1612600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADyaK3sXktVajs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1992&pages=437-440&author=L.+Baoauthor=N.+P.+Gerardauthor=R.+L.+Eddyauthor=T.+B.+Showsauthor=C.+Gerard&title=Mapping+of+genes+for+the+human+C5a+receptor+%28C5AR%29%2C+human+FMLP+receptor+%28FPR%29%2C+and+two+FMLP+receptor+homologue+orphan+receptors+%28FPRH1%2C+FPRH2%29+to+chromosome+19&doi=10.1016%2F0888-7543%2892%2990265-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homolog orphan receptors (FPRH1, FPRH2) to chromosome 19</span></div><div class="casAuthors">Bao, Lu; Gerard, Norma P.; Eddy, Roger L., Jr.; Shows, Thomas B.; Gerard, Craig</div><div class="citationInfo"><span class="NLM_cas:title">Genomics</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">437-40</span>CODEN:
                <span class="NLM_cas:coden">GNMCEP</span>;
        ISSN:<span class="NLM_cas:issn">0888-7543</span>.
    </div><div class="casAbstract">The genes encoding receptors for the chemotactic ligands C5a (C5AR) and FMLP (FPR) were mapped using a panel of somatic cell hybrids to chromosome 19.  Because the hybridization pattern on Southern anal. suggested an intron structure or related genes in the case of FPR, genomic clones were characterized.  Two structural homologs of the FMLP receptor, clones 81 (FPRH1) and 82 (FPRH2), were identified, which similarly map to chromosome 19.  The structural homologs do not recognize the ligand FMLP, but are likely chemotactic receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfeaNIfzst1bVg90H21EOLACvtfcHk0lij4FnQJLxDCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXktVajs78%253D&md5=d9dd076841eb58da286e2a8b8dfa879a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0888-7543%2892%2990265-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0888-7543%252892%252990265-T%26sid%3Dliteratum%253Aachs%26aulast%3DBao%26aufirst%3DL.%26aulast%3DGerard%26aufirst%3DN.%2BP.%26aulast%3DEddy%26aufirst%3DR.%2BL.%26aulast%3DShows%26aufirst%3DT.%2BB.%26aulast%3DGerard%26aufirst%3DC.%26atitle%3DMapping%2520of%2520genes%2520for%2520the%2520human%2520C5a%2520receptor%2520%2528C5AR%2529%252C%2520human%2520FMLP%2520receptor%2520%2528FPR%2529%252C%2520and%2520two%2520FMLP%2520receptor%2520homologue%2520orphan%2520receptors%2520%2528FPRH1%252C%2520FPRH2%2529%2520to%2520chromosome%252019%26jtitle%3DGenomics%26date%3D1992%26volume%3D13%26spage%3D437%26epage%3D440%26doi%3D10.1016%2F0888-7543%2892%2990265-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Le, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. M.</span></span> <span> </span><span class="NLM_article-title">Formyl-peptide receptors revisited</span>. <i>Trends Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">548</span>, <span class="refDoi"> DOI: 10.1016/S1471-4906(02)02316-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1016%2FS1471-4906%2802%2902316-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=12401407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVKktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=541-548&author=Y.+Leauthor=P.+M.+Murphyauthor=J.+M.+Wang&title=Formyl-peptide+receptors+revisited&doi=10.1016%2FS1471-4906%2802%2902316-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Formyl-peptide receptors revisited</span></div><div class="casAuthors">Le, Yingying; Murphy, Philip M.; Wang, Ji Ming</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">541-548</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Leukocytes accumulate at sites of inflammation and microbial infection in direct response to locally produced chemotactic factors, which signal through specific G protein-coupled receptors.  The first chemotactic factors to be structurally defined were the N-formyl peptides.  Unlike other leukocyte chemoattractants, N-formyl peptides could originate from either an endogenous source, such as the mitochondrial proteins of ruptured host cells, or an exogenous source, such as the proteins of invading pathogens.  This suggests that the formyl-peptide receptor (FPR) and its variant FPRL1 (FPR-like 1) are involved in host defense against bacterial infection and in the clearance of damaged cells.  Recently, addnl., more complex, roles for these receptors have been proposed because FPR, and to a greater extent FPRL1, have been found to interact with a menagerie of structurally diverse pro- and anti-inflammatory ligands assocd. with different diseases, including amyloidosis, Alzheimer's disease, prion disease and HIV.  How these receptors recognize such diverse ligands, which are the most important in vivo, and how they contribute to disease pathogenesis and host defense are basic questions currently under investigation that could lead to new therapeutic targets.  How formyl-peptide receptors recognize diverse pro- and anti-inflammatory ligands assocd. with different diseases, and how they contribute to disease pathogenesis and host defense, are basic questions currently under investigation that could lead to new therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSJJ2GIyvVdLVg90H21EOLACvtfcHk0li0sRPRf5l1_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVKktrY%253D&md5=8ec2794e8ae0f5de140752c06621e7b6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1471-4906%2802%2902316-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4906%252802%252902316-5%26sid%3Dliteratum%253Aachs%26aulast%3DLe%26aufirst%3DY.%26aulast%3DMurphy%26aufirst%3DP.%2BM.%26aulast%3DWang%26aufirst%3DJ.%2BM.%26atitle%3DFormyl-peptide%2520receptors%2520revisited%26jtitle%3DTrends%2520Immunol.%26date%3D2002%26volume%3D23%26spage%3D541%26epage%3D548%26doi%3D10.1016%2FS1471-4906%2802%2902316-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, T.-L.</span></span> <span> </span><span class="NLM_article-title">The potential impacts of formylpeptide receptor 1 in inflammatory diseases</span>. <i>Front. Biosci., Elite Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">436</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.2741/e778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.2741%2Fe778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=27100350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmvVWmtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=436-449&author=S.+C.+Yangauthor=T.-L.+Hwang&title=The+potential+impacts+of+formylpeptide+receptor+1+in+inflammatory+diseases&doi=10.2741%2Fe778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The potential impacts of formyl peptide receptor 1 in inflammatory diseases</span></div><div class="casAuthors">Yang, Shun-Chin; Hwang, Tsong-Long</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience, Elite Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">E8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">436-449</span>CODEN:
                <span class="NLM_cas:coden">FBEEAS</span>;
        ISSN:<span class="NLM_cas:issn">1945-0508</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">Neutrophils play a crit. role in acute and chronic inflammatory diseases.  N-formyl peptides, which originate from bacterial peptides or mitochondrial proteins bind with a high binding affinity to formyl peptide receptor 1 (FPR1).  N-formyl peptide-FPR1 is involved in the pathogenesis of sterile and infectious inflammatory processes and causes phagocytosis of pathogens or injured cells by neutrophils.  Excessive activation of neutrophils by binding of N-formyl peptides is assocd. with tissue injury requiring drugs that block FPR1-dependent signaling.  Here, we review the roles of FPR1 as a crit. regulator of inflammatory processes and its involvement in pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqScXJr1KZ2OLVg90H21EOLACvtfcHk0li0sRPRf5l1_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmvVWmtL8%253D&md5=52bdf99c9f1c6590c40f2edacbc61474</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2741%2Fe778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252Fe778%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.%2BC.%26aulast%3DHwang%26aufirst%3DT.-L.%26atitle%3DThe%2520potential%2520impacts%2520of%2520formylpeptide%2520receptor%25201%2520in%2520inflammatory%2520diseases%26jtitle%3DFront.%2520Biosci.%252C%2520Elite%2520Ed.%26date%3D2016%26volume%3D8%26spage%3D436%26epage%3D449%26doi%3D10.2741%2Fe778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, R. D.</span></span> <span> </span><span class="NLM_article-title">Serum amyloid A induced IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">1572</span>– <span class="NLM_lpage">1581</span>, <span class="refDoi"> DOI: 10.1182/blood-2002-05-1431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1182%2Fblood-2002-05-1431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=12393391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1ansrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2003&pages=1572-1581&author=R.+Heauthor=H.+Sangauthor=R.+D.+Ye&title=Serum+amyloid+A+induced+IL-8+secretion+through+a+G+protein-coupled+receptor%2C+FPRL1%2FLXA4R&doi=10.1182%2Fblood-2002-05-1431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R</span></div><div class="casAuthors">He, Rong; Sang, Hairong; Ye, Richard D.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1572-1581</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Host response to injury and infection is accompanied by a rapid rise in the blood of acute-phase proteins such as serum amyloid A (SAA).  Although SAA has been used as a marker for inflammatory diseases, its role in the modulation of inflammation and immunity has not been defined.  Human neutrophils respond to SAA with secretion of the proinflammatory cytokines interleukin 8 (IL-8) and, to a lesser extent, tumor necrosis factor α (TNF-α).  The induction of IL-8 secretion by SAA involves both transcription and translation and correlates with activation of nuclear factor κB (NF-κB).  The proximal signaling events induced by SAA include mobilization of intracellular Ca2+ and activation of the mitogen-activated protein kinases ERK1/2 and p38, both required for the induced IL-8 secretion.  Pertussis toxin effectively blocks SAA-induced IL-8 secretion indicating involvement of a Gi-coupled receptor.  Overexpression of FPRL1/LXA4R in HeLa cells results in a significant increase of the expression of NF-κB and IL-8 luciferase reporters by SAA, and an antibody against the N-terminal domain of FPRL1/LXA4R inhibits IL-8 secretion.  Lipoxin A4, which binds to FPRL1/LXA4R specifically, decreases SAA-induced IL-8 secretion significantly.  Collectively, these results indicate that the cytokine-like property of SAA is manifested through activation of the Gi-coupled FPRL1/LXA4R, which has been known to mediate the anti-inflammatory effects of lipoxin A4.  The ability of FPRL1/LXA4R to mediate 2 drastically different and opposite functions suggests that it plays a role in the modulation of inflammatory and immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwYQCbUjerwLVg90H21EOLACvtfcHk0li0sRPRf5l1_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1ansrk%253D&md5=a369ff46bedefb354d5f9ac5970e3dbc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1182%2Fblood-2002-05-1431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2002-05-1431%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DR.%26aulast%3DSang%26aufirst%3DH.%26aulast%3DYe%26aufirst%3DR.%2BD.%26atitle%3DSerum%2520amyloid%2520A%2520induced%2520IL-8%2520secretion%2520through%2520a%2520G%2520protein-coupled%2520receptor%252C%2520FPRL1%252FLXA4R%26jtitle%3DBlood%26date%3D2003%26volume%3D101%26spage%3D1572%26epage%3D1581%26doi%3D10.1182%2Fblood-2002-05-1431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serhan, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlén, S.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drazen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, D. W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rovati, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokomizo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brink, C.</span></span> <span> </span><span class="NLM_article-title">The lipoxin receptor ALX: Potent ligand-specific and stereoselective actions in vivo</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1124/pr.58.3.4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1124%2Fpr.58.3.4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=16968948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=463-489&author=N.+Chiangauthor=C.+N.+Serhanauthor=S.-E.+Dahl%C3%A9nauthor=J.+M.+Drazenauthor=D.+W.+P.+Hayauthor=G.+E.+Rovatiauthor=T.+Shimizuauthor=T.+Yokomizoauthor=C.+Brink&title=The+lipoxin+receptor+ALX%3A+Potent+ligand-specific+and+stereoselective+actions+in+vivo&doi=10.1124%2Fpr.58.3.4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The Lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo</span></div><div class="casAuthors">Chiang, Nan; Serhan, Charles N.; Dahlen, Sven-Erik; Drazen, Jeffrey M.; Hay, Douglas W. P.; Rovati, G. Enrico; Shimizu, Takao; Yokomizo, Takehiko; Brink, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">463-487</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Lipoxins (LXs) and aspirin-triggered LX (ATL) are trihydroxytetraene-contg. eicosanoids generated from arachidonic acid that are distinct in structure, formation, and function from the many other proinflammatory lipid-derived mediators.  These endogenous eicosanoids have now emerged as founding members of the first class of lipid/chem. mediators involved in the resoln. of the inflammatory response.  Lipoxin A4 (LXA4), ATL, and their metabolic stable analogs elicit cellular responses and regulate leukocyte trafficking in vivo by activating the specific receptor, ALX.  ALX was the first receptor cloned and identified as a G protein-coupled receptor (GPCR) for lipoxygenase-derived eicosanoids with demonstrated cell type-specific signaling pathways.  ALX at the level of DNA has sequence homol. to the N-formylpeptide receptor and as an orphan GPCR was initially referred to as the N-formylpeptide receptor-like 1.  Although LXA4 is the endogenous potent ligand for ALX activation, a no. of peptides can also activate this receptor to stimulate calcium mobilization and chemotaxis in vitro.  In contrast with LXA4, the counterparts of many of these peptides in vivo remain to be established.  The purpose of this review is to highlight the mol. characterization of the ALX receptor and provide an overview of the ALX-LXA4 axis responsible for anti-inflammatory and proresolving signals in vivo.  The information in this review provides further support for the initial nomenclature proposition for this GPCR as ALX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgWfE_vQ2J7rVg90H21EOLACvtfcHk0li0sRPRf5l1_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfP&md5=69738d2c64ff851cf058e6fb1ac5cb84</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1124%2Fpr.58.3.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.58.3.4%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DN.%26aulast%3DSerhan%26aufirst%3DC.%2BN.%26aulast%3DDahl%25C3%25A9n%26aufirst%3DS.-E.%26aulast%3DDrazen%26aufirst%3DJ.%2BM.%26aulast%3DHay%26aufirst%3DD.%2BW.%2BP.%26aulast%3DRovati%26aufirst%3DG.%2BE.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DYokomizo%26aufirst%3DT.%26aulast%3DBrink%26aufirst%3DC.%26atitle%3DThe%2520lipoxin%2520receptor%2520ALX%253A%2520Potent%2520ligand-specific%2520and%2520stereoselective%2520actions%2520in%2520vivo%26jtitle%3DPharmacol.%2520Rev.%26date%3D2006%26volume%3D58%26spage%3D463%26epage%3D489%26doi%3D10.1124%2Fpr.58.3.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perretti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fierro, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marullo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getting, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solito, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serhan, C. N.</span></span> <span> </span><span class="NLM_article-title">Endogenous lipid- and peptide derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1296</span>– <span class="NLM_lpage">1302</span>, <span class="refDoi"> DOI: 10.1038/nm786</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1038%2Fnm786" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=12368905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BD38XotlWlsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=1296-1302&author=M.+Perrettiauthor=N.+Chiangauthor=M.+Laauthor=I.+M.+Fierroauthor=S.+Marulloauthor=S.+J.+Gettingauthor=E.+Solitoauthor=C.+N.+Serhan&title=Endogenous+lipid-+and+peptide+derived+anti-inflammatory+pathways+generated+with+glucocorticoid+and+aspirin+treatment+activate+the+lipoxin+A4+receptor&doi=10.1038%2Fnm786"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor</span></div><div class="casAuthors">Perretti, Mauro; Chiang, Nan; La, Mylinh; Fierro, Iolanda M.; Marullo, Stefano; Getting, Stephen J.; Solito, Egle; Serhan, Charles N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1296-1302</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aspirin (ASA) and dexamethasone (DEX) are widely used anti-inflammatory agents yet their mechanism(s) for blocking polymorphonuclear neutrophil (PMN) accumulation at sites of inflammation remain(s) unclear.  Here, the authors report that inhibition of PMN infiltration by ASA and DEX is a property shared by aspirin-triggered lipoxins (ATL) and the glucocorticoid-induced annexin 1 (ANXA1)-derived peptides that are both generated in vivo and act at the lipoxin A4 receptor (ALXR/FPRL1) to halt PMN diapedesis.  These structurally diverse ligands specifically interact directly with recombinant human ALXR demonstrated by specific radioligand binding and function as well as immunopptn. of PMN receptors.  In addn., the combination of both ATL and ANXA1-derived peptides limited PMN infiltration and reduced prodn. of inflammatory mediators (i.e., prostaglandins and chemokines) in vivo.  Together, these results indicate functional redundancies in endogenous lipid and peptide anti-inflammatory circuits that are spatially and temporally sep., where both ATL and specific ANXA1-derived peptides act in concert at ALXR to downregulate PMN recruitment to inflammatory loci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9Co2__EAxG7Vg90H21EOLACvtfcHk0lg2GYyirFGeUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotlWlsro%253D&md5=29c758bdb086c783ef123cf918617d34</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnm786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm786%26sid%3Dliteratum%253Aachs%26aulast%3DPerretti%26aufirst%3DM.%26aulast%3DChiang%26aufirst%3DN.%26aulast%3DLa%26aufirst%3DM.%26aulast%3DFierro%26aufirst%3DI.%2BM.%26aulast%3DMarullo%26aufirst%3DS.%26aulast%3DGetting%26aufirst%3DS.%2BJ.%26aulast%3DSolito%26aufirst%3DE.%26aulast%3DSerhan%26aufirst%3DC.%2BN.%26atitle%3DEndogenous%2520lipid-%2520and%2520peptide%2520derived%2520anti-inflammatory%2520pathways%2520generated%2520with%2520glucocorticoid%2520and%2520aspirin%2520treatment%2520activate%2520the%2520lipoxin%2520A4%2520receptor%26jtitle%3DNat.%2520Med.%26date%3D2002%26volume%3D8%26spage%3D1296%26epage%3D1302%26doi%3D10.1038%2Fnm786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bena, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancaleone, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perretti, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flower, R. J.</span></span> <span> </span><span class="NLM_article-title">Annexin A1 interaction with the FPR2/ALX receptor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">24690</span>– <span class="NLM_lpage">24697</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.377101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1074%2Fjbc.M112.377101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=22610094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWgtb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=24690-24697&author=S.+Benaauthor=V.+Brancaleoneauthor=J.+M.+Wangauthor=J.+M.+Perrettiauthor=R.+J.+Flower&title=Annexin+A1+interaction+with+the+FPR2%2FALX+receptor&doi=10.1074%2Fjbc.M112.377101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Annexin A1 Interaction with the FPR2/ALX Receptor. Identification of Distinct Domains and Downstream Associated Signaling.</span></div><div class="casAuthors">Bena, Stefania; Brancaleone, Vincenzo; Wang, Ji Ming; Perretti, Mauro; Flower, Roderick J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">24690-24697</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Understanding how proresolving agonists selectively activate FPR2/ALX is a crucial step in the clarification of proresoln. mol. networks that can be harnessed for the design of novel therapeutics for inflammatory disease.  FPR2/ALX, a G protein-coupled receptor belonging to the formyl peptide receptor (FPR) family, conveys the biol. functions of a variety of ligands, including the proresoln. mediators annexin A1 (AnxA1) and lipoxin A4, as well as the activating and proinflammatory protein serum amyloid A.  FPR2/ALX is the focus of intense screening for novel anti-inflammatory therapeutics, and the small mol. compd. 43 was identified as a receptor ligand.  Here, we used chimeric FPR1 and FPR2/ALX clones (stably transfected in HEK293 cells) to identify the N-terminal region and extracellular loop II as the FPR2/ALX domain required for AnxA1-mediated signaling.  Genomic responses were also assessed with domain-specific effects emerging, so the N-terminal region is required for AnxA1 induction of JAG1 and JAM3, whereas it is dispensable for modulation of SGPP2.  By comparison, serum amyloid A non-genomic responses were reliant on extracellular loops I and II, whereas the small mol. compd. 43 activated extracellular loop I with downstream signaling dependent on transmembrane region II.  In desensitization expts., the N-terminal region was dispensable for AnxA1-induced FPR2/ALX down-regulation in both the homologous and heterologous desensitization modes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPIsfWk8-ZDrVg90H21EOLACvtfcHk0lg2GYyirFGeUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWgtb7J&md5=66c04f0814bada8bd4f47819bdcc5c49</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.377101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.377101%26sid%3Dliteratum%253Aachs%26aulast%3DBena%26aufirst%3DS.%26aulast%3DBrancaleone%26aufirst%3DV.%26aulast%3DWang%26aufirst%3DJ.%2BM.%26aulast%3DPerretti%26aufirst%3DJ.%2BM.%26aulast%3DFlower%26aufirst%3DR.%2BJ.%26atitle%3DAnnexin%2520A1%2520interaction%2520with%2520the%2520FPR2%252FALX%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D24690%26epage%3D24697%26doi%3D10.1074%2Fjbc.M112.377101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cattaneo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ammendola, R.</span></span> <span> </span><span class="NLM_article-title">Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">7193</span>– <span class="NLM_lpage">7230</span>, <span class="refDoi"> DOI: 10.3390/ijms14047193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.3390%2Fijms14047193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=23549262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtFWktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=7193-7230&author=F.+Cattaneoauthor=M.+Parisiauthor=R.+Ammendola&title=Distinct+signaling+cascades+elicited+by+different+formyl+peptide+receptor+2+%28FPR2%29+agonists&doi=10.3390%2Fijms14047193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists</span></div><div class="casAuthors">Cattaneo, Fabio; Parisi, Melania; Ammendola, Rosario</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7193-7230</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  The formyl peptide receptor 2 (FPR2) is a remarkably versatile transmembrane protein belonging to the G-protein coupled receptor (GPCR) family.  FPR2 is activated by an array of ligands, which include structurally unrelated lipids and peptide/proteins agonists, resulting in different intracellular responses in a ligand-specific fashion.  In addn. to the anti-inflammatory lipid, lipoxin A4, several other endogenous agonists also bind FPR2, including serum amyloid A, glucocorticoid-induced annexin 1, urokinase and its receptor, suggesting that the activation of FPR2 may result in potent pro- or anti-inflammatory responses.  Other endogenous ligands, also present in biol. samples, include resolvins, amyloidogenic proteins, such as beta amyloid (Aβ)-42 and prion protein (Prp)106-126, the neuroprotective peptide, humanin, antibacterial peptides, annexin 1-derived peptides, chemokine variants, the neuropeptides, vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP)-27 and mitochondrial peptides.  Upon activation, intracellular domains of FPR2 mediate signaling to G-proteins, which trigger several agonist-dependent signal transduction pathways, including activation of phospholipase C (PLC), protein kinase C (PKC) isoforms, the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway, the mitogen-activated protein kinase (MAPK) pathway, p38MAPK, as well as the phosphorylation of cytosolic tyrosine kinases, tyrosine kinase receptor transactivation, phosphorylation and nuclear translocation of regulatory transcriptional factors, release of calcium and prodn. of oxidants.  FPR2 is an attractive therapeutic target, because of its involvement in a range of normal physiol. processes and pathol. diseases.  Here, we review and discuss the most significant findings on the intracellular pathways and on the cross-communication between FPR2 and tyrosine kinase receptors triggered by different FPR2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBKmHveSDBH7Vg90H21EOLACvtfcHk0lg2GYyirFGeUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtFWktr8%253D&md5=b3d1ed852ecb5a03e114d4d4a0beb036</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3390%2Fijms14047193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms14047193%26sid%3Dliteratum%253Aachs%26aulast%3DCattaneo%26aufirst%3DF.%26aulast%3DParisi%26aufirst%3DM.%26aulast%3DAmmendola%26aufirst%3DR.%26atitle%3DDistinct%2520signaling%2520cascades%2520elicited%2520by%2520different%2520formyl%2520peptide%2520receptor%25202%2520%2528FPR2%2529%2520agonists%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2013%26volume%3D14%26spage%3D7193%26epage%3D7230%26doi%3D10.3390%2Fijms14047193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nash, N.</span>; <span class="NLM_string-name">Scully, A.</span>; <span class="NLM_string-name">Gardeli, L.</span>; <span class="NLM_string-name">Olsson, R.</span>; <span class="NLM_string-name">Gustafsson, M.</span></span> <span> </span><span class="NLM_article-title">Use of the Lipoxin Receptor, FPRL1, as a Tool for Identifying Compounds Effective in the Treatment of Pain and Onflammation</span>. PCT Int. Appl. <span class="NLM_patent">WO2005/047899</span>, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=N.+Nash&author=A.+Scully&author=L.+Gardeli&author=R.+Olsson&author=M.+Gustafsson&title=Use+of+the+Lipoxin+Receptor%2C+FPRL1%2C+as+a+Tool+for+Identifying+Compounds+Effective+in+the+Treatment+of+Pain+and+Onflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNash%26aufirst%3DN.%26atitle%3DUse%2520of%2520the%2520Lipoxin%2520Receptor%252C%2520FPRL1%252C%2520as%2520a%2520Tool%2520for%2520Identifying%2520Compounds%2520Effective%2520in%2520the%2520Treatment%2520of%2520Pain%2520and%2520Onflammation%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schepetkin, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khlebnikov, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giovannoni, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirpotina, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cilibrizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, M. T.</span></span> <span> </span><span class="NLM_article-title">Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1478</span>– <span class="NLM_lpage">1504</span>, <span class="refDoi"> DOI: 10.2174/0929867321666131218095521</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.2174%2F0929867321666131218095521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=24350845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlt1eksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1478-1504&author=I.+A.+Schepetkinauthor=A.+I.+Khlebnikovauthor=M.+P.+Giovannoniauthor=L.+N.+Kirpotinaauthor=A.+Cilibrizziauthor=M.+T.+Quinn&title=Development+of+small+molecule+non-peptide+formyl+peptide+receptor+%28FPR%29+ligands+and+molecular+modeling+of+their+recognition&doi=10.2174%2F0929867321666131218095521"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Small Molecule Non-peptide Formyl Peptide Receptor (FPR) Ligands and Molecular Modeling of Their Recognition</span></div><div class="casAuthors">Schepetkin, I. A.; Khlebnikov, A. I.; Giovannoni, M. P.; Kirpotina, L. N.; Cilibrizzi, A.; Quinn, M. T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1478-1504</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Formyl peptide receptors (FPRs) are G protein-coupled receptors (GPCRs) expressed on a variety of cell types.  These receptors play an important role in the regulation of inflammatory reactions and sensing cellular damage.  They have also been implicated in the pathogenesis of various diseases, including neurodegenerative diseases, cataract formation, and atherogenesis.  Thus, FPR ligands, both agonists and antagonists, may represent novel therapeutics for modulating host defense and innate immunity.  A variety of mols. have been identified as receptor subtype-selective and mixed FPR agonists with potential therapeutic value during last decade.  This review describes our efforts along with recent advances in the identification, optimization, biol. evaluation, and structure-activity relationship (SAR) anal. of small mol. non-peptide FPR agonists and antagonists, including chiral mols.  Questions regarding the interaction at the mol. level of benzimidazoles, pyrazolones, pyridazin-3(2H)-ones, N-phenylureas and other derivs. with FPR1 and FPR2 are discussed.  Application of computational models for virtual screening and design of FPR ligands is also considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzzE_LFKfCHbVg90H21EOLACvtfcHk0lgJSJUuW9XiSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlt1eksrY%253D&md5=7386bfdfaf9d01aec9ec679375a42d2b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F0929867321666131218095521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666131218095521%26sid%3Dliteratum%253Aachs%26aulast%3DSchepetkin%26aufirst%3DI.%2BA.%26aulast%3DKhlebnikov%26aufirst%3DA.%2BI.%26aulast%3DGiovannoni%26aufirst%3DM.%2BP.%26aulast%3DKirpotina%26aufirst%3DL.%2BN.%26aulast%3DCilibrizzi%26aufirst%3DA.%26aulast%3DQuinn%26aufirst%3DM.%2BT.%26atitle%3DDevelopment%2520of%2520small%2520molecule%2520non-peptide%2520formyl%2520peptide%2520receptor%2520%2528FPR%2529%2520ligands%2520and%2520molecular%2520modeling%2520of%2520their%2520recognition%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D1478%26epage%3D1504%26doi%3D10.2174%2F0929867321666131218095521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corminboeuf, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, X.</span></span> <span> </span><span class="NLM_article-title">FPR2/ALXR agonists and the resolution of inflammation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">559</span>, <span class="refDoi"> DOI: 10.1021/jm501051x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501051x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGjtLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=537-559&author=O.+Corminboeufauthor=X.+Leroy&title=FPR2%2FALXR+agonists+and+the+resolution+of+inflammation&doi=10.1021%2Fjm501051x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">FPR2/ALXR Agonists and the Resolution of Inflammation</span></div><div class="casAuthors">Corminboeuf, Olivier; Leroy, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">537-559</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The resoln. of inflammation (RoI), once believed to be a passive process, has lately been shown to be an active and delicately orchestrated process.  During the resoln. phase of acute inflammation, novel mediators, including lipoxins and resolvins, which are members of the specialized pro-resolving mediators of inflammation, are produced.  FPR2/ALXR, a receptor modulated by some of these lipids as well as by peptides (e.g., annexin A1), has been shown to be one of the receptors involved in the RoI.  The aim of this perspective is to present the concept of the RoI from a medicinal chem. point of view and to highlight the effort of the research community to discover and develop anti-inflammatory/pro-resoln. small mols. to orchestrate inflammation by activation of FPR2/ALXR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-uVie3v-44bVg90H21EOLACvtfcHk0lgJSJUuW9XiSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGjtLbJ&md5=3b595d7c70e5d2336c6fb832b372ba7b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm501051x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501051x%26sid%3Dliteratum%253Aachs%26aulast%3DCorminboeuf%26aufirst%3DO.%26aulast%3DLeroy%26aufirst%3DX.%26atitle%3DFPR2%252FALXR%2520agonists%2520and%2520the%2520resolution%2520of%2520inflammation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D537%26epage%3D559%26doi%3D10.1021%2Fjm501051x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, Y.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, T.-L.</span></span> <span> </span><span class="NLM_article-title">Formyl peptide receptor modulators: a patent review and potential applications for inflammatory diseases (2012–2015)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1139</span>– <span class="NLM_lpage">1156</span>, <span class="refDoi"> DOI: 10.1080/13543776.2016.1216546</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1080%2F13543776.2016.1216546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=27454150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ygu7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1139-1156&author=Y.-F.+Tsaiauthor=S.-C.+Yangauthor=T.-L.+Hwang&title=Formyl+peptide+receptor+modulators%3A+a+patent+review+and+potential+applications+for+inflammatory+diseases+%282012%E2%80%932015%29&doi=10.1080%2F13543776.2016.1216546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Formyl peptide receptor modulators: a patent review and potential applications for inflammatory diseases (2012-2015)</span></div><div class="casAuthors">Tsai, Yung-Fong; Yang, Shun-Chin; Hwang, Tsong-Long</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1139-1156</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The activation of leukocytes and the subsequent immune cascade play an essential role in sterile and infectious inflammation.  Dysregulation of these immune responses or excess leukocyte activation can induce tissue damage, organ dysfunction and mortality.  Formyl peptide receptors (FPRs) are functionally diverse pattern recognition receptors responsible for recognizing different endogenous damage-assocd. mol. patterns or exogenous pathogen-assocd. mol. patterns.  FPRs mediate leukocyte activation during inflammation.  FPR1 antagonists and FPR2 agonists have demonstrated significant anti-inflammatory effects based on in vitro and in vivo studies.  An increasing no. of synthesized compds. targeting FPRs, esp. potential FPR1 antagonists and FPR2 agonists, have been disclosed in patents.: This article summarizes the current pharmacol. patents related to FPR family modulators and their therapeutic indications based on a review of patent applications disclosed between 2012 and 2015.: In this review, FPR1 modulators comprise β-1,3-glucan synthase inhibitors contg. an FPR ligand moiety, template-fixed peptidomimetics, cyclosporin H, and dipeptide derivs.  FPR2 modulators include phenylurea, bridged spiro[2.4]heptane ester, naphthalene, aminotriazole, polycyclic pyrrolidine-2,5-dione, imidazolidine-2,4-dione, (2-ureidoacetamido)alkyl, amide, oxazolyl-methylether, oxazole, thiazole, and cryst. potassium salt derivs.  These compds. have potential applications for human conditions such as inflammatory lung diseases, ischemia-reperfusion injury, sepsis, inflammatory bowel disease, and wound healing.  FPRs are emerging as important targets for treating leukocyte-dominant inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyIsfHf0r2V7Vg90H21EOLACvtfcHk0lgJSJUuW9XiSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ygu7zL&md5=81effbca0b29e494d386c9cca8b0764c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1080%2F13543776.2016.1216546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2016.1216546%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DY.-F.%26aulast%3DYang%26aufirst%3DS.-C.%26aulast%3DHwang%26aufirst%3DT.-L.%26atitle%3DFormyl%2520peptide%2520receptor%2520modulators%253A%2520a%2520patent%2520review%2520and%2520potential%2520applications%2520for%2520inflammatory%2520diseases%2520%25282012%25E2%2580%25932015%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2016%26volume%3D26%26spage%3D1139%26epage%3D1156%26doi%3D10.1080%2F13543776.2016.1216546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schepetkin, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khlebnikov, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirpotina, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, M. T.</span></span> <span> </span><span class="NLM_article-title">Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2015.08.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1016%2Fj.intimp.2015.08.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=26382576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWmtL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2016&pages=43-58&author=I.+A.+Schepetkinauthor=A.+I.+Khlebnikovauthor=L.+N.+Kirpotinaauthor=M.+T.+Quinn&title=Antagonism+of+human+formyl+peptide+receptor+1+with+natural+compounds+and+their+synthetic+derivatives&doi=10.1016%2Fj.intimp.2015.08.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives</span></div><div class="casAuthors">Schepetkin, Igor A.; Khlebnikov, Andrei I.; Kirpotina, Liliya N.; Quinn, Mark T.</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">43-58</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Formyl peptide receptor 1 (FPR1) regulates a wide variety of neutrophil functional responses and plays an important role in inflammation and the pathogenesis of various diseases.  To date, a variety of natural and synthetic mols. have been identified as FPR1 ligands.  Here, we review current knowledge on natural products and natural product-inspired small mols. reported to antagonize and/or inhibit the FPR1-mediated responses.  Based on this literature, addnl. screening of selected com. available natural compds. for their ability to inhibit fMLF-induced Ca2 + mobilization in human neutrophils and FPR1 transfected HL-60 cells, and pharmacophore modeling, natural products with potential as FPR1 antagonists are considered and discussed in this review.  The identification and characterization of natural products that antagonize FPR1 activity may have potential for the development of novel therapeutics to limit or alter the outcome of inflammatory processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv14UhNod09rVg90H21EOLACvtfcHk0ljbpS61LW4oEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWmtL%252FE&md5=3ae643f4f1b6c343cec8b3aa815570e8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2015.08.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2015.08.036%26sid%3Dliteratum%253Aachs%26aulast%3DSchepetkin%26aufirst%3DI.%2BA.%26aulast%3DKhlebnikov%26aufirst%3DA.%2BI.%26aulast%3DKirpotina%26aufirst%3DL.%2BN.%26aulast%3DQuinn%26aufirst%3DM.%2BT.%26atitle%3DAntagonism%2520of%2520human%2520formyl%2520peptide%2520receptor%25201%2520with%2520natural%2520compounds%2520and%2520their%2520synthetic%2520derivatives%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2016%26volume%3D37%26spage%3D43%26epage%3D58%26doi%3D10.1016%2Fj.intimp.2015.08.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bürli, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frohn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adlam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plant, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElvain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viswanadhan, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hungate, R.</span></span> <span> </span><span class="NLM_article-title">Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3713</span>– <span class="NLM_lpage">3718</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.04.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1016%2Fj.bmcl.2006.04.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=16697190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVyktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3713-3718&author=R.+W.+B%C3%BCrliauthor=H.+Xuauthor=X.+Zouauthor=L.+Mullerauthor=J.+Goldenauthor=M.+Frohnauthor=M.+Adlamauthor=M.+H.+Plantauthor=M.+Wongauthor=M.+McElvainauthor=K.+Regalauthor=V.+N.+Viswanadhanauthor=P.+Tagariauthor=R.+Hungate&title=Potent+hFPRL1+%28ALXR%29+agonists+as+potential+anti-inflammatory+agents&doi=10.1016%2Fj.bmcl.2006.04.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents</span></div><div class="casAuthors">Buerli, Roland W.; Xu, Han; Zou, Xiaoming; Muller, Kristine; Golden, Jennifer; Frohn, Mike; Adlam, Matthew; Plant, Matthew H.; Wong, Min; McElvain, Michele; Regal, Kelly; Viswanadhan, Vellarkad N.; Tagari, Philip; Hungate, Randall</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3713-3718</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We report the discovery of potent agonists for the human formyl-peptide-like 1 receptor (hFPRL1).  These compds. did not act at a closely related receptor denoted human formyl peptide receptor (hFPR) up to 10 μM concn.  Recent studies have indicated that agonizing this receptor may promote resoln. of inflammation.  In an exploratory study, a novel hFPRL1 agonist showed efficacy in a mouse ear inflammation model following oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo30KuAluzMR7Vg90H21EOLACvtfcHk0ljbpS61LW4oEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVyktLc%253D&md5=c0743a061b0856d26b4203980098b559</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.04.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.04.068%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25BCrli%26aufirst%3DR.%2BW.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DZou%26aufirst%3DX.%26aulast%3DMuller%26aufirst%3DL.%26aulast%3DGolden%26aufirst%3DJ.%26aulast%3DFrohn%26aufirst%3DM.%26aulast%3DAdlam%26aufirst%3DM.%26aulast%3DPlant%26aufirst%3DM.%2BH.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DMcElvain%26aufirst%3DM.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DViswanadhan%26aufirst%3DV.%2BN.%26aulast%3DTagari%26aufirst%3DP.%26aulast%3DHungate%26aufirst%3DR.%26atitle%3DPotent%2520hFPRL1%2520%2528ALXR%2529%2520agonists%2520as%2520potential%2520anti-inflammatory%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3713%26epage%3D3718%26doi%3D10.1016%2Fj.bmcl.2006.04.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">García, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupisella, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernando, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heroux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouvier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dierks, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kick, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St-Onge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towne, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bucardo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurtz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostrowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarreal, F.</span></span> <span> </span><span class="NLM_article-title">Preservation of post-infarction cardiac structure and function via long-term oral formyl peptide receptor agonist treatment</span>. <i>J. Am. Coll. Cardiol. Basic Trans. Science</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">905</span>– <span class="NLM_lpage">920</span>, <span class="refDoi"> DOI: 10.1016/j.jacbts.2019.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1016%2Fj.jacbts.2019.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=31909300" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2019&pages=905-920&author=R.+Garc%C3%ADaauthor=B.+Itoauthor=J.+Lupisellaauthor=N.+Carsonauthor=M.+Hsuauthor=G.+Fernandoauthor=M.+Herouxauthor=M.+Bouvierauthor=E.+Dierksauthor=E.+Kickauthor=D.+Gordonauthor=J.+Chenauthor=G.+Mintierauthor=M.+Carrierauthor=S.+St-Ongeauthor=H.+Shahauthor=J.+Towneauthor=M.+Bucardoauthor=X.+Maauthor=C.+Ryanauthor=N.+Wurtzauthor=J.+Ostrowskiauthor=F.+Villarreal&title=Preservation+of+post-infarction+cardiac+structure+and+function+via+long-term+oral+formyl+peptide+receptor+agonist+treatment&doi=10.1016%2Fj.jacbts.2019.07.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.jacbts.2019.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacbts.2019.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa%26aufirst%3DR.%26aulast%3DIto%26aufirst%3DB.%26aulast%3DLupisella%26aufirst%3DJ.%26aulast%3DCarson%26aufirst%3DN.%26aulast%3DHsu%26aufirst%3DM.%26aulast%3DFernando%26aufirst%3DG.%26aulast%3DHeroux%26aufirst%3DM.%26aulast%3DBouvier%26aufirst%3DM.%26aulast%3DDierks%26aufirst%3DE.%26aulast%3DKick%26aufirst%3DE.%26aulast%3DGordon%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DMintier%26aufirst%3DG.%26aulast%3DCarrier%26aufirst%3DM.%26aulast%3DSt-Onge%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DH.%26aulast%3DTowne%26aufirst%3DJ.%26aulast%3DBucardo%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DRyan%26aufirst%3DC.%26aulast%3DWurtz%26aufirst%3DN.%26aulast%3DOstrowski%26aufirst%3DJ.%26aulast%3DVillarreal%26aufirst%3DF.%26atitle%3DPreservation%2520of%2520post-infarction%2520cardiac%2520structure%2520and%2520function%2520via%2520long-term%2520oral%2520formyl%2520peptide%2520receptor%2520agonist%2520treatment%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%2520Basic%2520Trans.%2520Science%26date%3D2019%26volume%3D4%26spage%3D905%26epage%3D920%26doi%3D10.1016%2Fj.jacbts.2019.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frohn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElvaine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plant, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hungate, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bürli, R. W.</span></span> <span> </span><span class="NLM_article-title">New ‘chemical probes’ to examine the role of the hFPRL1 (or ALXR) receptor in inflammation</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">6633</span>– <span class="NLM_lpage">6637</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.09.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1016%2Fj.bmcl.2007.09.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=17920884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1OqsLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6633-6637&author=M.+Frohnauthor=H.+Xuauthor=X.+Zouauthor=C.+Changauthor=M.+McElvaineauthor=M.+H.+Plantauthor=M.+Wongauthor=P.+Tagariauthor=R.+Hungateauthor=R.+W.+B%C3%BCrli&title=New+%E2%80%98chemical+probes%E2%80%99+to+examine+the+role+of+the+hFPRL1+%28or+ALXR%29+receptor+in+inflammation&doi=10.1016%2Fj.bmcl.2007.09.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">New 'chemical probes' to examine the role of the hFPRL1 (or ALXR) receptor in inflammation</span></div><div class="casAuthors">Frohn, Mike; Xu, Han; Zou, Xiaoming; Chang, Catherine; McElvaine, Michele; Plant, Matthew H.; Wong, Min; Tagari, Philip; Hungate, Randall; Buerli, Roland W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6633-6637</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The authors report the development of the novel N-substituted benzimidazole (I) as a potent and selective human formyl peptide receptor-like 1 (hFPRL1) agonist.  This compd. and its less active enantiomer (II) were identified as useful tools for studying receptor function in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQfWeuA14eL7Vg90H21EOLACvtfcHk0lgm0SSMNUTUpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1OqsLnO&md5=e6c72f7bb5777babeb9fe95593a99c73</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.09.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.09.043%26sid%3Dliteratum%253Aachs%26aulast%3DFrohn%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DZou%26aufirst%3DX.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DMcElvaine%26aufirst%3DM.%26aulast%3DPlant%26aufirst%3DM.%2BH.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DTagari%26aufirst%3DP.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DB%25C3%25BCrli%26aufirst%3DR.%2BW.%26atitle%3DNew%2520%25E2%2580%2598chemical%2520probes%25E2%2580%2599%2520to%2520examine%2520the%2520role%2520of%2520the%2520hFPRL1%2520%2528or%2520ALXR%2529%2520receptor%2520in%2520inflammation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6633%26epage%3D6637%26doi%3D10.1016%2Fj.bmcl.2007.09.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corminboeuf, O.</span>; <span class="NLM_string-name">Cren, S.</span></span> <span> </span><span class="NLM_article-title">1-(p-Tolyl)cyclopropyl Substituted Bridged Spiro[2.4]heptane Derivatives as ALX Receptor Agonists</span>. PCT Int. Appl. <span class="NLM_patent">WO2013/171687</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=O.+Corminboeuf&author=S.+Cren&title=1-%28p-Tolyl%29cyclopropyl+Substituted+Bridged+Spiro%5B2.4%5Dheptane+Derivatives+as+ALX+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCorminboeuf%26aufirst%3DO.%26atitle%3D1-%2528p-Tolyl%2529cyclopropyl%2520Substituted%2520Bridged%2520Spiro%255B2.4%255Dheptane%2520Derivatives%2520as%2520ALX%2520Receptor%2520Agonists%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bur, D.</span>; <span class="NLM_string-name">Corminboeuf, O.</span>; <span class="NLM_string-name">Cren, S.</span>; <span class="NLM_string-name">Grisostomi, C.</span>; <span class="NLM_string-name">Leroy, X.</span>; <span class="NLM_string-name">Richard-Bikdstein, S.</span></span> <span> </span><span class="NLM_article-title">Fluorinated Aminotriazole Derivatives</span>. PCT Int. Appl. <span class="NLM_patent">WO2010/143116</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+Bur&author=O.+Corminboeuf&author=S.+Cren&author=C.+Grisostomi&author=X.+Leroy&author=S.+Richard-Bikdstein&title=Fluorinated+Aminotriazole+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBur%26aufirst%3DD.%26atitle%3DFluorinated%2520Aminotriazole%2520Derivatives%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qin, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horlock, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourke, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, R. H.</span></span> <span> </span><span class="NLM_article-title">Small-molecule-biased formyl peptide receptor agonist compound 17b protects agonist myocardial ischaemia-reperfusion injury in mice</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">14232</span>, <span class="refDoi"> DOI: 10.1038/ncomms14232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1038%2Fncomms14232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=28169296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlCrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=14232&author=C.+X.+Qinauthor=L.+T.+Mayauthor=R.+Liauthor=N.+Caoauthor=S.+Rosliauthor=M.+Deoauthor=A.+E.+Alexanderauthor=D.+Horlockauthor=J.+E.+Bourkeauthor=Y.+H.+Yangauthor=A.+G.+Stewartauthor=D.+M.+Kayeauthor=X.-J.+Duauthor=P.+M.+Sextonauthor=A.+Christopoulosauthor=X.-M.+Gaoauthor=R.+H.+Ritchie&title=Small-molecule-biased+formyl+peptide+receptor+agonist+compound+17b+protects+agonist+myocardial+ischaemia-reperfusion+injury+in+mice&doi=10.1038%2Fncomms14232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice</span></div><div class="casAuthors">Qin, Cheng Xue; May, Lauren T.; Li, Renming; Cao, Nga; Rosli, Sarah; Deo, Minh; Alexander, Amy E.; Horlock, Duncan; Bourke, Jane E.; Yang, Yuan H.; Stewart, Alastair G.; Kaye, David M.; Du, Xiao-Jun; Sexton, Patrick M.; Christopoulos, Arthur; Gao, Xiao-Ming; Ritchie, Rebecca H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14232</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Effective treatment for managing myocardial infarction (MI) remains an urgent, unmet clin. need.  Formyl peptide receptors (FPR) regulate inflammation, a major contributing mechanism to cardiac injury following MI.  Here we demonstrate that FPR1/FPR2-biased agonism may represent a novel therapeutic strategy for the treatment of MI.  The small-mol. FPR1/FPR2 agonist, Compd. 17b (Cmpd17b), exhibits a distinct signalling fingerprint to the conventional FPR1/FPR2 agonist, Compd.-43 (Cmpd43).  In Chinese hamster ovary (CHO) cells stably transfected with human FPR1 or FPR2, Compd17b is biased away from potentially detrimental FPR1/2-mediated calcium mobilization, but retains the pro-survival signalling, ERK1/2 and Akt phosphorylation, relative to Compd43.  The pathol. importance of the biased agonism of Cmpd17b is demonstrable as superior cardioprotection in both in vitro (cardiomyocytes and cardiofibroblasts) and MI injury in mice in vivo.  These findings reveal new insights for development of small mol. FPR agonists with an improved cardioprotective profile for treating MI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpip9WEaLzP6rVg90H21EOLACvtfcHk0lgm0SSMNUTUpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlCrsL8%253D&md5=d1e05a2f97268a088d54d7b54491f8cd</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fncomms14232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms14232%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DC.%2BX.%26aulast%3DMay%26aufirst%3DL.%2BT.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DCao%26aufirst%3DN.%26aulast%3DRosli%26aufirst%3DS.%26aulast%3DDeo%26aufirst%3DM.%26aulast%3DAlexander%26aufirst%3DA.%2BE.%26aulast%3DHorlock%26aufirst%3DD.%26aulast%3DBourke%26aufirst%3DJ.%2BE.%26aulast%3DYang%26aufirst%3DY.%2BH.%26aulast%3DStewart%26aufirst%3DA.%2BG.%26aulast%3DKaye%26aufirst%3DD.%2BM.%26aulast%3DDu%26aufirst%3DX.-J.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DX.-M.%26aulast%3DRitchie%26aufirst%3DR.%2BH.%26atitle%3DSmall-molecule-biased%2520formyl%2520peptide%2520receptor%2520agonist%2520compound%252017b%2520protects%2520agonist%2520myocardial%2520ischaemia-reperfusion%2520injury%2520in%2520mice%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D14232%26doi%3D10.1038%2Fncomms14232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stalder, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lott, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruz, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groenen, P. M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingemanse, J.</span></span> <span> </span><span class="NLM_article-title">Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2/ALX agonist ACT-389949</span>. <i>Br. J. Clin. Parmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">476</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1111/bcp.13149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1111%2Fbcp.13149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=27730665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC2sXis1WjtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2017&pages=476-486&author=A.+K.+Stalderauthor=D.+Lottauthor=D.+S.+Strasserauthor=H.+G.+Cruzauthor=A.+Krauseauthor=P.+M.+A.+Groenenauthor=J.+Dingemanse&title=Biomarker-guided+clinical+development+of+the+first-in-class+anti-inflammatory+FPR2%2FALX+agonist+ACT-389949&doi=10.1111%2Fbcp.13149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2/ALX agonist ACT-389949</span></div><div class="casAuthors">Stalder, Anna K.; Lott, Dominik; Strasser, Daniel S.; Cruz, Hans G.; Krause, Andreas; Groenen, Peter M. A.; Dingemanse, Jasper</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">476-486</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The main objectives of these two phase I studies were to investigate safety and tolerability as well as the pharmacokinetic/pharmacodynamic profile of the novel potent and selective formyl peptide receptor type 2 (FPR2)/Lipoxin A4 receptor (ALX) agonist ACT-389949.  A challenge model was used to assess the drug's anti-inflammatory potential, with the aim of selecting a dosing regimen for future patient studies.  Two double-blind, randomized phase I studies investigated the safety, tolerability, pharmacokinetics and pharmacodynamics of ACT-389949 at different doses and dosing regimens.  Drug exposure was correlated with target engagement markers such as receptor internalization and cytokine measurements.  The effect of FPR2/ALX agonism on neutrophil migration was studied in a lipopolysaccharide (LPS) inhalation model.  ACT-389949 was well tolerated.  Maximum concns. were reached around 2 h after dosing, with a mean terminal half-life of 29.3 h [95% confidence interval (CI) 25.5, 33.7].  After multiple-dose administration, exposure increased by 111% (95% CI 89, 136), indicating drug accumulation.  Administration of ACT-389949 resulted in a dose-dependent, long-lasting internalization of FPR2/ALX into leukocytes.  Pro- and anti-inflammatory cytokines were dose-dependently but transiently upregulated only after the first dose.  No pharmacol. effect on neutrophil count was obsd. in the LPS challenge test performed at steady state.  FPR2/ALX agonism with ACT-389949 was shown to be safe and well tolerated in healthy subjects.  Receptor internalization and downstream mediators pointed towards a desensitization of the system, which may explain the lack of effect on neutrophil recruitment in the LPS challenge model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoApTxECNNIvbVg90H21EOLACvtfcHk0lhdLqsjU50hKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXis1WjtL8%253D&md5=495d4c4768dcd2727a1914ad38854c88</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fbcp.13149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.13149%26sid%3Dliteratum%253Aachs%26aulast%3DStalder%26aufirst%3DA.%2BK.%26aulast%3DLott%26aufirst%3DD.%26aulast%3DStrasser%26aufirst%3DD.%2BS.%26aulast%3DCruz%26aufirst%3DH.%2BG.%26aulast%3DKrause%26aufirst%3DA.%26aulast%3DGroenen%26aufirst%3DP.%2BM.%2BA.%26aulast%3DDingemanse%26aufirst%3DJ.%26atitle%3DBiomarker-guided%2520clinical%2520development%2520of%2520the%2520first-in-class%2520anti-inflammatory%2520FPR2%252FALX%2520agonist%2520ACT-389949%26jtitle%3DBr.%2520J.%2520Clin.%2520Parmacol.%26date%3D2017%26volume%3D83%26spage%3D476%26epage%3D486%26doi%3D10.1111%2Fbcp.13149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kirpotina, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khlebnikov, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepetkin, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiet, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jutila, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, M. T.</span></span> <span> </span><span class="NLM_article-title">identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1124/mol.109.060673</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1124%2Fmol.109.060673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=19903830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFeitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=159-170&author=L.+N.+Kirpotinaauthor=A.+I.+Khlebnikovauthor=I.+A.+Schepetkinauthor=R.+D.+Yeauthor=M.-J.+Rabietauthor=M.+A.+Jutilaauthor=M.+T.+Quinn&title=identification+of+novel+small-molecule+agonists+for+human+formyl+peptide+receptors+and+pharmacophore+models+of+their+recognition&doi=10.1124%2Fmol.109.060673"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition</span></div><div class="casAuthors">Kirpotina, Liliya N.; Khlebnikov, Andrei I.; Schepetkin, Igor A.; Ye, Richard D.; Rabiet, Marie-Josephe; Jutila, Mark A.; Quinn, Mark T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-170</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">N-formyl peptide receptor (FPR1) and N-formyl peptide receptor-like 1 (FPRL1, now known as FPR2) are G protein-coupled receptors involved in host defense and sensing cellular dysfunction.  Because of the potential for FPR1/FPR2 as a therapeutic target, our recent high-throughput screening efforts have focused on the identification of unique nonpeptide agonists of FPR1/FPR2.  In the present studies, we screened a chemolibrary of drug-like mols. for their ability to induce intracellular calcium mobilization in RBL-2H3 cells transfected with human FPR1 or FPR2.  Screening of these compds. resulted in the identification of novel and potent agonists that activated both FPR1 and FPR2, as well as compds. that were specific for either FPR1 or FPR2 with EC50 values in the low micromolar range.  Specificity of the compds. was supported by anal. of calcium mobilization in HL-60 cells transfected with human FPR1 and FPR2.  In addn., all but one agonist activated intracellular calcium flux and chemotaxis in human neutrophils, irresp. of agonist specificity for FPR1 or FPR2.  Mol. modeling of the group of FPR1 and FPR2-agonists using field point methodol. allowed us to create pharmacophore models for ligand binding sites and formulate requirements for these specific N-formyl peptide receptor agonists.  These studies further demonstrate that agonists of FPR1/FPR2 include compds. with wide chem. diversity and that anal. of such compds. can enhance our understanding of their ligand/receptor interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGOcc3Pr_QbrVg90H21EOLACvtfcHk0lhdLqsjU50hKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFeitL4%253D&md5=dc61b162bf12dcc374a17b25b6e13cee</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fmol.109.060673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.109.060673%26sid%3Dliteratum%253Aachs%26aulast%3DKirpotina%26aufirst%3DL.%2BN.%26aulast%3DKhlebnikov%26aufirst%3DA.%2BI.%26aulast%3DSchepetkin%26aufirst%3DI.%2BA.%26aulast%3DYe%26aufirst%3DR.%2BD.%26aulast%3DRabiet%26aufirst%3DM.-J.%26aulast%3DJutila%26aufirst%3DM.%2BA.%26aulast%3DQuinn%26aufirst%3DM.%2BT.%26atitle%3Didentification%2520of%2520novel%2520small-molecule%2520agonists%2520for%2520human%2520formyl%2520peptide%2520receptors%2520and%2520pharmacophore%2520models%2520of%2520their%2520recognition%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D77%26spage%3D159%26epage%3D170%26doi%3D10.1124%2Fmol.109.060673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zarei, M.</span></span> <span> </span><span class="NLM_article-title">A straightforward approach to 2-azetidinones from imines and carboxylic acids using dimethylsulfoxide and acetic anhydride</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5354</span>– <span class="NLM_lpage">5357</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2014.07.089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1016%2Fj.tetlet.2014.07.089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlWmtbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=5354-5357&author=M.+Zarei&title=A+straightforward+approach+to+2-azetidinones+from+imines+and+carboxylic+acids+using+dimethylsulfoxide+and+acetic+anhydride&doi=10.1016%2Fj.tetlet.2014.07.089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">A straightforward approach to 2-azetidinones from imines and carboxylic acids using dimethyl sulfoxide and acetic anhydride</span></div><div class="casAuthors">Zarei, Maaroof</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">5354-5357</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The direct synthesis of 2-azetidinones from imines and carboxylic acids under mild conditions is developed.  DMSO (DMSO) can be activated by acetic anhydride and the resulting active species is used for the in situ generation of ketenes from carboxylic acids.  This method is cheap, simple, convenient, and efficient and the products are easily isolated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohnKQwVi6VULVg90H21EOLACvtfcHk0lhdLqsjU50hKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlWmtbvK&md5=75773167d9186b7b5e2627683635ce83</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2014.07.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2014.07.089%26sid%3Dliteratum%253Aachs%26aulast%3DZarei%26aufirst%3DM.%26atitle%3DA%2520straightforward%2520approach%2520to%25202-azetidinones%2520from%2520imines%2520and%2520carboxylic%2520acids%2520using%2520dimethylsulfoxide%2520and%2520acetic%2520anhydride%26jtitle%3DTetrahedron%2520Lett.%26date%3D2014%26volume%3D55%26spage%3D5354%26epage%3D5357%26doi%3D10.1016%2Fj.tetlet.2014.07.089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zarei, M.</span></span> <span> </span><span class="NLM_article-title">β-Lactam preparation via Staudinger reaction with activated dimethylsulfoxide</span>. <i>J. Hetrocycl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1161</span>– <span class="NLM_lpage">1166</span>, <span class="refDoi"> DOI: 10.1002/jhet.2685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1002%2Fjhet.2685" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2017&pages=1161-1166&author=M.+Zarei&title=%CE%B2-Lactam+preparation+via+Staudinger+reaction+with+activated+dimethylsulfoxide&doi=10.1002%2Fjhet.2685"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1002%2Fjhet.2685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.2685%26sid%3Dliteratum%253Aachs%26aulast%3DZarei%26aufirst%3DM.%26atitle%3D%25CE%25B2-Lactam%2520preparation%2520via%2520Staudinger%2520reaction%2520with%2520activated%2520dimethylsulfoxide%26jtitle%3DJ.%2520Hetrocycl.%2520Chem.%26date%3D2017%26volume%3D54%26spage%3D1161%26epage%3D1166%26doi%3D10.1002%2Fjhet.2685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">Studies on monocyclic β-lactams. (I). Synthesis of 3-hydroxy-4-substituted-2-azetidinones</span>. <i>Gaodeng Xuexiao Huaxue Xuebao</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">919</span>– <span class="NLM_lpage">922</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1992&pages=919-922&author=M.+Guoauthor=J.+Minauthor=R.+Liauthor=L.+Zhang&title=Studies+on+monocyclic+%CE%B2-lactams.+%28I%29.+Synthesis+of+3-hydroxy-4-substituted-2-azetidinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DMin%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DStudies%2520on%2520monocyclic%2520%25CE%25B2-lactams.%2520%2528I%2529.%2520Synthesis%2520of%25203-hydroxy-4-substituted-2-azetidinones%26jtitle%3DGaodeng%2520Xuexiao%2520Huaxue%2520Xuebao%26date%3D1992%26volume%3D13%26spage%3D919%26epage%3D922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, D.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">Notable and obvious ketene substituent-dependent effect pf temperature on the stereoselectivity in the Staudinger reaction</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">990</span>– <span class="NLM_lpage">997</span>, <span class="refDoi"> DOI: 10.1021/jo0622734</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0622734" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Cltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=990-997&author=B.+Liauthor=Y.+Wangauthor=D.-M.+Duauthor=J.+Xu&title=Notable+and+obvious+ketene+substituent-dependent+effect+pf+temperature+on+the+stereoselectivity+in+the+Staudinger+reaction&doi=10.1021%2Fjo0622734"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Notable and Obvious Ketene Substituent-Dependent Effect of Temperature on the Stereoselectivity in the Staudinger Reaction</span></div><div class="casAuthors">Li, Bonan; Wang, Yikai; Du, Da-Ming; Xu, Jiaxi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">990-997</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A notable and obvious ketene substituent-dependent effect of temp. on the stereoselectivity in the Staudinger reaction was obsd.  Most Staudinger reactions show concave Eyring plots characterized by two lines with an inversion point, following the principle of isoinversion.  Their cis-selectivities decrease with increasing temp.  Reactions involving intramol. p-π and π-π interactions between the ketene substituents and imine C-substituents reveal protruding, S-shaped or straight-line Eyring plots.  Their cis-selectivities increase with increasing temp. in a certain temp. region because such interactions enhance the cis-selectivity.  Staudinger reactions involving cyclic imines with different ketenes clearly indicate that the temp.-dependent stereoselectivity is caused by the different rate increases of the direct ring closure, which are affected by the p-π and π-π interactions between ketene substituents and imine C-substituents if they exist, and the isomerization of the zwitterionic intermediates generated from ketenes and imines during the change in the reaction temp., not by the competition of the imine exo and endo attacks to the ketenes.  Our results also indicate that nonlinear Eyring plots do not always reveal a change of the stereoselectivity-detg. step.  Thus, one should use them carefully to det. any changes in the stereoselectivity-detg. step during the change in the reaction temp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr_cT2SzJI_bVg90H21EOLACvtfcHk0ljEhPiY9MujYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Cltg%253D%253D&md5=50076048798022c2a9cafcfe74347fb2</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo0622734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0622734%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DD.-M.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DNotable%2520and%2520obvious%2520ketene%2520substituent-dependent%2520effect%2520pf%2520temperature%2520on%2520the%2520stereoselectivity%2520in%2520the%2520Staudinger%2520reaction%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26spage%3D990%26epage%3D997%26doi%3D10.1021%2Fjo0622734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gairaud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lappin, G. R.</span></span> <span> </span><span class="NLM_article-title">The synthesis of ω-nitrostyrenes</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1953</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">3</span>, <span class="refDoi"> DOI: 10.1021/jo01129a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01129a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADyaG2cXntFSm" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1953&pages=1-3&author=C.+Gairaudauthor=G.+R.+Lappin&title=The+synthesis+of+%CF%89-nitrostyrenes&doi=10.1021%2Fjo01129a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis of ω-nitrostyrenes</span></div><div class="casAuthors">Gairaud, Catherine B.; Lappin, Gerald R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1953</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-3</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Adding 5 cc. 5% NH2Me in MeOH to 0.1 mol aldehyde (I) and 0.15 mol R'''CH2NO2 in sufficient MeOH to dissolve I (method A) gives 2,3,4-RR'R''C6H2CH:CR'''NO2 (II) in addn. to some higher condensation products [e.g. BzH and MeNO2 give a compd. (C8H7NO2)3, pink crystals, m. 216-18°].  Refluxing 5 cc. R'''CH2NO2, 5 g. I, and 2 g. NH4OAc in 20 cc. AcOH 2 h. and pouring the mixt. into ice H2O give II (method B).  The following II are prepd. (R, R', R'', R''', % yield according to method A and B, m.p. in the order given): H, H, H, H, 55, 60, 58-9°; H, H, HO, H, 20, 60, 168-9°; MeO, H, H, H,, 50, 82, 48-9°; H, H, MeO, H, 40, 65, 86-7°; EtO,H H, H, 30, 20, 37-8°; MeO, MeO, H, H, 50, 60, 84-5°; H, MeO, MeO, H, 80, 70, 141-2°; H, MeO, HO, H, 95, 50, 167-8°; H, EtO, HO, H, 75, 78, 170-1°; HO, MeO, H, H, 45, 75, 122-4°; H, H, H, Me, 52, 55, 64-5°; H, H, HO, Me, 0, 35, 124-5°; H, H, MeO, Me, 60, 80, 44-5°; H, MeO, MeO, Me, 30, 35, 67-8°; MeO, MeO, H, Me, 50, 75, 78-9°; H, MeO, HO, Me, trace, 20, 100-1°; H, EtO, HO, Me, trace, 50, 108-9°; HO, MeO, H, Me, trace 45, 104-5°; MeO, MeO, H, Et, 0, 60, 64-5°; H, MeO, MeO, Et, 0, 52, 78-9°; H, MeO, HO, Et, 0, 40, 79-80°; MeO, H, H, Et, 0, 34, oil; H, MeO, H, Et, -, -, oil; EtO, H, H, Et, -, -, oil.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6InXphQEQRLVg90H21EOLACvtfcHk0ljEhPiY9MujYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG2cXntFSm&md5=575e942fcb809cf39c164e33455f7211</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo01129a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01129a001%26sid%3Dliteratum%253Aachs%26aulast%3DGairaud%26aufirst%3DC.%26aulast%3DLappin%26aufirst%3DG.%2BR.%26atitle%3DThe%2520synthesis%2520of%2520%25CF%2589-nitrostyrenes%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1953%26volume%3D18%26spage%3D1%26epage%3D3%26doi%3D10.1021%2Fjo01129a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Stereospecificity of the photorearrangement of nitronate anions and its utilization for stereospecific cleavage of cyclic compounds</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2327</span>– <span class="NLM_lpage">2330</span>, <span class="refDoi"> DOI: 10.1021/jo00387a049</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00387a049" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADyaL2sXktlykt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1987&pages=2327-2330&author=K.+Yamadaauthor=K.+Kishikawaauthor=M.+Yamamoto&title=Stereospecificity+of+the+photorearrangement+of+nitronate+anions+and+its+utilization+for+stereospecific+cleavage+of+cyclic+compounds&doi=10.1021%2Fjo00387a049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Stereospecificity of the photorearrangement of nitronate anions and its utilization for stereospecific cleavage of cyclic compounds</span></div><div class="casAuthors">Yamada, Kazutoshi; Kishikawa, Keiki; Yamamoto, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2327-30</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The stereospecificity of the photorearrangement of nitronate anions was demonstrated.  Several nitro compds. [methyl 2-nitrocyclohexaneacetate (I), 1.7.7-trimethyl-2-nitrobicyclo[2.2.1]heptane, 2-nitro-3-phenylbicyclo[2.2.1]heptane, N-butyl-3-nitrobicyclo[2.2.1]-heptane-2-carboxamide, and N-butyl-3-nitro-7-oxabicyclo[2.2.1]heptane-2-carboxamide] were irradiated in MeONa/MeOH or NH3/MeOH, using a low-pressure mercury lamp to produce in each case a hydroxamic acid.  Thus, irradn. of I produced azepine deriv. II.  From 1H NMR study, abs. retention was obsd. during the photorearrangement.  A route by which the nitro group is utilized as an essential element in a 3-ring cleavage of cyclic compds. was developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaM8b6WSV_GbVg90H21EOLACvtfcHk0ljEhPiY9MujYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXktlykt7c%253D&md5=c630e376f1011a930ab63e9a1068ce09</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjo00387a049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00387a049%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DKishikawa%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DStereospecificity%2520of%2520the%2520photorearrangement%2520of%2520nitronate%2520anions%2520and%2520its%2520utilization%2520for%2520stereospecific%2520cleavage%2520of%2520cyclic%2520compounds%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1987%26volume%3D52%26spage%3D2327%26epage%3D2330%26doi%3D10.1021%2Fjo00387a049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ronsen, B.</span>; <span class="NLM_string-name">Upadiyaya, S. P.</span></span> <span> </span><span class="NLM_article-title">Process for Preparing Arylpiperidine Carbinol Intermediates and Derivatives</span>. PCT Int. Appl. <span class="NLM_patent">WO2000/037443</span>, <span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=B.+Ronsen&author=S.+P.+Upadiyaya&title=Process+for+Preparing+Arylpiperidine+Carbinol+Intermediates+and+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRonsen%26aufirst%3DB.%26atitle%3DProcess%2520for%2520Preparing%2520Arylpiperidine%2520Carbinol%2520Intermediates%2520and%2520Derivatives%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, D.</span></span> <span> </span><span class="NLM_article-title">Scope and mechanism of enantioselective Michael additions of 1,3-dicarbonyl compounds to nitroalkenes catalyzed by nickel(II)-diamine complexes</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">11583</span>– <span class="NLM_lpage">11592</span>, <span class="refDoi"> DOI: 10.1021/ja0735913</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0735913" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsVelu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=11583-11592&author=D.+A.+Evansauthor=S.+Mitoauthor=D.+Seidel&title=Scope+and+mechanism+of+enantioselective+Michael+additions+of+1%2C3-dicarbonyl+compounds+to+nitroalkenes+catalyzed+by+nickel%28II%29-diamine+complexes&doi=10.1021%2Fja0735913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">Scope and Mechanism of Enantioselective Michael Additions of 1,3-Dicarbonyl Compounds to Nitroalkenes Catalyzed by Nickel(II)-Diamine Complexes</span></div><div class="casAuthors">Evans, David A.; Mito, Shizue; Seidel, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">11583-11592</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Readily prepd. Ni(II)-bis[(R,R)-N,N'-dibenzylcyclohexane-1,2-diamine]Br2 was shown to catalyze the Michael addn. of 1,3-dicarbonyl compds. to nitroalkenes at room temp. in good yields with high enantioselectivities.  The two diamine ligands in this system each play a distinct role: one serves as a chiral ligand to provide stereoinduction in the addn. step while the other functions as a base for substrate enolization.  Ligand modification within the catalyst was also investigated to facilitate the reaction of aliph. nitroalkenes, 1,3-diketones, and β-ketoacids.  Ni(II)-bis[(R,R)-N,N'-di-p-bromobenzylcyclohexane-1,2-diamine]Br2 was found to be an effective catalyst in these instances.  Furthermore, monodiamine complex, Ni(II)-[(R,R)-N,N'-dibenzylcyclohexane-1,2-diamine]Br2, catalyzed the addn. reaction in the presence of water.  The proposed model for stereochem. induction is shown to be consistent with X-ray structure anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooci96-aJCLrVg90H21EOLACvtfcHk0lhynKdbTAL8zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsVelu7Y%253D&md5=3c3e55b7672928924f22da91dfd3d3e9</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1021%2Fja0735913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0735913%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BA.%26aulast%3DMito%26aufirst%3DS.%26aulast%3DSeidel%26aufirst%3DD.%26atitle%3DScope%2520and%2520mechanism%2520of%2520enantioselective%2520Michael%2520additions%2520of%25201%252C3-dicarbonyl%2520compounds%2520to%2520nitroalkenes%2520catalyzed%2520by%2520nickel%2528II%2529-diamine%2520complexes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D11583%26epage%3D11592%26doi%3D10.1021%2Fja0735913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Okino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furukawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takemoto, Y.</span></span> <span> </span><span class="NLM_article-title">Enantio- and diastereoselective Michael reaction of 1,3-dicarbonyl compounds to nitroolefins catalyzed by a bifunctional thiourea</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1021/ja044370p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja044370p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVCrurbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=119-125&author=T.+Okinoauthor=Y.+Hoashiauthor=T.+Furukawaauthor=X.+Xuauthor=Y.+Takemoto&title=Enantio-+and+diastereoselective+Michael+reaction+of+1%2C3-dicarbonyl+compounds+to+nitroolefins+catalyzed+by+a+bifunctional+thiourea&doi=10.1021%2Fja044370p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">Enantio- and Diastereoselective Michael Reaction of 1,3-Dicarbonyl Compounds to Nitroolefins Catalyzed by a Bifunctional Thiourea</span></div><div class="casAuthors">Okino, Tomotaka; Hoashi, Yasutaka; Furukawa, Tomihiro; Xu, Xuenong; Takemoto, Yoshiji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-125</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of bifunctional catalysts bearing a thiourea moiety and an amino group on a chiral scaffold was synthesized.  Among them, thiourea I was revealed to be highly efficient for the asym. Michael reaction of 1,3-dicarbonyl compds. to nitroolefins.  Furthermore, a new synthetic route for (R)-(-)-baclofen and the generation of a chiral quaternary carbon center with high enantioselectivity by Michael reaction were developed.  In these reactions, it was assumed that the thiourea moiety and the amino group of the catalyst activates the nitroolefin and the 1,3-dicarbonyl compd., resp., to afford the Michael adduct with high enantio- and diastereoselectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIOOIirlLPDrVg90H21EOLACvtfcHk0lhynKdbTAL8zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVCrurbI&md5=4e6e4f379f3cc8814dc931666a0ce881</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1021%2Fja044370p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja044370p%26sid%3Dliteratum%253Aachs%26aulast%3DOkino%26aufirst%3DT.%26aulast%3DHoashi%26aufirst%3DY.%26aulast%3DFurukawa%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DTakemoto%26aufirst%3DY.%26atitle%3DEnantio-%2520and%2520diastereoselective%2520Michael%2520reaction%2520of%25201%252C3-dicarbonyl%2520compounds%2520to%2520nitroolefins%2520catalyzed%2520by%2520a%2520bifunctional%2520thiourea%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D119%26epage%3D125%26doi%3D10.1021%2Fja044370p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit29c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span> <span> </span><span class="NLM_article-title">Highly enantioselective conjugate addition of malonate and β-ketoester to nitroalkenes: Asymmetric C–C bond formation with new bifunctional organic catalysts based on cinchona alkaloids</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">9906</span>– <span class="NLM_lpage">9907</span>, <span class="refDoi"> DOI: 10.1021/ja047281l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja047281l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFGju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=9906-9907&author=H.+Liauthor=Y.+Wangauthor=L.+Tangauthor=L.+Deng&title=Highly+enantioselective+conjugate+addition+of+malonate+and+%CE%B2-ketoester+to+nitroalkenes%3A+Asymmetric+C%E2%80%93C+bond+formation+with+new+bifunctional+organic+catalysts+based+on+cinchona+alkaloids&doi=10.1021%2Fja047281l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29cR"><div class="casContent"><span class="casTitleNuber">29c</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Enantioselective Conjugate Addition of Malonate and β-Ketoester to Nitroalkenes: Asymmetric C-C Bond Formation with New Bifunctional Organic Catalysts Based on Cinchona Alkaloids</span></div><div class="casAuthors">Li, Hongming; Wang, Yi; Tang, Liang; Deng, Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">9906-9907</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Quinine and quinidine derivs. such as I and II are prepd.; in the presence of I or II, nitroalkanes (E)-RCH:CHNO2 (R = Ph, 4-FC6H4, 4-ClC6H4, 4-BrC6H4, 4-MeC6H4, 4-Me2CHC6H4, 4-MeOC6H4, 3-MeC6H4, 2-MeC6H4, 2-FC6H4, 2-O2NC6H4, 1-naphthyl, 2-thienyl, 2-furyl, 3-pyridinyl, BuCH2, Me2CHCH2, c-C6H11) undergo enantioselective addn. reactions with di-Me malonate to provide either enantiomer of the nitroesters O2NCH2CHRCH(CO2Me)2 (III) (R = Ph, 4-FC6H4, 4-ClC6H4, 4-BrC6H4, 4-MeC6H4, 4-Me2CHC6H4, 4-MeOC6H4, 3-MeC6H4, 2-MeC6H4, 2-FC6H4, 2-O2NC6H4, 1-naphthyl, 2-thienyl, 2-furyl, 3-pyridinyl, BuCH2, Me2CHCH2, c-C6H11) in 71-99% yields and in 91-97% ee.  Aryl, heteroaryl, and alkyl-substituted nitroalkenes give conjugate addn. products in high yields and enantioselectivities.  Cinchona alkaloids with a 6'-hydroxy group yield III with much higher enantioselectivities than those bearing 6'-methoxy groups; etherification of the secondary alc. of alkaloids such as I or II alters the enantioselectivity and yield of Michael addn. reactions catalyzed by them minimally.  The enantioselectivity of Michael addns. catalyzed by I and II is attributed to bifunctional catalysis using both the 6'-hydroxy group and the quinuclidine amine moiety.  Kinetic studies on the addn. of di-Me malonate to III (R = Ph) in the presence of I indicate that the rate of reaction is first order in nitroalkene, di-Me malonate, and catalyst.  Et acetoacetate undergoes conjugate addn. to trans-β-nitrostyrene III (R = Ph) to yield γ-nitro ester O2NCH2CHPhCHAcCO2Et as a 1:1 mixt. of diastereomers at the α-acetyl ester in 93% yield; both diastereomers are isolated in 91% ee.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUvuQac6sfYLVg90H21EOLACvtfcHk0lhynKdbTAL8zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFGju7k%253D&md5=115a9882869c0f81628f0a3b22fcf9b0</span></div><a href="/servlet/linkout?suffix=cit29c&amp;dbid=16384&amp;doi=10.1021%2Fja047281l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja047281l%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DL.%26atitle%3DHighly%2520enantioselective%2520conjugate%2520addition%2520of%2520malonate%2520and%2520%25CE%25B2-ketoester%2520to%2520nitroalkenes%253A%2520Asymmetric%2520C%25E2%2580%2593C%2520bond%2520formation%2520with%2520new%2520bifunctional%2520organic%2520catalysts%2520based%2520on%2520cinchona%2520alkaloids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D9906%26epage%3D9907%26doi%3D10.1021%2Fja047281l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hynes, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, D. J.</span></span> <span> </span><span class="NLM_article-title">Organocatalytic asymmetric total synthesis of (R)-Rolipram and formal synthesis of (3S,4R)-Paroxetine</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1389</span>– <span class="NLM_lpage">1391</span>, <span class="refDoi"> DOI: 10.1021/ol800108u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol800108u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivV2nsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=1389-1391&author=P.+S.+Hynesauthor=P.+A.+Stuppleauthor=D.+J.+Dixon&title=Organocatalytic+asymmetric+total+synthesis+of+%28R%29-Rolipram+and+formal+synthesis+of+%283S%2C4R%29-Paroxetine&doi=10.1021%2Fol800108u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Organocatalytic Asymmetric Total Synthesis of (R)-Rolipram and Formal Synthesis of (3S,4R)-Paroxetine</span></div><div class="casAuthors">Hynes, Peter S.; Stupple, Paul A.; Dixon, Darren J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1389-1391</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient enantioselective total synthesis of (R)-rolipram (I) and an efficient enantioselective formal synthesis of (3S,4R)-paroxetine (II) have been achieved using the highly enantioselective Michael addn. of di-Me malonate as the nucleophile as key steps in both cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4VPhNqMJqErVg90H21EOLACvtfcHk0ljhLfoS4JWpxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivV2nsrc%253D&md5=51c2c737a5e85782c9441de53ffded79</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fol800108u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol800108u%26sid%3Dliteratum%253Aachs%26aulast%3DHynes%26aufirst%3DP.%2BS.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DDixon%26aufirst%3DD.%2BJ.%26atitle%3DOrganocatalytic%2520asymmetric%2520total%2520synthesis%2520of%2520%2528R%2529-Rolipram%2520and%2520formal%2520synthesis%2520of%2520%25283S%252C4R%2529-Paroxetine%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26spage%3D1389%26epage%3D1391%26doi%3D10.1021%2Fol800108u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23a','cit23b'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29a','cit29b','cit29c'],'ref30':['cit30']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ross  Doyle</span>, <span class="hlFld-ContribAuthor ">Catherine  Godson</span>. </span><span class="cited-content_cbyCitation_article-title">Endogenous antiinflammatory and proresolving lipid mediators in renal disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2022,</strong>,, 55-67. <a href="https://doi.org/10.1016/B978-0-12-823318-4.00009-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-823318-4.00009-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-823318-4.00009-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-823318-4.00009-3%26sid%3Dliteratum%253Aachs%26atitle%3DEndogenous%252Bantiinflammatory%252Band%252Bproresolving%252Blipid%252Bmediators%252Bin%252Brenal%252Bdisease%26aulast%3DDoyle%26aufirst%3DRoss%26date%3D2022%26spage%3D55%26epage%3D67%26pub%3DElsevier%26atitle%3DRegenerative%252BNephrology%26date%3D2022%26volume%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eoin  Brennan</span>, <span class="hlFld-ContribAuthor ">Phillip  Kantharidis</span>, <span class="hlFld-ContribAuthor ">Mark E.  Cooper</span>, <span class="hlFld-ContribAuthor ">Catherine  Godson</span>. </span><span class="cited-content_cbyCitation_article-title">Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Nephrology</span><span> <strong>2021,</strong> <em>157 </em><a href="https://doi.org/10.1038/s41581-021-00454-y" title="DOI URL">https://doi.org/10.1038/s41581-021-00454-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41581-021-00454-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41581-021-00454-y%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Nephrology%26atitle%3DPro-resolving%252Blipid%252Bmediators%25253A%252Bregulators%252Bof%252Binflammation%25252C%252Bmetabolism%252Band%252Bkidney%252Bfunction%26aulast%3DBrennan%26aufirst%3DEoin%26date%3D2021%26date%3D2021%26volume%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kinga  Tylek</span>, <span class="hlFld-ContribAuthor ">Ewa  Trojan</span>, <span class="hlFld-ContribAuthor ">Magdalena  Regulska</span>, <span class="hlFld-ContribAuthor ">Enza  Lacivita</span>, <span class="hlFld-ContribAuthor ">Marcello  Leopoldo</span>, <span class="hlFld-ContribAuthor ">Agnieszka  Basta-Kaim</span>. </span><span class="cited-content_cbyCitation_article-title">Formyl peptide receptor 2, as an important target for ligands triggering the inflammatory response regulation: a link to brain pathology. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reports</span><span> <strong>2021,</strong> <em>21 </em><a href="https://doi.org/10.1007/s43440-021-00271-x" title="DOI URL">https://doi.org/10.1007/s43440-021-00271-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s43440-021-00271-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs43440-021-00271-x%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reports%26atitle%3DFormyl%252Bpeptide%252Breceptor%252B2%25252C%252Bas%252Ban%252Bimportant%252Btarget%252Bfor%252Bligands%252Btriggering%252Bthe%252Binflammatory%252Bresponse%252Bregulation%25253A%252Ba%252Blink%252Bto%252Bbrain%252Bpathology%26aulast%3DTylek%26aufirst%3DKinga%26date%3D2021%26date%3D2021%26volume%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexia  Dumas</span>, <span class="hlFld-ContribAuthor ">Ulla G.  Knaus</span>. </span><span class="cited-content_cbyCitation_article-title">Raising the ‘Good’ Oxidants for Immune Protection. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fimmu.2021.698042" title="DOI URL">https://doi.org/10.3389/fimmu.2021.698042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2021.698042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2021.698042%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DRaising%252Bthe%252B%2525E2%252580%252598Good%2525E2%252580%252599%252BOxidants%252Bfor%252BImmune%252BProtection%26aulast%3DDumas%26aufirst%3DAlexia%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon  Lind</span>, <span class="hlFld-ContribAuthor ">Claes  Dahlgren</span>, <span class="hlFld-ContribAuthor ">Rikard  Holmdahl</span>, <span class="hlFld-ContribAuthor ">Peter  Olofsson</span>, <span class="hlFld-ContribAuthor ">Huamei  Forsman</span>. </span><span class="cited-content_cbyCitation_article-title">Functional selective FPR1 signaling in favor of an activation of the neutrophil superoxide generating NOX2 complex. </span><span class="cited-content_cbyCitation_journal-name">Journal of Leukocyte Biology</span><span> <strong>2021,</strong> <em>109 </em>
                                    (6)
                                     , 1105-1120. <a href="https://doi.org/10.1002/JLB.2HI0520-317R" title="DOI URL">https://doi.org/10.1002/JLB.2HI0520-317R</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/JLB.2HI0520-317R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2FJLB.2HI0520-317R%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Leukocyte%2520Biology%26atitle%3DFunctional%252Bselective%252BFPR1%252Bsignaling%252Bin%252Bfavor%252Bof%252Ban%252Bactivation%252Bof%252Bthe%252Bneutrophil%252Bsuperoxide%252Bgenerating%252BNOX2%252Bcomplex%26aulast%3DLind%26aufirst%3DSimon%26date%3D2021%26date%3D2020%26volume%3D109%26issue%3D6%26spage%3D1105%26epage%3D1120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianmin  Chen</span>, <span class="hlFld-ContribAuthor ">Lucy V.  Norling</span>, <span class="hlFld-ContribAuthor ">Dianne  Cooper</span>. </span><span class="cited-content_cbyCitation_article-title">Cardiac Dysfunction in Rheumatoid Arthritis: The Role of Inflammation. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2021,</strong> <em>10 </em>
                                    (4)
                                     , 881. <a href="https://doi.org/10.3390/cells10040881" title="DOI URL">https://doi.org/10.3390/cells10040881</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells10040881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells10040881%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DCardiac%252BDysfunction%252Bin%252BRheumatoid%252BArthritis%25253A%252BThe%252BRole%252Bof%252BInflammation%26aulast%3DChen%26aufirst%3DJianmin%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D4%26spage%3D881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monika  Maciuszek</span>, <span class="hlFld-ContribAuthor ">Antonino  Cacace</span>, <span class="hlFld-ContribAuthor ">Eoin  Brennan</span>, <span class="hlFld-ContribAuthor ">Catherine  Godson</span>, <span class="hlFld-ContribAuthor ">Timothy M.  Chapman</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the design and development of formyl peptide receptor 2 (FPR2/ALX) agonists as pro-resolving agents with diverse therapeutic potential. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113167. <a href="https://doi.org/10.1016/j.ejmech.2021.113167" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113167</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113167%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdesign%252Band%252Bdevelopment%252Bof%252Bformyl%252Bpeptide%252Breceptor%252B2%252B%252528FPR2%25252FALX%252529%252Bagonists%252Bas%252Bpro-resolving%252Bagents%252Bwith%252Bdiverse%252Btherapeutic%252Bpotential%26aulast%3DMaciuszek%26aufirst%3DMonika%26date%3D2021%26volume%3D213%26spage%3D113167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valentina Maria  Caso</span>, <span class="hlFld-ContribAuthor ">Valentina  Manzo</span>, <span class="hlFld-ContribAuthor ">Tiziana  Pecchillo Cimmino</span>, <span class="hlFld-ContribAuthor ">Valeria  Conti</span>, <span class="hlFld-ContribAuthor ">Pio  Caso</span>, <span class="hlFld-ContribAuthor ">Gabriella  Esposito</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Russo</span>, <span class="hlFld-ContribAuthor ">Amelia  Filippelli</span>, <span class="hlFld-ContribAuthor ">Rosario  Ammendola</span>, <span class="hlFld-ContribAuthor ">Fabio  Cattaneo</span>. </span><span class="cited-content_cbyCitation_article-title">Regulation of Inflammation and Oxidative Stress by Formyl Peptide Receptors in Cardiovascular Disease Progression. </span><span class="cited-content_cbyCitation_journal-name">Life</span><span> <strong>2021,</strong> <em>11 </em>
                                    (3)
                                     , 243. <a href="https://doi.org/10.3390/life11030243" title="DOI URL">https://doi.org/10.3390/life11030243</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/life11030243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Flife11030243%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%26atitle%3DRegulation%252Bof%252BInflammation%252Band%252BOxidative%252BStress%252Bby%252BFormyl%252BPeptide%252BReceptors%252Bin%252BCardiovascular%252BDisease%252BProgression%26aulast%3DCaso%26aufirst%3DValentina%2BMaria%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D3%26spage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monika  Maciuszek</span>, <span class="hlFld-ContribAuthor ">Almudena  Ortega-Gomez</span>, <span class="hlFld-ContribAuthor ">Sanne L.  Maas</span>, <span class="hlFld-ContribAuthor ">Mauro  Perretti</span>, <span class="hlFld-ContribAuthor ">Andy  Merritt</span>, <span class="hlFld-ContribAuthor ">Oliver  Soehnlein</span>, <span class="hlFld-ContribAuthor ">Timothy M.  Chapman</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of novel cyclopentane urea FPR2 agonists and their potential application in the treatment of cardiovascular inflammation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113194. <a href="https://doi.org/10.1016/j.ejmech.2021.113194" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113194</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113194%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bnovel%252Bcyclopentane%252Burea%252BFPR2%252Bagonists%252Band%252Btheir%252Bpotential%252Bapplication%252Bin%252Bthe%252Btreatment%252Bof%252Bcardiovascular%252Binflammation%26aulast%3DMaciuszek%26aufirst%3DMonika%26date%3D2021%26volume%3D214%26spage%3D113194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Synthesis of BMS-986235/LAR-1219. </span><span class="cited-content_cbyCitation_journal-name">Synfacts</span><span> <strong>2020,</strong>,, 1392. <a href="https://doi.org/10.1055/s-0040-1706385" title="DOI URL">https://doi.org/10.1055/s-0040-1706385</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1055/s-0040-1706385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1055%2Fs-0040-1706385%26sid%3Dliteratum%253Aachs%26jtitle%3DSynfacts%26atitle%3DSynthesis%252Bof%252BBMS-986235%25252FLAR-1219%26date%3D2020%26date%3D2020%26volume%3D16%26issue%3D12%26spage%3D1392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mauro  Perretti</span>, <span class="hlFld-ContribAuthor ">Catherine  Godson</span>. </span><span class="cited-content_cbyCitation_article-title">Formyl peptide receptor type 2 agonists to kick‐start resolution pharmacology. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2020,</strong> <em>177 </em>
                                    (20)
                                     , 4595-4600. <a href="https://doi.org/10.1111/bph.15212" title="DOI URL">https://doi.org/10.1111/bph.15212</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.15212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.15212%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DFormyl%252Bpeptide%252Breceptor%252Btype%252B2%252Bagonists%252Bto%252Bkick%2525E2%252580%252590start%252Bresolution%252Bpharmacology%26aulast%3DPerretti%26aufirst%3DMauro%26date%3D2020%26date%3D2020%26volume%3D177%26issue%3D20%26spage%3D4595%26epage%3D4600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02101&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0001.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of selected reported FPR2 agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02101&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure–activity relationship (SAR) summary of pyrrolidinone urea FPR2 agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02101&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of <b>13c</b> and captopril (ACEi) treatment on myocardial structure and function after LAD in mice. (A) Left ventricular pressure–volume curves. (B) Heart weights 28 days after MI. (C) Representative heart cross sections by histology depicting the degree of myocardial infarction. Noninfarcted surgical sham animals are shown for comparison. (D) Scar length 28 days after MI. Doses: <b>13c</b>, 0.3 mg kg<sup>–1</sup> d<sup>–1</sup>; captoril, 100 mg kg<sup>–1</sup> d<sup>–1</sup>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02101&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Azetidinone Urea Derivatives <b>3</b> and <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02101&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-(1,3-dioxoisoindolin-2-yl)acetyl chloride, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 28%; (b) CAN, MeCN–THF–H<sub>2</sub>O, 62%; (c) (1) hydrazine monohydrate, dioxane, (2) HCl, 53%; (d) 4-chlorophenyl isocyanate, sat. NaHCO<sub>3</sub> aq, AcOEt, 63%; (e) (1) MsCl, Et<sub>3</sub>N, (2) NaN<sub>3</sub>, DMF, 89%; (f) CAN, MeCN, 85%; (g) (1) PPh<sub>3</sub>, THF, (2) H<sub>2</sub>O, (3) 4-chlorophenyl isocyanate, 48% (three steps) .</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Pyrrolidinone Urea Derivatives <b>5</b> and <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02101&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>tert</i>-butyl (2,2,2-trifluoroacetyl)glycinate, LHMDS, THF, 88%; (b) TFA, 58%; (c) MeI, KHCO<sub>3</sub>, DMF, 92%; (d) (1) Zn, NH<sub>4</sub>Cl, MeOH–H<sub>2</sub>O, (2) 20% TiCl<sub>3</sub>, NaOAc, MeOH–H<sub>2</sub>O 63% (two steps); (e) 1 M aq NaOH, MeOH; (f) 4-chlorophenyl isocyanate, EtOAc, 4% (two steps for <b>5</b>), 44% (2 steps for <b>6</b>).</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Piperidinone Urea Derivative <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02101&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) dimethyl malonate, NaOMe, MeOH, 24%; (b) NaBH<sub>4</sub>, NiCl<sub>2</sub>·6H<sub>2</sub>O, MeOH, 65%; (c) 1 M NaOH, MeOH, 92%; (d) DPPA, Et<sub>3</sub>N, toluene, then 4-chloroaniline (6.5%).</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Optically Active <i>Cis</i>-Oriented Pyrrolidinone Urea Derivatives <b>8</b> and <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02101&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (1) ethyl 2-[(diphenylmethylene)amino]acetate, LDA, THF, (2) AcOH, H<sub>2</sub>O, (3) Boc<sub>2</sub>O, NaHCO<sub>3</sub> aq, THF, 63% (three steps); (b) (1) NaBH<sub>4</sub>, NiCl<sub>2</sub>·6H<sub>2</sub>O, MeOH, 84%, (2) HPLC separation, CHIRALPAK ID, 35% (for <b>32</b>), 43% (for <b>33</b>); (c) (1) TFA, CH<sub>2</sub>Cl<sub>2</sub>, (2) 4-chlorophenyl isocyanate, sat. NaHCO<sub>3</sub>, THF, 56% (two steps for <b>8</b>), 56% (two steps for <b>9</b>).</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Optically Active <i>Trans</i>-Oriented Pyrrolidinone Ureas <b>10</b> and <b>11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02101&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) dimethyl malonate, Ni(II)-bis[(<i>R</i>,<i>R)</i>-<i>N</i>,<i>N</i>′-dibenzylcyclohexane-1,2-diamine]bromide (3 mol %), toluene; (b) dimethyl malonate, Ni(II)-bis[(<i>S</i>,<i>S</i>)-<i>N</i>,<i>N</i>′-dibenzylcyclohexane-1,2-diamine]bromide (3 mol %), toluene; (c) NaBH<sub>4</sub>, NiCl<sub>2</sub>·6H<sub>2</sub>O, MeOH, 73% (two steps for <b>35</b>), 68% (two steps for <b>38</b>); (d) 1 M NaOH aq, MeOH, 88%, (for <b>36</b>), 98% (for <b>39</b>); (e) DPPA, Et<sub>3</sub>N, toluene, then 4-chloroaniline, 53% (for <b>10</b>), 24% (for <b>11a</b>); (f) DPPA, Et<sub>3</sub>N, toluene, then 4-fluoroaniline, 18% (for <b>11b</b>).</p></p></figure><figure data-id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/medium/jm9b02101_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Selected Compounds <b>12g</b>, <b>13c</b>, <b>13i</b>, <b>13l</b>, and <b>13n</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.9b02101/20200903/images/large/jm9b02101_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02101&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) MeNO<sub>2</sub>, ammonium acetate, AcOH, 95%; (b) dimethyl malonate, Ni(II)-bis[(<i>S</i>,<i>S</i>)-<i>N</i>,<i>N</i>′-dibenzylcyclohexane-1,2-diamine]bromide (3 mol %), toluene, 95%; (c) NaBH<sub>4</sub>, NiCl<sub>2</sub>·6H<sub>2</sub>O, MeOH, 55%; (d) 1 M NaOH aq, MeOH, 99%; (e) DPPA, Et<sub>3</sub>N, toluene then BnOH, 47%; (f) H<sub>2</sub>, 10% Pd–C, EtOH, 100%; (g) <b>44</b>, DPPA, Et<sub>3</sub>N, toluene then 4-fluoroaniline or 5-amino-2-methylphenol, 55% (for <b>12g</b>), 65% (for <b>13l</b>); (h) <b>46</b>, phenyl isocyanate or 3,4-difluorophenyl isocyanate, THF, 76% (for <b>13c</b>), 86% (for <b>13i</b>); (i) <b>46</b>, 2-chlorothiophene-5-carboxylic acid, DPPA, Et<sub>3</sub>N, toluene, 38% (for <b>13n</b>).</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i73">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13247" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13247" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 30 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boulay, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmentier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serhan, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, P. M.</span></span> <span> </span><span class="NLM_article-title">International union of basic and clinical pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1124/pr.109.001578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1124%2Fpr.109.001578" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=19498085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWmu7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2009&pages=119-161&author=R.+D.+Yeauthor=F.+Boulayauthor=J.+M.+Wangauthor=C.+Dahlgrenauthor=C.+Gerardauthor=M.+Parmentierauthor=C.+N.+Serhanauthor=P.+M.+Murphy&title=International+union+of+basic+and+clinical+pharmacology.+LXXIII.+Nomenclature+for+the+formyl+peptide+receptor+%28FPR%29+family&doi=10.1124%2Fpr.109.001578"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">International union of basic and clinical pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family</span></div><div class="casAuthors">Ye, Richard D.; Boulay, Francois; Wang, Ji Ming; Dahlgren, Claes; Gerard, Craig; Parmentier, Marc; Serhan, Charles N.; Murphy, Philip M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-161</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Formyl peptide receptors (FPRs) are a small group of seven-transmembrane domain, G protein-coupled receptors that are expressed mainly by mammalian phagocytic leukocytes and are known to be important in host defense and inflammation.  The three human FPRs (FPR1, FPR2/ALX, and FPR3) share significant sequence homol. and are encoded by clustered genes.  Collectively, these receptors bind an extraordinarily numerous and structurally diverse group of agonistic ligands, including N-formyl and nonformyl peptides of different compn., that chemoattract and activate phagocytes.  N-formyl peptides, which are encoded in nature only by bacterial and mitochondrial genes and result from obligatory initiation of bacterial and mitochondrial protein synthesis with N-formylmethionine, is the only ligand class common to all three human receptors.  Surprisingly, the endogenous anti-inflammatory peptide annexin 1 and its N-terminal fragments also bind human FPR1 and FPR2/ALX, and the anti-inflammatory eicosanoid lipoxin A4 is an agonist at FPR2/ALX.  In comparison, fewer agonists have been identified for FPR3, the third member in this receptor family.  Structural and functional studies of the FPRs have produced important information for understanding the general pharmacol. principles governing all leukocyte chemoattractant receptors.  This article aims to provide an overview of the discovery and pharmacol. characterization of FPRs, to introduce an International Union of Basic and Clin. Pharmacol. (IUPHAR)-recommended nomenclature, and to discuss unmet challenges, including the mechanisms used by these receptors to bind diverse ligands and mediate different biol. functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK2C5MK1gTQrVg90H21EOLACvtfcHk0lgl7iOZWx41UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWmu7jO&md5=b4c8b0c6642881d9c19c885301fd9c0a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1124%2Fpr.109.001578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.109.001578%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DR.%2BD.%26aulast%3DBoulay%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DJ.%2BM.%26aulast%3DDahlgren%26aufirst%3DC.%26aulast%3DGerard%26aufirst%3DC.%26aulast%3DParmentier%26aufirst%3DM.%26aulast%3DSerhan%26aufirst%3DC.%2BN.%26aulast%3DMurphy%26aufirst%3DP.%2BM.%26atitle%3DInternational%2520union%2520of%2520basic%2520and%2520clinical%2520pharmacology.%2520LXXIII.%2520Nomenclature%2520for%2520the%2520formyl%2520peptide%2520receptor%2520%2528FPR%2529%2520family%26jtitle%3DPharmacol.%2520Rev.%26date%3D2009%26volume%3D61%26spage%3D119%26epage%3D161%26doi%3D10.1124%2Fpr.109.001578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerard, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eddy, R. L.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shows, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerard, C.</span></span> <span> </span><span class="NLM_article-title">Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19</span>. <i>Genomics</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">440</span>, <span class="refDoi"> DOI: 10.1016/0888-7543(92)90265-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1016%2F0888-7543%2892%2990265-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1612600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADyaK3sXktVajs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1992&pages=437-440&author=L.+Baoauthor=N.+P.+Gerardauthor=R.+L.+Eddyauthor=T.+B.+Showsauthor=C.+Gerard&title=Mapping+of+genes+for+the+human+C5a+receptor+%28C5AR%29%2C+human+FMLP+receptor+%28FPR%29%2C+and+two+FMLP+receptor+homologue+orphan+receptors+%28FPRH1%2C+FPRH2%29+to+chromosome+19&doi=10.1016%2F0888-7543%2892%2990265-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homolog orphan receptors (FPRH1, FPRH2) to chromosome 19</span></div><div class="casAuthors">Bao, Lu; Gerard, Norma P.; Eddy, Roger L., Jr.; Shows, Thomas B.; Gerard, Craig</div><div class="citationInfo"><span class="NLM_cas:title">Genomics</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">437-40</span>CODEN:
                <span class="NLM_cas:coden">GNMCEP</span>;
        ISSN:<span class="NLM_cas:issn">0888-7543</span>.
    </div><div class="casAbstract">The genes encoding receptors for the chemotactic ligands C5a (C5AR) and FMLP (FPR) were mapped using a panel of somatic cell hybrids to chromosome 19.  Because the hybridization pattern on Southern anal. suggested an intron structure or related genes in the case of FPR, genomic clones were characterized.  Two structural homologs of the FMLP receptor, clones 81 (FPRH1) and 82 (FPRH2), were identified, which similarly map to chromosome 19.  The structural homologs do not recognize the ligand FMLP, but are likely chemotactic receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfeaNIfzst1bVg90H21EOLACvtfcHk0lgEO9kgtXEZ7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXktVajs78%253D&md5=d9dd076841eb58da286e2a8b8dfa879a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0888-7543%2892%2990265-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0888-7543%252892%252990265-T%26sid%3Dliteratum%253Aachs%26aulast%3DBao%26aufirst%3DL.%26aulast%3DGerard%26aufirst%3DN.%2BP.%26aulast%3DEddy%26aufirst%3DR.%2BL.%26aulast%3DShows%26aufirst%3DT.%2BB.%26aulast%3DGerard%26aufirst%3DC.%26atitle%3DMapping%2520of%2520genes%2520for%2520the%2520human%2520C5a%2520receptor%2520%2528C5AR%2529%252C%2520human%2520FMLP%2520receptor%2520%2528FPR%2529%252C%2520and%2520two%2520FMLP%2520receptor%2520homologue%2520orphan%2520receptors%2520%2528FPRH1%252C%2520FPRH2%2529%2520to%2520chromosome%252019%26jtitle%3DGenomics%26date%3D1992%26volume%3D13%26spage%3D437%26epage%3D440%26doi%3D10.1016%2F0888-7543%2892%2990265-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Le, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. M.</span></span> <span> </span><span class="NLM_article-title">Formyl-peptide receptors revisited</span>. <i>Trends Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">548</span>, <span class="refDoi"> DOI: 10.1016/S1471-4906(02)02316-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1016%2FS1471-4906%2802%2902316-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=12401407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVKktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=541-548&author=Y.+Leauthor=P.+M.+Murphyauthor=J.+M.+Wang&title=Formyl-peptide+receptors+revisited&doi=10.1016%2FS1471-4906%2802%2902316-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Formyl-peptide receptors revisited</span></div><div class="casAuthors">Le, Yingying; Murphy, Philip M.; Wang, Ji Ming</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">541-548</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Leukocytes accumulate at sites of inflammation and microbial infection in direct response to locally produced chemotactic factors, which signal through specific G protein-coupled receptors.  The first chemotactic factors to be structurally defined were the N-formyl peptides.  Unlike other leukocyte chemoattractants, N-formyl peptides could originate from either an endogenous source, such as the mitochondrial proteins of ruptured host cells, or an exogenous source, such as the proteins of invading pathogens.  This suggests that the formyl-peptide receptor (FPR) and its variant FPRL1 (FPR-like 1) are involved in host defense against bacterial infection and in the clearance of damaged cells.  Recently, addnl., more complex, roles for these receptors have been proposed because FPR, and to a greater extent FPRL1, have been found to interact with a menagerie of structurally diverse pro- and anti-inflammatory ligands assocd. with different diseases, including amyloidosis, Alzheimer's disease, prion disease and HIV.  How these receptors recognize such diverse ligands, which are the most important in vivo, and how they contribute to disease pathogenesis and host defense are basic questions currently under investigation that could lead to new therapeutic targets.  How formyl-peptide receptors recognize diverse pro- and anti-inflammatory ligands assocd. with different diseases, and how they contribute to disease pathogenesis and host defense, are basic questions currently under investigation that could lead to new therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSJJ2GIyvVdLVg90H21EOLACvtfcHk0lgEO9kgtXEZ7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVKktrY%253D&md5=8ec2794e8ae0f5de140752c06621e7b6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1471-4906%2802%2902316-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4906%252802%252902316-5%26sid%3Dliteratum%253Aachs%26aulast%3DLe%26aufirst%3DY.%26aulast%3DMurphy%26aufirst%3DP.%2BM.%26aulast%3DWang%26aufirst%3DJ.%2BM.%26atitle%3DFormyl-peptide%2520receptors%2520revisited%26jtitle%3DTrends%2520Immunol.%26date%3D2002%26volume%3D23%26spage%3D541%26epage%3D548%26doi%3D10.1016%2FS1471-4906%2802%2902316-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, T.-L.</span></span> <span> </span><span class="NLM_article-title">The potential impacts of formylpeptide receptor 1 in inflammatory diseases</span>. <i>Front. Biosci., Elite Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">436</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.2741/e778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.2741%2Fe778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=27100350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmvVWmtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=436-449&author=S.+C.+Yangauthor=T.-L.+Hwang&title=The+potential+impacts+of+formylpeptide+receptor+1+in+inflammatory+diseases&doi=10.2741%2Fe778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The potential impacts of formyl peptide receptor 1 in inflammatory diseases</span></div><div class="casAuthors">Yang, Shun-Chin; Hwang, Tsong-Long</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience, Elite Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">E8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">436-449</span>CODEN:
                <span class="NLM_cas:coden">FBEEAS</span>;
        ISSN:<span class="NLM_cas:issn">1945-0508</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">Neutrophils play a crit. role in acute and chronic inflammatory diseases.  N-formyl peptides, which originate from bacterial peptides or mitochondrial proteins bind with a high binding affinity to formyl peptide receptor 1 (FPR1).  N-formyl peptide-FPR1 is involved in the pathogenesis of sterile and infectious inflammatory processes and causes phagocytosis of pathogens or injured cells by neutrophils.  Excessive activation of neutrophils by binding of N-formyl peptides is assocd. with tissue injury requiring drugs that block FPR1-dependent signaling.  Here, we review the roles of FPR1 as a crit. regulator of inflammatory processes and its involvement in pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqScXJr1KZ2OLVg90H21EOLACvtfcHk0lgEO9kgtXEZ7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmvVWmtL8%253D&md5=52bdf99c9f1c6590c40f2edacbc61474</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2741%2Fe778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252Fe778%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.%2BC.%26aulast%3DHwang%26aufirst%3DT.-L.%26atitle%3DThe%2520potential%2520impacts%2520of%2520formylpeptide%2520receptor%25201%2520in%2520inflammatory%2520diseases%26jtitle%3DFront.%2520Biosci.%252C%2520Elite%2520Ed.%26date%3D2016%26volume%3D8%26spage%3D436%26epage%3D449%26doi%3D10.2741%2Fe778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, R. D.</span></span> <span> </span><span class="NLM_article-title">Serum amyloid A induced IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">1572</span>– <span class="NLM_lpage">1581</span>, <span class="refDoi"> DOI: 10.1182/blood-2002-05-1431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1182%2Fblood-2002-05-1431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=12393391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1ansrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2003&pages=1572-1581&author=R.+Heauthor=H.+Sangauthor=R.+D.+Ye&title=Serum+amyloid+A+induced+IL-8+secretion+through+a+G+protein-coupled+receptor%2C+FPRL1%2FLXA4R&doi=10.1182%2Fblood-2002-05-1431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R</span></div><div class="casAuthors">He, Rong; Sang, Hairong; Ye, Richard D.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1572-1581</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Host response to injury and infection is accompanied by a rapid rise in the blood of acute-phase proteins such as serum amyloid A (SAA).  Although SAA has been used as a marker for inflammatory diseases, its role in the modulation of inflammation and immunity has not been defined.  Human neutrophils respond to SAA with secretion of the proinflammatory cytokines interleukin 8 (IL-8) and, to a lesser extent, tumor necrosis factor α (TNF-α).  The induction of IL-8 secretion by SAA involves both transcription and translation and correlates with activation of nuclear factor κB (NF-κB).  The proximal signaling events induced by SAA include mobilization of intracellular Ca2+ and activation of the mitogen-activated protein kinases ERK1/2 and p38, both required for the induced IL-8 secretion.  Pertussis toxin effectively blocks SAA-induced IL-8 secretion indicating involvement of a Gi-coupled receptor.  Overexpression of FPRL1/LXA4R in HeLa cells results in a significant increase of the expression of NF-κB and IL-8 luciferase reporters by SAA, and an antibody against the N-terminal domain of FPRL1/LXA4R inhibits IL-8 secretion.  Lipoxin A4, which binds to FPRL1/LXA4R specifically, decreases SAA-induced IL-8 secretion significantly.  Collectively, these results indicate that the cytokine-like property of SAA is manifested through activation of the Gi-coupled FPRL1/LXA4R, which has been known to mediate the anti-inflammatory effects of lipoxin A4.  The ability of FPRL1/LXA4R to mediate 2 drastically different and opposite functions suggests that it plays a role in the modulation of inflammatory and immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwYQCbUjerwLVg90H21EOLACvtfcHk0lgEO9kgtXEZ7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1ansrk%253D&md5=a369ff46bedefb354d5f9ac5970e3dbc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1182%2Fblood-2002-05-1431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2002-05-1431%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DR.%26aulast%3DSang%26aufirst%3DH.%26aulast%3DYe%26aufirst%3DR.%2BD.%26atitle%3DSerum%2520amyloid%2520A%2520induced%2520IL-8%2520secretion%2520through%2520a%2520G%2520protein-coupled%2520receptor%252C%2520FPRL1%252FLXA4R%26jtitle%3DBlood%26date%3D2003%26volume%3D101%26spage%3D1572%26epage%3D1581%26doi%3D10.1182%2Fblood-2002-05-1431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serhan, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlén, S.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drazen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, D. W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rovati, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokomizo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brink, C.</span></span> <span> </span><span class="NLM_article-title">The lipoxin receptor ALX: Potent ligand-specific and stereoselective actions in vivo</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1124/pr.58.3.4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1124%2Fpr.58.3.4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=16968948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=463-489&author=N.+Chiangauthor=C.+N.+Serhanauthor=S.-E.+Dahl%C3%A9nauthor=J.+M.+Drazenauthor=D.+W.+P.+Hayauthor=G.+E.+Rovatiauthor=T.+Shimizuauthor=T.+Yokomizoauthor=C.+Brink&title=The+lipoxin+receptor+ALX%3A+Potent+ligand-specific+and+stereoselective+actions+in+vivo&doi=10.1124%2Fpr.58.3.4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The Lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo</span></div><div class="casAuthors">Chiang, Nan; Serhan, Charles N.; Dahlen, Sven-Erik; Drazen, Jeffrey M.; Hay, Douglas W. P.; Rovati, G. Enrico; Shimizu, Takao; Yokomizo, Takehiko; Brink, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">463-487</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Lipoxins (LXs) and aspirin-triggered LX (ATL) are trihydroxytetraene-contg. eicosanoids generated from arachidonic acid that are distinct in structure, formation, and function from the many other proinflammatory lipid-derived mediators.  These endogenous eicosanoids have now emerged as founding members of the first class of lipid/chem. mediators involved in the resoln. of the inflammatory response.  Lipoxin A4 (LXA4), ATL, and their metabolic stable analogs elicit cellular responses and regulate leukocyte trafficking in vivo by activating the specific receptor, ALX.  ALX was the first receptor cloned and identified as a G protein-coupled receptor (GPCR) for lipoxygenase-derived eicosanoids with demonstrated cell type-specific signaling pathways.  ALX at the level of DNA has sequence homol. to the N-formylpeptide receptor and as an orphan GPCR was initially referred to as the N-formylpeptide receptor-like 1.  Although LXA4 is the endogenous potent ligand for ALX activation, a no. of peptides can also activate this receptor to stimulate calcium mobilization and chemotaxis in vitro.  In contrast with LXA4, the counterparts of many of these peptides in vivo remain to be established.  The purpose of this review is to highlight the mol. characterization of the ALX receptor and provide an overview of the ALX-LXA4 axis responsible for anti-inflammatory and proresolving signals in vivo.  The information in this review provides further support for the initial nomenclature proposition for this GPCR as ALX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgWfE_vQ2J7rVg90H21EOLACvtfcHk0licV7cHtbhYtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfP&md5=69738d2c64ff851cf058e6fb1ac5cb84</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1124%2Fpr.58.3.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.58.3.4%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DN.%26aulast%3DSerhan%26aufirst%3DC.%2BN.%26aulast%3DDahl%25C3%25A9n%26aufirst%3DS.-E.%26aulast%3DDrazen%26aufirst%3DJ.%2BM.%26aulast%3DHay%26aufirst%3DD.%2BW.%2BP.%26aulast%3DRovati%26aufirst%3DG.%2BE.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DYokomizo%26aufirst%3DT.%26aulast%3DBrink%26aufirst%3DC.%26atitle%3DThe%2520lipoxin%2520receptor%2520ALX%253A%2520Potent%2520ligand-specific%2520and%2520stereoselective%2520actions%2520in%2520vivo%26jtitle%3DPharmacol.%2520Rev.%26date%3D2006%26volume%3D58%26spage%3D463%26epage%3D489%26doi%3D10.1124%2Fpr.58.3.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perretti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fierro, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marullo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getting, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solito, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serhan, C. N.</span></span> <span> </span><span class="NLM_article-title">Endogenous lipid- and peptide derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1296</span>– <span class="NLM_lpage">1302</span>, <span class="refDoi"> DOI: 10.1038/nm786</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1038%2Fnm786" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=12368905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BD38XotlWlsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=1296-1302&author=M.+Perrettiauthor=N.+Chiangauthor=M.+Laauthor=I.+M.+Fierroauthor=S.+Marulloauthor=S.+J.+Gettingauthor=E.+Solitoauthor=C.+N.+Serhan&title=Endogenous+lipid-+and+peptide+derived+anti-inflammatory+pathways+generated+with+glucocorticoid+and+aspirin+treatment+activate+the+lipoxin+A4+receptor&doi=10.1038%2Fnm786"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor</span></div><div class="casAuthors">Perretti, Mauro; Chiang, Nan; La, Mylinh; Fierro, Iolanda M.; Marullo, Stefano; Getting, Stephen J.; Solito, Egle; Serhan, Charles N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1296-1302</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aspirin (ASA) and dexamethasone (DEX) are widely used anti-inflammatory agents yet their mechanism(s) for blocking polymorphonuclear neutrophil (PMN) accumulation at sites of inflammation remain(s) unclear.  Here, the authors report that inhibition of PMN infiltration by ASA and DEX is a property shared by aspirin-triggered lipoxins (ATL) and the glucocorticoid-induced annexin 1 (ANXA1)-derived peptides that are both generated in vivo and act at the lipoxin A4 receptor (ALXR/FPRL1) to halt PMN diapedesis.  These structurally diverse ligands specifically interact directly with recombinant human ALXR demonstrated by specific radioligand binding and function as well as immunopptn. of PMN receptors.  In addn., the combination of both ATL and ANXA1-derived peptides limited PMN infiltration and reduced prodn. of inflammatory mediators (i.e., prostaglandins and chemokines) in vivo.  Together, these results indicate functional redundancies in endogenous lipid and peptide anti-inflammatory circuits that are spatially and temporally sep., where both ATL and specific ANXA1-derived peptides act in concert at ALXR to downregulate PMN recruitment to inflammatory loci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9Co2__EAxG7Vg90H21EOLACvtfcHk0licV7cHtbhYtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotlWlsro%253D&md5=29c758bdb086c783ef123cf918617d34</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnm786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm786%26sid%3Dliteratum%253Aachs%26aulast%3DPerretti%26aufirst%3DM.%26aulast%3DChiang%26aufirst%3DN.%26aulast%3DLa%26aufirst%3DM.%26aulast%3DFierro%26aufirst%3DI.%2BM.%26aulast%3DMarullo%26aufirst%3DS.%26aulast%3DGetting%26aufirst%3DS.%2BJ.%26aulast%3DSolito%26aufirst%3DE.%26aulast%3DSerhan%26aufirst%3DC.%2BN.%26atitle%3DEndogenous%2520lipid-%2520and%2520peptide%2520derived%2520anti-inflammatory%2520pathways%2520generated%2520with%2520glucocorticoid%2520and%2520aspirin%2520treatment%2520activate%2520the%2520lipoxin%2520A4%2520receptor%26jtitle%3DNat.%2520Med.%26date%3D2002%26volume%3D8%26spage%3D1296%26epage%3D1302%26doi%3D10.1038%2Fnm786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bena, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancaleone, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perretti, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flower, R. J.</span></span> <span> </span><span class="NLM_article-title">Annexin A1 interaction with the FPR2/ALX receptor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">24690</span>– <span class="NLM_lpage">24697</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.377101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1074%2Fjbc.M112.377101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=22610094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWgtb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=24690-24697&author=S.+Benaauthor=V.+Brancaleoneauthor=J.+M.+Wangauthor=J.+M.+Perrettiauthor=R.+J.+Flower&title=Annexin+A1+interaction+with+the+FPR2%2FALX+receptor&doi=10.1074%2Fjbc.M112.377101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Annexin A1 Interaction with the FPR2/ALX Receptor. Identification of Distinct Domains and Downstream Associated Signaling.</span></div><div class="casAuthors">Bena, Stefania; Brancaleone, Vincenzo; Wang, Ji Ming; Perretti, Mauro; Flower, Roderick J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">24690-24697</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Understanding how proresolving agonists selectively activate FPR2/ALX is a crucial step in the clarification of proresoln. mol. networks that can be harnessed for the design of novel therapeutics for inflammatory disease.  FPR2/ALX, a G protein-coupled receptor belonging to the formyl peptide receptor (FPR) family, conveys the biol. functions of a variety of ligands, including the proresoln. mediators annexin A1 (AnxA1) and lipoxin A4, as well as the activating and proinflammatory protein serum amyloid A.  FPR2/ALX is the focus of intense screening for novel anti-inflammatory therapeutics, and the small mol. compd. 43 was identified as a receptor ligand.  Here, we used chimeric FPR1 and FPR2/ALX clones (stably transfected in HEK293 cells) to identify the N-terminal region and extracellular loop II as the FPR2/ALX domain required for AnxA1-mediated signaling.  Genomic responses were also assessed with domain-specific effects emerging, so the N-terminal region is required for AnxA1 induction of JAG1 and JAM3, whereas it is dispensable for modulation of SGPP2.  By comparison, serum amyloid A non-genomic responses were reliant on extracellular loops I and II, whereas the small mol. compd. 43 activated extracellular loop I with downstream signaling dependent on transmembrane region II.  In desensitization expts., the N-terminal region was dispensable for AnxA1-induced FPR2/ALX down-regulation in both the homologous and heterologous desensitization modes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPIsfWk8-ZDrVg90H21EOLACvtfcHk0licV7cHtbhYtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWgtb7J&md5=66c04f0814bada8bd4f47819bdcc5c49</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.377101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.377101%26sid%3Dliteratum%253Aachs%26aulast%3DBena%26aufirst%3DS.%26aulast%3DBrancaleone%26aufirst%3DV.%26aulast%3DWang%26aufirst%3DJ.%2BM.%26aulast%3DPerretti%26aufirst%3DJ.%2BM.%26aulast%3DFlower%26aufirst%3DR.%2BJ.%26atitle%3DAnnexin%2520A1%2520interaction%2520with%2520the%2520FPR2%252FALX%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D24690%26epage%3D24697%26doi%3D10.1074%2Fjbc.M112.377101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cattaneo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ammendola, R.</span></span> <span> </span><span class="NLM_article-title">Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">7193</span>– <span class="NLM_lpage">7230</span>, <span class="refDoi"> DOI: 10.3390/ijms14047193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.3390%2Fijms14047193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=23549262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtFWktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=7193-7230&author=F.+Cattaneoauthor=M.+Parisiauthor=R.+Ammendola&title=Distinct+signaling+cascades+elicited+by+different+formyl+peptide+receptor+2+%28FPR2%29+agonists&doi=10.3390%2Fijms14047193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists</span></div><div class="casAuthors">Cattaneo, Fabio; Parisi, Melania; Ammendola, Rosario</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7193-7230</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  The formyl peptide receptor 2 (FPR2) is a remarkably versatile transmembrane protein belonging to the G-protein coupled receptor (GPCR) family.  FPR2 is activated by an array of ligands, which include structurally unrelated lipids and peptide/proteins agonists, resulting in different intracellular responses in a ligand-specific fashion.  In addn. to the anti-inflammatory lipid, lipoxin A4, several other endogenous agonists also bind FPR2, including serum amyloid A, glucocorticoid-induced annexin 1, urokinase and its receptor, suggesting that the activation of FPR2 may result in potent pro- or anti-inflammatory responses.  Other endogenous ligands, also present in biol. samples, include resolvins, amyloidogenic proteins, such as beta amyloid (Aβ)-42 and prion protein (Prp)106-126, the neuroprotective peptide, humanin, antibacterial peptides, annexin 1-derived peptides, chemokine variants, the neuropeptides, vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP)-27 and mitochondrial peptides.  Upon activation, intracellular domains of FPR2 mediate signaling to G-proteins, which trigger several agonist-dependent signal transduction pathways, including activation of phospholipase C (PLC), protein kinase C (PKC) isoforms, the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway, the mitogen-activated protein kinase (MAPK) pathway, p38MAPK, as well as the phosphorylation of cytosolic tyrosine kinases, tyrosine kinase receptor transactivation, phosphorylation and nuclear translocation of regulatory transcriptional factors, release of calcium and prodn. of oxidants.  FPR2 is an attractive therapeutic target, because of its involvement in a range of normal physiol. processes and pathol. diseases.  Here, we review and discuss the most significant findings on the intracellular pathways and on the cross-communication between FPR2 and tyrosine kinase receptors triggered by different FPR2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBKmHveSDBH7Vg90H21EOLACvtfcHk0ljS1uJaF5ncug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtFWktr8%253D&md5=b3d1ed852ecb5a03e114d4d4a0beb036</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3390%2Fijms14047193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms14047193%26sid%3Dliteratum%253Aachs%26aulast%3DCattaneo%26aufirst%3DF.%26aulast%3DParisi%26aufirst%3DM.%26aulast%3DAmmendola%26aufirst%3DR.%26atitle%3DDistinct%2520signaling%2520cascades%2520elicited%2520by%2520different%2520formyl%2520peptide%2520receptor%25202%2520%2528FPR2%2529%2520agonists%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2013%26volume%3D14%26spage%3D7193%26epage%3D7230%26doi%3D10.3390%2Fijms14047193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nash, N.</span>; <span class="NLM_string-name">Scully, A.</span>; <span class="NLM_string-name">Gardeli, L.</span>; <span class="NLM_string-name">Olsson, R.</span>; <span class="NLM_string-name">Gustafsson, M.</span></span> <span> </span><span class="NLM_article-title">Use of the Lipoxin Receptor, FPRL1, as a Tool for Identifying Compounds Effective in the Treatment of Pain and Onflammation</span>. PCT Int. Appl. <span class="NLM_patent">WO2005/047899</span>, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=N.+Nash&author=A.+Scully&author=L.+Gardeli&author=R.+Olsson&author=M.+Gustafsson&title=Use+of+the+Lipoxin+Receptor%2C+FPRL1%2C+as+a+Tool+for+Identifying+Compounds+Effective+in+the+Treatment+of+Pain+and+Onflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNash%26aufirst%3DN.%26atitle%3DUse%2520of%2520the%2520Lipoxin%2520Receptor%252C%2520FPRL1%252C%2520as%2520a%2520Tool%2520for%2520Identifying%2520Compounds%2520Effective%2520in%2520the%2520Treatment%2520of%2520Pain%2520and%2520Onflammation%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schepetkin, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khlebnikov, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giovannoni, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirpotina, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cilibrizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, M. T.</span></span> <span> </span><span class="NLM_article-title">Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1478</span>– <span class="NLM_lpage">1504</span>, <span class="refDoi"> DOI: 10.2174/0929867321666131218095521</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.2174%2F0929867321666131218095521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=24350845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlt1eksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1478-1504&author=I.+A.+Schepetkinauthor=A.+I.+Khlebnikovauthor=M.+P.+Giovannoniauthor=L.+N.+Kirpotinaauthor=A.+Cilibrizziauthor=M.+T.+Quinn&title=Development+of+small+molecule+non-peptide+formyl+peptide+receptor+%28FPR%29+ligands+and+molecular+modeling+of+their+recognition&doi=10.2174%2F0929867321666131218095521"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Small Molecule Non-peptide Formyl Peptide Receptor (FPR) Ligands and Molecular Modeling of Their Recognition</span></div><div class="casAuthors">Schepetkin, I. A.; Khlebnikov, A. I.; Giovannoni, M. P.; Kirpotina, L. N.; Cilibrizzi, A.; Quinn, M. T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1478-1504</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Formyl peptide receptors (FPRs) are G protein-coupled receptors (GPCRs) expressed on a variety of cell types.  These receptors play an important role in the regulation of inflammatory reactions and sensing cellular damage.  They have also been implicated in the pathogenesis of various diseases, including neurodegenerative diseases, cataract formation, and atherogenesis.  Thus, FPR ligands, both agonists and antagonists, may represent novel therapeutics for modulating host defense and innate immunity.  A variety of mols. have been identified as receptor subtype-selective and mixed FPR agonists with potential therapeutic value during last decade.  This review describes our efforts along with recent advances in the identification, optimization, biol. evaluation, and structure-activity relationship (SAR) anal. of small mol. non-peptide FPR agonists and antagonists, including chiral mols.  Questions regarding the interaction at the mol. level of benzimidazoles, pyrazolones, pyridazin-3(2H)-ones, N-phenylureas and other derivs. with FPR1 and FPR2 are discussed.  Application of computational models for virtual screening and design of FPR ligands is also considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzzE_LFKfCHbVg90H21EOLACvtfcHk0ljS1uJaF5ncug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlt1eksrY%253D&md5=7386bfdfaf9d01aec9ec679375a42d2b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F0929867321666131218095521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666131218095521%26sid%3Dliteratum%253Aachs%26aulast%3DSchepetkin%26aufirst%3DI.%2BA.%26aulast%3DKhlebnikov%26aufirst%3DA.%2BI.%26aulast%3DGiovannoni%26aufirst%3DM.%2BP.%26aulast%3DKirpotina%26aufirst%3DL.%2BN.%26aulast%3DCilibrizzi%26aufirst%3DA.%26aulast%3DQuinn%26aufirst%3DM.%2BT.%26atitle%3DDevelopment%2520of%2520small%2520molecule%2520non-peptide%2520formyl%2520peptide%2520receptor%2520%2528FPR%2529%2520ligands%2520and%2520molecular%2520modeling%2520of%2520their%2520recognition%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D1478%26epage%3D1504%26doi%3D10.2174%2F0929867321666131218095521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corminboeuf, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, X.</span></span> <span> </span><span class="NLM_article-title">FPR2/ALXR agonists and the resolution of inflammation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">559</span>, <span class="refDoi"> DOI: 10.1021/jm501051x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501051x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGjtLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=537-559&author=O.+Corminboeufauthor=X.+Leroy&title=FPR2%2FALXR+agonists+and+the+resolution+of+inflammation&doi=10.1021%2Fjm501051x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">FPR2/ALXR Agonists and the Resolution of Inflammation</span></div><div class="casAuthors">Corminboeuf, Olivier; Leroy, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">537-559</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The resoln. of inflammation (RoI), once believed to be a passive process, has lately been shown to be an active and delicately orchestrated process.  During the resoln. phase of acute inflammation, novel mediators, including lipoxins and resolvins, which are members of the specialized pro-resolving mediators of inflammation, are produced.  FPR2/ALXR, a receptor modulated by some of these lipids as well as by peptides (e.g., annexin A1), has been shown to be one of the receptors involved in the RoI.  The aim of this perspective is to present the concept of the RoI from a medicinal chem. point of view and to highlight the effort of the research community to discover and develop anti-inflammatory/pro-resoln. small mols. to orchestrate inflammation by activation of FPR2/ALXR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-uVie3v-44bVg90H21EOLACvtfcHk0ljS1uJaF5ncug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGjtLbJ&md5=3b595d7c70e5d2336c6fb832b372ba7b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm501051x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501051x%26sid%3Dliteratum%253Aachs%26aulast%3DCorminboeuf%26aufirst%3DO.%26aulast%3DLeroy%26aufirst%3DX.%26atitle%3DFPR2%252FALXR%2520agonists%2520and%2520the%2520resolution%2520of%2520inflammation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D537%26epage%3D559%26doi%3D10.1021%2Fjm501051x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, Y.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, T.-L.</span></span> <span> </span><span class="NLM_article-title">Formyl peptide receptor modulators: a patent review and potential applications for inflammatory diseases (2012–2015)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1139</span>– <span class="NLM_lpage">1156</span>, <span class="refDoi"> DOI: 10.1080/13543776.2016.1216546</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1080%2F13543776.2016.1216546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=27454150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ygu7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1139-1156&author=Y.-F.+Tsaiauthor=S.-C.+Yangauthor=T.-L.+Hwang&title=Formyl+peptide+receptor+modulators%3A+a+patent+review+and+potential+applications+for+inflammatory+diseases+%282012%E2%80%932015%29&doi=10.1080%2F13543776.2016.1216546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Formyl peptide receptor modulators: a patent review and potential applications for inflammatory diseases (2012-2015)</span></div><div class="casAuthors">Tsai, Yung-Fong; Yang, Shun-Chin; Hwang, Tsong-Long</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1139-1156</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The activation of leukocytes and the subsequent immune cascade play an essential role in sterile and infectious inflammation.  Dysregulation of these immune responses or excess leukocyte activation can induce tissue damage, organ dysfunction and mortality.  Formyl peptide receptors (FPRs) are functionally diverse pattern recognition receptors responsible for recognizing different endogenous damage-assocd. mol. patterns or exogenous pathogen-assocd. mol. patterns.  FPRs mediate leukocyte activation during inflammation.  FPR1 antagonists and FPR2 agonists have demonstrated significant anti-inflammatory effects based on in vitro and in vivo studies.  An increasing no. of synthesized compds. targeting FPRs, esp. potential FPR1 antagonists and FPR2 agonists, have been disclosed in patents.: This article summarizes the current pharmacol. patents related to FPR family modulators and their therapeutic indications based on a review of patent applications disclosed between 2012 and 2015.: In this review, FPR1 modulators comprise β-1,3-glucan synthase inhibitors contg. an FPR ligand moiety, template-fixed peptidomimetics, cyclosporin H, and dipeptide derivs.  FPR2 modulators include phenylurea, bridged spiro[2.4]heptane ester, naphthalene, aminotriazole, polycyclic pyrrolidine-2,5-dione, imidazolidine-2,4-dione, (2-ureidoacetamido)alkyl, amide, oxazolyl-methylether, oxazole, thiazole, and cryst. potassium salt derivs.  These compds. have potential applications for human conditions such as inflammatory lung diseases, ischemia-reperfusion injury, sepsis, inflammatory bowel disease, and wound healing.  FPRs are emerging as important targets for treating leukocyte-dominant inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyIsfHf0r2V7Vg90H21EOLACvtfcHk0ljuNfNG3ItBjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ygu7zL&md5=81effbca0b29e494d386c9cca8b0764c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1080%2F13543776.2016.1216546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2016.1216546%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DY.-F.%26aulast%3DYang%26aufirst%3DS.-C.%26aulast%3DHwang%26aufirst%3DT.-L.%26atitle%3DFormyl%2520peptide%2520receptor%2520modulators%253A%2520a%2520patent%2520review%2520and%2520potential%2520applications%2520for%2520inflammatory%2520diseases%2520%25282012%25E2%2580%25932015%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2016%26volume%3D26%26spage%3D1139%26epage%3D1156%26doi%3D10.1080%2F13543776.2016.1216546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schepetkin, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khlebnikov, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirpotina, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, M. T.</span></span> <span> </span><span class="NLM_article-title">Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2015.08.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1016%2Fj.intimp.2015.08.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=26382576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWmtL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2016&pages=43-58&author=I.+A.+Schepetkinauthor=A.+I.+Khlebnikovauthor=L.+N.+Kirpotinaauthor=M.+T.+Quinn&title=Antagonism+of+human+formyl+peptide+receptor+1+with+natural+compounds+and+their+synthetic+derivatives&doi=10.1016%2Fj.intimp.2015.08.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives</span></div><div class="casAuthors">Schepetkin, Igor A.; Khlebnikov, Andrei I.; Kirpotina, Liliya N.; Quinn, Mark T.</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">43-58</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Formyl peptide receptor 1 (FPR1) regulates a wide variety of neutrophil functional responses and plays an important role in inflammation and the pathogenesis of various diseases.  To date, a variety of natural and synthetic mols. have been identified as FPR1 ligands.  Here, we review current knowledge on natural products and natural product-inspired small mols. reported to antagonize and/or inhibit the FPR1-mediated responses.  Based on this literature, addnl. screening of selected com. available natural compds. for their ability to inhibit fMLF-induced Ca2 + mobilization in human neutrophils and FPR1 transfected HL-60 cells, and pharmacophore modeling, natural products with potential as FPR1 antagonists are considered and discussed in this review.  The identification and characterization of natural products that antagonize FPR1 activity may have potential for the development of novel therapeutics to limit or alter the outcome of inflammatory processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv14UhNod09rVg90H21EOLACvtfcHk0ljuNfNG3ItBjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWmtL%252FE&md5=3ae643f4f1b6c343cec8b3aa815570e8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2015.08.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2015.08.036%26sid%3Dliteratum%253Aachs%26aulast%3DSchepetkin%26aufirst%3DI.%2BA.%26aulast%3DKhlebnikov%26aufirst%3DA.%2BI.%26aulast%3DKirpotina%26aufirst%3DL.%2BN.%26aulast%3DQuinn%26aufirst%3DM.%2BT.%26atitle%3DAntagonism%2520of%2520human%2520formyl%2520peptide%2520receptor%25201%2520with%2520natural%2520compounds%2520and%2520their%2520synthetic%2520derivatives%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2016%26volume%3D37%26spage%3D43%26epage%3D58%26doi%3D10.1016%2Fj.intimp.2015.08.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bürli, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frohn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adlam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plant, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElvain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viswanadhan, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hungate, R.</span></span> <span> </span><span class="NLM_article-title">Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3713</span>– <span class="NLM_lpage">3718</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.04.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1016%2Fj.bmcl.2006.04.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=16697190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVyktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3713-3718&author=R.+W.+B%C3%BCrliauthor=H.+Xuauthor=X.+Zouauthor=L.+Mullerauthor=J.+Goldenauthor=M.+Frohnauthor=M.+Adlamauthor=M.+H.+Plantauthor=M.+Wongauthor=M.+McElvainauthor=K.+Regalauthor=V.+N.+Viswanadhanauthor=P.+Tagariauthor=R.+Hungate&title=Potent+hFPRL1+%28ALXR%29+agonists+as+potential+anti-inflammatory+agents&doi=10.1016%2Fj.bmcl.2006.04.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents</span></div><div class="casAuthors">Buerli, Roland W.; Xu, Han; Zou, Xiaoming; Muller, Kristine; Golden, Jennifer; Frohn, Mike; Adlam, Matthew; Plant, Matthew H.; Wong, Min; McElvain, Michele; Regal, Kelly; Viswanadhan, Vellarkad N.; Tagari, Philip; Hungate, Randall</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3713-3718</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We report the discovery of potent agonists for the human formyl-peptide-like 1 receptor (hFPRL1).  These compds. did not act at a closely related receptor denoted human formyl peptide receptor (hFPR) up to 10 μM concn.  Recent studies have indicated that agonizing this receptor may promote resoln. of inflammation.  In an exploratory study, a novel hFPRL1 agonist showed efficacy in a mouse ear inflammation model following oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo30KuAluzMR7Vg90H21EOLACvtfcHk0ljuNfNG3ItBjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVyktLc%253D&md5=c0743a061b0856d26b4203980098b559</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.04.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.04.068%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25BCrli%26aufirst%3DR.%2BW.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DZou%26aufirst%3DX.%26aulast%3DMuller%26aufirst%3DL.%26aulast%3DGolden%26aufirst%3DJ.%26aulast%3DFrohn%26aufirst%3DM.%26aulast%3DAdlam%26aufirst%3DM.%26aulast%3DPlant%26aufirst%3DM.%2BH.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DMcElvain%26aufirst%3DM.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DViswanadhan%26aufirst%3DV.%2BN.%26aulast%3DTagari%26aufirst%3DP.%26aulast%3DHungate%26aufirst%3DR.%26atitle%3DPotent%2520hFPRL1%2520%2528ALXR%2529%2520agonists%2520as%2520potential%2520anti-inflammatory%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3713%26epage%3D3718%26doi%3D10.1016%2Fj.bmcl.2006.04.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">García, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupisella, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernando, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heroux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouvier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dierks, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kick, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St-Onge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towne, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bucardo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurtz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostrowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarreal, F.</span></span> <span> </span><span class="NLM_article-title">Preservation of post-infarction cardiac structure and function via long-term oral formyl peptide receptor agonist treatment</span>. <i>J. Am. Coll. Cardiol. Basic Trans. Science</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">905</span>– <span class="NLM_lpage">920</span>, <span class="refDoi"> DOI: 10.1016/j.jacbts.2019.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1016%2Fj.jacbts.2019.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=31909300" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2019&pages=905-920&author=R.+Garc%C3%ADaauthor=B.+Itoauthor=J.+Lupisellaauthor=N.+Carsonauthor=M.+Hsuauthor=G.+Fernandoauthor=M.+Herouxauthor=M.+Bouvierauthor=E.+Dierksauthor=E.+Kickauthor=D.+Gordonauthor=J.+Chenauthor=G.+Mintierauthor=M.+Carrierauthor=S.+St-Ongeauthor=H.+Shahauthor=J.+Towneauthor=M.+Bucardoauthor=X.+Maauthor=C.+Ryanauthor=N.+Wurtzauthor=J.+Ostrowskiauthor=F.+Villarreal&title=Preservation+of+post-infarction+cardiac+structure+and+function+via+long-term+oral+formyl+peptide+receptor+agonist+treatment&doi=10.1016%2Fj.jacbts.2019.07.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.jacbts.2019.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacbts.2019.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa%26aufirst%3DR.%26aulast%3DIto%26aufirst%3DB.%26aulast%3DLupisella%26aufirst%3DJ.%26aulast%3DCarson%26aufirst%3DN.%26aulast%3DHsu%26aufirst%3DM.%26aulast%3DFernando%26aufirst%3DG.%26aulast%3DHeroux%26aufirst%3DM.%26aulast%3DBouvier%26aufirst%3DM.%26aulast%3DDierks%26aufirst%3DE.%26aulast%3DKick%26aufirst%3DE.%26aulast%3DGordon%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DMintier%26aufirst%3DG.%26aulast%3DCarrier%26aufirst%3DM.%26aulast%3DSt-Onge%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DH.%26aulast%3DTowne%26aufirst%3DJ.%26aulast%3DBucardo%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DRyan%26aufirst%3DC.%26aulast%3DWurtz%26aufirst%3DN.%26aulast%3DOstrowski%26aufirst%3DJ.%26aulast%3DVillarreal%26aufirst%3DF.%26atitle%3DPreservation%2520of%2520post-infarction%2520cardiac%2520structure%2520and%2520function%2520via%2520long-term%2520oral%2520formyl%2520peptide%2520receptor%2520agonist%2520treatment%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%2520Basic%2520Trans.%2520Science%26date%3D2019%26volume%3D4%26spage%3D905%26epage%3D920%26doi%3D10.1016%2Fj.jacbts.2019.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frohn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElvaine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plant, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hungate, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bürli, R. W.</span></span> <span> </span><span class="NLM_article-title">New ‘chemical probes’ to examine the role of the hFPRL1 (or ALXR) receptor in inflammation</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">6633</span>– <span class="NLM_lpage">6637</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.09.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1016%2Fj.bmcl.2007.09.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=17920884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1OqsLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6633-6637&author=M.+Frohnauthor=H.+Xuauthor=X.+Zouauthor=C.+Changauthor=M.+McElvaineauthor=M.+H.+Plantauthor=M.+Wongauthor=P.+Tagariauthor=R.+Hungateauthor=R.+W.+B%C3%BCrli&title=New+%E2%80%98chemical+probes%E2%80%99+to+examine+the+role+of+the+hFPRL1+%28or+ALXR%29+receptor+in+inflammation&doi=10.1016%2Fj.bmcl.2007.09.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">New 'chemical probes' to examine the role of the hFPRL1 (or ALXR) receptor in inflammation</span></div><div class="casAuthors">Frohn, Mike; Xu, Han; Zou, Xiaoming; Chang, Catherine; McElvaine, Michele; Plant, Matthew H.; Wong, Min; Tagari, Philip; Hungate, Randall; Buerli, Roland W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6633-6637</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The authors report the development of the novel N-substituted benzimidazole (I) as a potent and selective human formyl peptide receptor-like 1 (hFPRL1) agonist.  This compd. and its less active enantiomer (II) were identified as useful tools for studying receptor function in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQfWeuA14eL7Vg90H21EOLACvtfcHk0ljCrTyML6yMAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1OqsLnO&md5=e6c72f7bb5777babeb9fe95593a99c73</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.09.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.09.043%26sid%3Dliteratum%253Aachs%26aulast%3DFrohn%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DZou%26aufirst%3DX.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DMcElvaine%26aufirst%3DM.%26aulast%3DPlant%26aufirst%3DM.%2BH.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DTagari%26aufirst%3DP.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DB%25C3%25BCrli%26aufirst%3DR.%2BW.%26atitle%3DNew%2520%25E2%2580%2598chemical%2520probes%25E2%2580%2599%2520to%2520examine%2520the%2520role%2520of%2520the%2520hFPRL1%2520%2528or%2520ALXR%2529%2520receptor%2520in%2520inflammation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6633%26epage%3D6637%26doi%3D10.1016%2Fj.bmcl.2007.09.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corminboeuf, O.</span>; <span class="NLM_string-name">Cren, S.</span></span> <span> </span><span class="NLM_article-title">1-(p-Tolyl)cyclopropyl Substituted Bridged Spiro[2.4]heptane Derivatives as ALX Receptor Agonists</span>. PCT Int. Appl. <span class="NLM_patent">WO2013/171687</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=O.+Corminboeuf&author=S.+Cren&title=1-%28p-Tolyl%29cyclopropyl+Substituted+Bridged+Spiro%5B2.4%5Dheptane+Derivatives+as+ALX+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCorminboeuf%26aufirst%3DO.%26atitle%3D1-%2528p-Tolyl%2529cyclopropyl%2520Substituted%2520Bridged%2520Spiro%255B2.4%255Dheptane%2520Derivatives%2520as%2520ALX%2520Receptor%2520Agonists%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bur, D.</span>; <span class="NLM_string-name">Corminboeuf, O.</span>; <span class="NLM_string-name">Cren, S.</span>; <span class="NLM_string-name">Grisostomi, C.</span>; <span class="NLM_string-name">Leroy, X.</span>; <span class="NLM_string-name">Richard-Bikdstein, S.</span></span> <span> </span><span class="NLM_article-title">Fluorinated Aminotriazole Derivatives</span>. PCT Int. Appl. <span class="NLM_patent">WO2010/143116</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+Bur&author=O.+Corminboeuf&author=S.+Cren&author=C.+Grisostomi&author=X.+Leroy&author=S.+Richard-Bikdstein&title=Fluorinated+Aminotriazole+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBur%26aufirst%3DD.%26atitle%3DFluorinated%2520Aminotriazole%2520Derivatives%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qin, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horlock, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourke, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, R. H.</span></span> <span> </span><span class="NLM_article-title">Small-molecule-biased formyl peptide receptor agonist compound 17b protects agonist myocardial ischaemia-reperfusion injury in mice</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">14232</span>, <span class="refDoi"> DOI: 10.1038/ncomms14232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1038%2Fncomms14232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=28169296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlCrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=14232&author=C.+X.+Qinauthor=L.+T.+Mayauthor=R.+Liauthor=N.+Caoauthor=S.+Rosliauthor=M.+Deoauthor=A.+E.+Alexanderauthor=D.+Horlockauthor=J.+E.+Bourkeauthor=Y.+H.+Yangauthor=A.+G.+Stewartauthor=D.+M.+Kayeauthor=X.-J.+Duauthor=P.+M.+Sextonauthor=A.+Christopoulosauthor=X.-M.+Gaoauthor=R.+H.+Ritchie&title=Small-molecule-biased+formyl+peptide+receptor+agonist+compound+17b+protects+agonist+myocardial+ischaemia-reperfusion+injury+in+mice&doi=10.1038%2Fncomms14232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice</span></div><div class="casAuthors">Qin, Cheng Xue; May, Lauren T.; Li, Renming; Cao, Nga; Rosli, Sarah; Deo, Minh; Alexander, Amy E.; Horlock, Duncan; Bourke, Jane E.; Yang, Yuan H.; Stewart, Alastair G.; Kaye, David M.; Du, Xiao-Jun; Sexton, Patrick M.; Christopoulos, Arthur; Gao, Xiao-Ming; Ritchie, Rebecca H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14232</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Effective treatment for managing myocardial infarction (MI) remains an urgent, unmet clin. need.  Formyl peptide receptors (FPR) regulate inflammation, a major contributing mechanism to cardiac injury following MI.  Here we demonstrate that FPR1/FPR2-biased agonism may represent a novel therapeutic strategy for the treatment of MI.  The small-mol. FPR1/FPR2 agonist, Compd. 17b (Cmpd17b), exhibits a distinct signalling fingerprint to the conventional FPR1/FPR2 agonist, Compd.-43 (Cmpd43).  In Chinese hamster ovary (CHO) cells stably transfected with human FPR1 or FPR2, Compd17b is biased away from potentially detrimental FPR1/2-mediated calcium mobilization, but retains the pro-survival signalling, ERK1/2 and Akt phosphorylation, relative to Compd43.  The pathol. importance of the biased agonism of Cmpd17b is demonstrable as superior cardioprotection in both in vitro (cardiomyocytes and cardiofibroblasts) and MI injury in mice in vivo.  These findings reveal new insights for development of small mol. FPR agonists with an improved cardioprotective profile for treating MI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpip9WEaLzP6rVg90H21EOLACvtfcHk0ljCrTyML6yMAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlCrsL8%253D&md5=d1e05a2f97268a088d54d7b54491f8cd</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fncomms14232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms14232%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DC.%2BX.%26aulast%3DMay%26aufirst%3DL.%2BT.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DCao%26aufirst%3DN.%26aulast%3DRosli%26aufirst%3DS.%26aulast%3DDeo%26aufirst%3DM.%26aulast%3DAlexander%26aufirst%3DA.%2BE.%26aulast%3DHorlock%26aufirst%3DD.%26aulast%3DBourke%26aufirst%3DJ.%2BE.%26aulast%3DYang%26aufirst%3DY.%2BH.%26aulast%3DStewart%26aufirst%3DA.%2BG.%26aulast%3DKaye%26aufirst%3DD.%2BM.%26aulast%3DDu%26aufirst%3DX.-J.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DX.-M.%26aulast%3DRitchie%26aufirst%3DR.%2BH.%26atitle%3DSmall-molecule-biased%2520formyl%2520peptide%2520receptor%2520agonist%2520compound%252017b%2520protects%2520agonist%2520myocardial%2520ischaemia-reperfusion%2520injury%2520in%2520mice%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D14232%26doi%3D10.1038%2Fncomms14232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stalder, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lott, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruz, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groenen, P. M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingemanse, J.</span></span> <span> </span><span class="NLM_article-title">Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2/ALX agonist ACT-389949</span>. <i>Br. J. Clin. Parmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">476</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1111/bcp.13149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1111%2Fbcp.13149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=27730665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC2sXis1WjtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2017&pages=476-486&author=A.+K.+Stalderauthor=D.+Lottauthor=D.+S.+Strasserauthor=H.+G.+Cruzauthor=A.+Krauseauthor=P.+M.+A.+Groenenauthor=J.+Dingemanse&title=Biomarker-guided+clinical+development+of+the+first-in-class+anti-inflammatory+FPR2%2FALX+agonist+ACT-389949&doi=10.1111%2Fbcp.13149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2/ALX agonist ACT-389949</span></div><div class="casAuthors">Stalder, Anna K.; Lott, Dominik; Strasser, Daniel S.; Cruz, Hans G.; Krause, Andreas; Groenen, Peter M. A.; Dingemanse, Jasper</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">476-486</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">1365-2125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The main objectives of these two phase I studies were to investigate safety and tolerability as well as the pharmacokinetic/pharmacodynamic profile of the novel potent and selective formyl peptide receptor type 2 (FPR2)/Lipoxin A4 receptor (ALX) agonist ACT-389949.  A challenge model was used to assess the drug's anti-inflammatory potential, with the aim of selecting a dosing regimen for future patient studies.  Two double-blind, randomized phase I studies investigated the safety, tolerability, pharmacokinetics and pharmacodynamics of ACT-389949 at different doses and dosing regimens.  Drug exposure was correlated with target engagement markers such as receptor internalization and cytokine measurements.  The effect of FPR2/ALX agonism on neutrophil migration was studied in a lipopolysaccharide (LPS) inhalation model.  ACT-389949 was well tolerated.  Maximum concns. were reached around 2 h after dosing, with a mean terminal half-life of 29.3 h [95% confidence interval (CI) 25.5, 33.7].  After multiple-dose administration, exposure increased by 111% (95% CI 89, 136), indicating drug accumulation.  Administration of ACT-389949 resulted in a dose-dependent, long-lasting internalization of FPR2/ALX into leukocytes.  Pro- and anti-inflammatory cytokines were dose-dependently but transiently upregulated only after the first dose.  No pharmacol. effect on neutrophil count was obsd. in the LPS challenge test performed at steady state.  FPR2/ALX agonism with ACT-389949 was shown to be safe and well tolerated in healthy subjects.  Receptor internalization and downstream mediators pointed towards a desensitization of the system, which may explain the lack of effect on neutrophil recruitment in the LPS challenge model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoApTxECNNIvbVg90H21EOLACvtfcHk0lgVIJww-3QerA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXis1WjtL8%253D&md5=495d4c4768dcd2727a1914ad38854c88</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fbcp.13149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcp.13149%26sid%3Dliteratum%253Aachs%26aulast%3DStalder%26aufirst%3DA.%2BK.%26aulast%3DLott%26aufirst%3DD.%26aulast%3DStrasser%26aufirst%3DD.%2BS.%26aulast%3DCruz%26aufirst%3DH.%2BG.%26aulast%3DKrause%26aufirst%3DA.%26aulast%3DGroenen%26aufirst%3DP.%2BM.%2BA.%26aulast%3DDingemanse%26aufirst%3DJ.%26atitle%3DBiomarker-guided%2520clinical%2520development%2520of%2520the%2520first-in-class%2520anti-inflammatory%2520FPR2%252FALX%2520agonist%2520ACT-389949%26jtitle%3DBr.%2520J.%2520Clin.%2520Parmacol.%26date%3D2017%26volume%3D83%26spage%3D476%26epage%3D486%26doi%3D10.1111%2Fbcp.13149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kirpotina, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khlebnikov, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepetkin, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiet, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jutila, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, M. T.</span></span> <span> </span><span class="NLM_article-title">identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1124/mol.109.060673</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1124%2Fmol.109.060673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=19903830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFeitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=159-170&author=L.+N.+Kirpotinaauthor=A.+I.+Khlebnikovauthor=I.+A.+Schepetkinauthor=R.+D.+Yeauthor=M.-J.+Rabietauthor=M.+A.+Jutilaauthor=M.+T.+Quinn&title=identification+of+novel+small-molecule+agonists+for+human+formyl+peptide+receptors+and+pharmacophore+models+of+their+recognition&doi=10.1124%2Fmol.109.060673"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition</span></div><div class="casAuthors">Kirpotina, Liliya N.; Khlebnikov, Andrei I.; Schepetkin, Igor A.; Ye, Richard D.; Rabiet, Marie-Josephe; Jutila, Mark A.; Quinn, Mark T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-170</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">N-formyl peptide receptor (FPR1) and N-formyl peptide receptor-like 1 (FPRL1, now known as FPR2) are G protein-coupled receptors involved in host defense and sensing cellular dysfunction.  Because of the potential for FPR1/FPR2 as a therapeutic target, our recent high-throughput screening efforts have focused on the identification of unique nonpeptide agonists of FPR1/FPR2.  In the present studies, we screened a chemolibrary of drug-like mols. for their ability to induce intracellular calcium mobilization in RBL-2H3 cells transfected with human FPR1 or FPR2.  Screening of these compds. resulted in the identification of novel and potent agonists that activated both FPR1 and FPR2, as well as compds. that were specific for either FPR1 or FPR2 with EC50 values in the low micromolar range.  Specificity of the compds. was supported by anal. of calcium mobilization in HL-60 cells transfected with human FPR1 and FPR2.  In addn., all but one agonist activated intracellular calcium flux and chemotaxis in human neutrophils, irresp. of agonist specificity for FPR1 or FPR2.  Mol. modeling of the group of FPR1 and FPR2-agonists using field point methodol. allowed us to create pharmacophore models for ligand binding sites and formulate requirements for these specific N-formyl peptide receptor agonists.  These studies further demonstrate that agonists of FPR1/FPR2 include compds. with wide chem. diversity and that anal. of such compds. can enhance our understanding of their ligand/receptor interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGOcc3Pr_QbrVg90H21EOLACvtfcHk0lgVIJww-3QerA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFeitL4%253D&md5=dc61b162bf12dcc374a17b25b6e13cee</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fmol.109.060673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.109.060673%26sid%3Dliteratum%253Aachs%26aulast%3DKirpotina%26aufirst%3DL.%2BN.%26aulast%3DKhlebnikov%26aufirst%3DA.%2BI.%26aulast%3DSchepetkin%26aufirst%3DI.%2BA.%26aulast%3DYe%26aufirst%3DR.%2BD.%26aulast%3DRabiet%26aufirst%3DM.-J.%26aulast%3DJutila%26aufirst%3DM.%2BA.%26aulast%3DQuinn%26aufirst%3DM.%2BT.%26atitle%3Didentification%2520of%2520novel%2520small-molecule%2520agonists%2520for%2520human%2520formyl%2520peptide%2520receptors%2520and%2520pharmacophore%2520models%2520of%2520their%2520recognition%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D77%26spage%3D159%26epage%3D170%26doi%3D10.1124%2Fmol.109.060673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zarei, M.</span></span> <span> </span><span class="NLM_article-title">A straightforward approach to 2-azetidinones from imines and carboxylic acids using dimethylsulfoxide and acetic anhydride</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5354</span>– <span class="NLM_lpage">5357</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2014.07.089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1016%2Fj.tetlet.2014.07.089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlWmtbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=5354-5357&author=M.+Zarei&title=A+straightforward+approach+to+2-azetidinones+from+imines+and+carboxylic+acids+using+dimethylsulfoxide+and+acetic+anhydride&doi=10.1016%2Fj.tetlet.2014.07.089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">A straightforward approach to 2-azetidinones from imines and carboxylic acids using dimethyl sulfoxide and acetic anhydride</span></div><div class="casAuthors">Zarei, Maaroof</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">5354-5357</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The direct synthesis of 2-azetidinones from imines and carboxylic acids under mild conditions is developed.  DMSO (DMSO) can be activated by acetic anhydride and the resulting active species is used for the in situ generation of ketenes from carboxylic acids.  This method is cheap, simple, convenient, and efficient and the products are easily isolated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohnKQwVi6VULVg90H21EOLACvtfcHk0lgVIJww-3QerA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlWmtbvK&md5=75773167d9186b7b5e2627683635ce83</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2014.07.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2014.07.089%26sid%3Dliteratum%253Aachs%26aulast%3DZarei%26aufirst%3DM.%26atitle%3DA%2520straightforward%2520approach%2520to%25202-azetidinones%2520from%2520imines%2520and%2520carboxylic%2520acids%2520using%2520dimethylsulfoxide%2520and%2520acetic%2520anhydride%26jtitle%3DTetrahedron%2520Lett.%26date%3D2014%26volume%3D55%26spage%3D5354%26epage%3D5357%26doi%3D10.1016%2Fj.tetlet.2014.07.089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zarei, M.</span></span> <span> </span><span class="NLM_article-title">β-Lactam preparation via Staudinger reaction with activated dimethylsulfoxide</span>. <i>J. Hetrocycl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1161</span>– <span class="NLM_lpage">1166</span>, <span class="refDoi"> DOI: 10.1002/jhet.2685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=10.1002%2Fjhet.2685" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2017&pages=1161-1166&author=M.+Zarei&title=%CE%B2-Lactam+preparation+via+Staudinger+reaction+with+activated+dimethylsulfoxide&doi=10.1002%2Fjhet.2685"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1002%2Fjhet.2685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.2685%26sid%3Dliteratum%253Aachs%26aulast%3DZarei%26aufirst%3DM.%26atitle%3D%25CE%25B2-Lactam%2520preparation%2520via%2520Staudinger%2520reaction%2520with%2520activated%2520dimethylsulfoxide%26jtitle%3DJ.%2520Hetrocycl.%2520Chem.%26date%3D2017%26volume%3D54%26spage%3D1161%26epage%3D1166%26doi%3D10.1002%2Fjhet.2685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">Studies on monocyclic β-lactams. (I). Synthesis of 3-hydroxy-4-substituted-2-azetidinones</span>. <i>Gaodeng Xuexiao Huaxue Xuebao</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">919</span>– <span class="NLM_lpage">922</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1992&pages=919-922&author=M.+Guoauthor=J.+Minauthor=R.+Liauthor=L.+Zhang&title=Studies+on+monocyclic+%CE%B2-lactams.+%28I%29.+Synthesis+of+3-hydroxy-4-substituted-2-azetidinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DMin%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DStudies%2520on%2520monocyclic%2520%25CE%25B2-lactams.%2520%2528I%2529.%2520Synthesis%2520of%25203-hydroxy-4-substituted-2-azetidinones%26jtitle%3DGaodeng%2520Xuexiao%2520Huaxue%2520Xuebao%26date%3D1992%26volume%3D13%26spage%3D919%26epage%3D922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, D.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">Notable and obvious ketene substituent-dependent effect pf temperature on the stereoselectivity in the Staudinger reaction</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">990</span>– <span class="NLM_lpage">997</span>, <span class="refDoi"> DOI: 10.1021/jo0622734</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0622734" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Cltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=990-997&author=B.+Liauthor=Y.+Wangauthor=D.-M.+Duauthor=J.+Xu&title=Notable+and+obvious+ketene+substituent-dependent+effect+pf+temperature+on+the+stereoselectivity+in+the+Staudinger+reaction&doi=10.1021%2Fjo0622734"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Notable and Obvious Ketene Substituent-Dependent Effect of Temperature on the Stereoselectivity in the Staudinger Reaction</span></div><div class="casAuthors">Li, Bonan; Wang, Yikai; Du, Da-Ming; Xu, Jiaxi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">990-997</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A notable and obvious ketene substituent-dependent effect of temp. on the stereoselectivity in the Staudinger reaction was obsd.  Most Staudinger reactions show concave Eyring plots characterized by two lines with an inversion point, following the principle of isoinversion.  Their cis-selectivities decrease with increasing temp.  Reactions involving intramol. p-π and π-π interactions between the ketene substituents and imine C-substituents reveal protruding, S-shaped or straight-line Eyring plots.  Their cis-selectivities increase with increasing temp. in a certain temp. region because such interactions enhance the cis-selectivity.  Staudinger reactions involving cyclic imines with different ketenes clearly indicate that the temp.-dependent stereoselectivity is caused by the different rate increases of the direct ring closure, which are affected by the p-π and π-π interactions between ketene substituents and imine C-substituents if they exist, and the isomerization of the zwitterionic intermediates generated from ketenes and imines during the change in the reaction temp., not by the competition of the imine exo and endo attacks to the ketenes.  Our results also indicate that nonlinear Eyring plots do not always reveal a change of the stereoselectivity-detg. step.  Thus, one should use them carefully to det. any changes in the stereoselectivity-detg. step during the change in the reaction temp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr_cT2SzJI_bVg90H21EOLACvtfcHk0liYUuEOGEEH-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Cltg%253D%253D&md5=50076048798022c2a9cafcfe74347fb2</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo0622734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0622734%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DD.-M.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DNotable%2520and%2520obvious%2520ketene%2520substituent-dependent%2520effect%2520pf%2520temperature%2520on%2520the%2520stereoselectivity%2520in%2520the%2520Staudinger%2520reaction%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26spage%3D990%26epage%3D997%26doi%3D10.1021%2Fjo0622734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gairaud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lappin, G. R.</span></span> <span> </span><span class="NLM_article-title">The synthesis of ω-nitrostyrenes</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1953</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">3</span>, <span class="refDoi"> DOI: 10.1021/jo01129a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01129a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADyaG2cXntFSm" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1953&pages=1-3&author=C.+Gairaudauthor=G.+R.+Lappin&title=The+synthesis+of+%CF%89-nitrostyrenes&doi=10.1021%2Fjo01129a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis of ω-nitrostyrenes</span></div><div class="casAuthors">Gairaud, Catherine B.; Lappin, Gerald R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1953</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-3</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Adding 5 cc. 5% NH2Me in MeOH to 0.1 mol aldehyde (I) and 0.15 mol R'''CH2NO2 in sufficient MeOH to dissolve I (method A) gives 2,3,4-RR'R''C6H2CH:CR'''NO2 (II) in addn. to some higher condensation products [e.g. BzH and MeNO2 give a compd. (C8H7NO2)3, pink crystals, m. 216-18°].  Refluxing 5 cc. R'''CH2NO2, 5 g. I, and 2 g. NH4OAc in 20 cc. AcOH 2 h. and pouring the mixt. into ice H2O give II (method B).  The following II are prepd. (R, R', R'', R''', % yield according to method A and B, m.p. in the order given): H, H, H, H, 55, 60, 58-9°; H, H, HO, H, 20, 60, 168-9°; MeO, H, H, H,, 50, 82, 48-9°; H, H, MeO, H, 40, 65, 86-7°; EtO,H H, H, 30, 20, 37-8°; MeO, MeO, H, H, 50, 60, 84-5°; H, MeO, MeO, H, 80, 70, 141-2°; H, MeO, HO, H, 95, 50, 167-8°; H, EtO, HO, H, 75, 78, 170-1°; HO, MeO, H, H, 45, 75, 122-4°; H, H, H, Me, 52, 55, 64-5°; H, H, HO, Me, 0, 35, 124-5°; H, H, MeO, Me, 60, 80, 44-5°; H, MeO, MeO, Me, 30, 35, 67-8°; MeO, MeO, H, Me, 50, 75, 78-9°; H, MeO, HO, Me, trace, 20, 100-1°; H, EtO, HO, Me, trace, 50, 108-9°; HO, MeO, H, Me, trace 45, 104-5°; MeO, MeO, H, Et, 0, 60, 64-5°; H, MeO, MeO, Et, 0, 52, 78-9°; H, MeO, HO, Et, 0, 40, 79-80°; MeO, H, H, Et, 0, 34, oil; H, MeO, H, Et, -, -, oil; EtO, H, H, Et, -, -, oil.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6InXphQEQRLVg90H21EOLACvtfcHk0liYUuEOGEEH-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG2cXntFSm&md5=575e942fcb809cf39c164e33455f7211</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo01129a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01129a001%26sid%3Dliteratum%253Aachs%26aulast%3DGairaud%26aufirst%3DC.%26aulast%3DLappin%26aufirst%3DG.%2BR.%26atitle%3DThe%2520synthesis%2520of%2520%25CF%2589-nitrostyrenes%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1953%26volume%3D18%26spage%3D1%26epage%3D3%26doi%3D10.1021%2Fjo01129a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Stereospecificity of the photorearrangement of nitronate anions and its utilization for stereospecific cleavage of cyclic compounds</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2327</span>– <span class="NLM_lpage">2330</span>, <span class="refDoi"> DOI: 10.1021/jo00387a049</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00387a049" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADyaL2sXktlykt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1987&pages=2327-2330&author=K.+Yamadaauthor=K.+Kishikawaauthor=M.+Yamamoto&title=Stereospecificity+of+the+photorearrangement+of+nitronate+anions+and+its+utilization+for+stereospecific+cleavage+of+cyclic+compounds&doi=10.1021%2Fjo00387a049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Stereospecificity of the photorearrangement of nitronate anions and its utilization for stereospecific cleavage of cyclic compounds</span></div><div class="casAuthors">Yamada, Kazutoshi; Kishikawa, Keiki; Yamamoto, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2327-30</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">The stereospecificity of the photorearrangement of nitronate anions was demonstrated.  Several nitro compds. [methyl 2-nitrocyclohexaneacetate (I), 1.7.7-trimethyl-2-nitrobicyclo[2.2.1]heptane, 2-nitro-3-phenylbicyclo[2.2.1]heptane, N-butyl-3-nitrobicyclo[2.2.1]-heptane-2-carboxamide, and N-butyl-3-nitro-7-oxabicyclo[2.2.1]heptane-2-carboxamide] were irradiated in MeONa/MeOH or NH3/MeOH, using a low-pressure mercury lamp to produce in each case a hydroxamic acid.  Thus, irradn. of I produced azepine deriv. II.  From 1H NMR study, abs. retention was obsd. during the photorearrangement.  A route by which the nitro group is utilized as an essential element in a 3-ring cleavage of cyclic compds. was developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaM8b6WSV_GbVg90H21EOLACvtfcHk0lggiEoquUTSSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXktlykt7c%253D&md5=c630e376f1011a930ab63e9a1068ce09</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjo00387a049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00387a049%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DKishikawa%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DStereospecificity%2520of%2520the%2520photorearrangement%2520of%2520nitronate%2520anions%2520and%2520its%2520utilization%2520for%2520stereospecific%2520cleavage%2520of%2520cyclic%2520compounds%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1987%26volume%3D52%26spage%3D2327%26epage%3D2330%26doi%3D10.1021%2Fjo00387a049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ronsen, B.</span>; <span class="NLM_string-name">Upadiyaya, S. P.</span></span> <span> </span><span class="NLM_article-title">Process for Preparing Arylpiperidine Carbinol Intermediates and Derivatives</span>. PCT Int. Appl. <span class="NLM_patent">WO2000/037443</span>, <span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=B.+Ronsen&author=S.+P.+Upadiyaya&title=Process+for+Preparing+Arylpiperidine+Carbinol+Intermediates+and+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRonsen%26aufirst%3DB.%26atitle%3DProcess%2520for%2520Preparing%2520Arylpiperidine%2520Carbinol%2520Intermediates%2520and%2520Derivatives%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, D.</span></span> <span> </span><span class="NLM_article-title">Scope and mechanism of enantioselective Michael additions of 1,3-dicarbonyl compounds to nitroalkenes catalyzed by nickel(II)-diamine complexes</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">11583</span>– <span class="NLM_lpage">11592</span>, <span class="refDoi"> DOI: 10.1021/ja0735913</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0735913" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsVelu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=11583-11592&author=D.+A.+Evansauthor=S.+Mitoauthor=D.+Seidel&title=Scope+and+mechanism+of+enantioselective+Michael+additions+of+1%2C3-dicarbonyl+compounds+to+nitroalkenes+catalyzed+by+nickel%28II%29-diamine+complexes&doi=10.1021%2Fja0735913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">Scope and Mechanism of Enantioselective Michael Additions of 1,3-Dicarbonyl Compounds to Nitroalkenes Catalyzed by Nickel(II)-Diamine Complexes</span></div><div class="casAuthors">Evans, David A.; Mito, Shizue; Seidel, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">11583-11592</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Readily prepd. Ni(II)-bis[(R,R)-N,N'-dibenzylcyclohexane-1,2-diamine]Br2 was shown to catalyze the Michael addn. of 1,3-dicarbonyl compds. to nitroalkenes at room temp. in good yields with high enantioselectivities.  The two diamine ligands in this system each play a distinct role: one serves as a chiral ligand to provide stereoinduction in the addn. step while the other functions as a base for substrate enolization.  Ligand modification within the catalyst was also investigated to facilitate the reaction of aliph. nitroalkenes, 1,3-diketones, and β-ketoacids.  Ni(II)-bis[(R,R)-N,N'-di-p-bromobenzylcyclohexane-1,2-diamine]Br2 was found to be an effective catalyst in these instances.  Furthermore, monodiamine complex, Ni(II)-[(R,R)-N,N'-dibenzylcyclohexane-1,2-diamine]Br2, catalyzed the addn. reaction in the presence of water.  The proposed model for stereochem. induction is shown to be consistent with X-ray structure anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooci96-aJCLrVg90H21EOLACvtfcHk0lggiEoquUTSSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsVelu7Y%253D&md5=3c3e55b7672928924f22da91dfd3d3e9</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1021%2Fja0735913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0735913%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BA.%26aulast%3DMito%26aufirst%3DS.%26aulast%3DSeidel%26aufirst%3DD.%26atitle%3DScope%2520and%2520mechanism%2520of%2520enantioselective%2520Michael%2520additions%2520of%25201%252C3-dicarbonyl%2520compounds%2520to%2520nitroalkenes%2520catalyzed%2520by%2520nickel%2528II%2529-diamine%2520complexes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D11583%26epage%3D11592%26doi%3D10.1021%2Fja0735913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Okino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furukawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takemoto, Y.</span></span> <span> </span><span class="NLM_article-title">Enantio- and diastereoselective Michael reaction of 1,3-dicarbonyl compounds to nitroolefins catalyzed by a bifunctional thiourea</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1021/ja044370p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja044370p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVCrurbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=119-125&author=T.+Okinoauthor=Y.+Hoashiauthor=T.+Furukawaauthor=X.+Xuauthor=Y.+Takemoto&title=Enantio-+and+diastereoselective+Michael+reaction+of+1%2C3-dicarbonyl+compounds+to+nitroolefins+catalyzed+by+a+bifunctional+thiourea&doi=10.1021%2Fja044370p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">Enantio- and Diastereoselective Michael Reaction of 1,3-Dicarbonyl Compounds to Nitroolefins Catalyzed by a Bifunctional Thiourea</span></div><div class="casAuthors">Okino, Tomotaka; Hoashi, Yasutaka; Furukawa, Tomihiro; Xu, Xuenong; Takemoto, Yoshiji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-125</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of bifunctional catalysts bearing a thiourea moiety and an amino group on a chiral scaffold was synthesized.  Among them, thiourea I was revealed to be highly efficient for the asym. Michael reaction of 1,3-dicarbonyl compds. to nitroolefins.  Furthermore, a new synthetic route for (R)-(-)-baclofen and the generation of a chiral quaternary carbon center with high enantioselectivity by Michael reaction were developed.  In these reactions, it was assumed that the thiourea moiety and the amino group of the catalyst activates the nitroolefin and the 1,3-dicarbonyl compd., resp., to afford the Michael adduct with high enantio- and diastereoselectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIOOIirlLPDrVg90H21EOLACvtfcHk0lggiEoquUTSSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVCrurbI&md5=4e6e4f379f3cc8814dc931666a0ce881</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1021%2Fja044370p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja044370p%26sid%3Dliteratum%253Aachs%26aulast%3DOkino%26aufirst%3DT.%26aulast%3DHoashi%26aufirst%3DY.%26aulast%3DFurukawa%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DTakemoto%26aufirst%3DY.%26atitle%3DEnantio-%2520and%2520diastereoselective%2520Michael%2520reaction%2520of%25201%252C3-dicarbonyl%2520compounds%2520to%2520nitroolefins%2520catalyzed%2520by%2520a%2520bifunctional%2520thiourea%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D119%26epage%3D125%26doi%3D10.1021%2Fja044370p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit29c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span> <span> </span><span class="NLM_article-title">Highly enantioselective conjugate addition of malonate and β-ketoester to nitroalkenes: Asymmetric C–C bond formation with new bifunctional organic catalysts based on cinchona alkaloids</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">9906</span>– <span class="NLM_lpage">9907</span>, <span class="refDoi"> DOI: 10.1021/ja047281l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja047281l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFGju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=9906-9907&author=H.+Liauthor=Y.+Wangauthor=L.+Tangauthor=L.+Deng&title=Highly+enantioselective+conjugate+addition+of+malonate+and+%CE%B2-ketoester+to+nitroalkenes%3A+Asymmetric+C%E2%80%93C+bond+formation+with+new+bifunctional+organic+catalysts+based+on+cinchona+alkaloids&doi=10.1021%2Fja047281l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29cR"><div class="casContent"><span class="casTitleNuber">29c</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Enantioselective Conjugate Addition of Malonate and β-Ketoester to Nitroalkenes: Asymmetric C-C Bond Formation with New Bifunctional Organic Catalysts Based on Cinchona Alkaloids</span></div><div class="casAuthors">Li, Hongming; Wang, Yi; Tang, Liang; Deng, Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">9906-9907</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Quinine and quinidine derivs. such as I and II are prepd.; in the presence of I or II, nitroalkanes (E)-RCH:CHNO2 (R = Ph, 4-FC6H4, 4-ClC6H4, 4-BrC6H4, 4-MeC6H4, 4-Me2CHC6H4, 4-MeOC6H4, 3-MeC6H4, 2-MeC6H4, 2-FC6H4, 2-O2NC6H4, 1-naphthyl, 2-thienyl, 2-furyl, 3-pyridinyl, BuCH2, Me2CHCH2, c-C6H11) undergo enantioselective addn. reactions with di-Me malonate to provide either enantiomer of the nitroesters O2NCH2CHRCH(CO2Me)2 (III) (R = Ph, 4-FC6H4, 4-ClC6H4, 4-BrC6H4, 4-MeC6H4, 4-Me2CHC6H4, 4-MeOC6H4, 3-MeC6H4, 2-MeC6H4, 2-FC6H4, 2-O2NC6H4, 1-naphthyl, 2-thienyl, 2-furyl, 3-pyridinyl, BuCH2, Me2CHCH2, c-C6H11) in 71-99% yields and in 91-97% ee.  Aryl, heteroaryl, and alkyl-substituted nitroalkenes give conjugate addn. products in high yields and enantioselectivities.  Cinchona alkaloids with a 6'-hydroxy group yield III with much higher enantioselectivities than those bearing 6'-methoxy groups; etherification of the secondary alc. of alkaloids such as I or II alters the enantioselectivity and yield of Michael addn. reactions catalyzed by them minimally.  The enantioselectivity of Michael addns. catalyzed by I and II is attributed to bifunctional catalysis using both the 6'-hydroxy group and the quinuclidine amine moiety.  Kinetic studies on the addn. of di-Me malonate to III (R = Ph) in the presence of I indicate that the rate of reaction is first order in nitroalkene, di-Me malonate, and catalyst.  Et acetoacetate undergoes conjugate addn. to trans-β-nitrostyrene III (R = Ph) to yield γ-nitro ester O2NCH2CHPhCHAcCO2Et as a 1:1 mixt. of diastereomers at the α-acetyl ester in 93% yield; both diastereomers are isolated in 91% ee.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUvuQac6sfYLVg90H21EOLACvtfcHk0lg6RMgdde1iPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFGju7k%253D&md5=115a9882869c0f81628f0a3b22fcf9b0</span></div><a href="/servlet/linkout?suffix=cit29c&amp;dbid=16384&amp;doi=10.1021%2Fja047281l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja047281l%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DL.%26atitle%3DHighly%2520enantioselective%2520conjugate%2520addition%2520of%2520malonate%2520and%2520%25CE%25B2-ketoester%2520to%2520nitroalkenes%253A%2520Asymmetric%2520C%25E2%2580%2593C%2520bond%2520formation%2520with%2520new%2520bifunctional%2520organic%2520catalysts%2520based%2520on%2520cinchona%2520alkaloids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D9906%26epage%3D9907%26doi%3D10.1021%2Fja047281l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hynes, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, D. J.</span></span> <span> </span><span class="NLM_article-title">Organocatalytic asymmetric total synthesis of (R)-Rolipram and formal synthesis of (3S,4R)-Paroxetine</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1389</span>– <span class="NLM_lpage">1391</span>, <span class="refDoi"> DOI: 10.1021/ol800108u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol800108u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivV2nsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=1389-1391&author=P.+S.+Hynesauthor=P.+A.+Stuppleauthor=D.+J.+Dixon&title=Organocatalytic+asymmetric+total+synthesis+of+%28R%29-Rolipram+and+formal+synthesis+of+%283S%2C4R%29-Paroxetine&doi=10.1021%2Fol800108u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Organocatalytic Asymmetric Total Synthesis of (R)-Rolipram and Formal Synthesis of (3S,4R)-Paroxetine</span></div><div class="casAuthors">Hynes, Peter S.; Stupple, Paul A.; Dixon, Darren J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1389-1391</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient enantioselective total synthesis of (R)-rolipram (I) and an efficient enantioselective formal synthesis of (3S,4R)-paroxetine (II) have been achieved using the highly enantioselective Michael addn. of di-Me malonate as the nucleophile as key steps in both cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4VPhNqMJqErVg90H21EOLACvtfcHk0lg6RMgdde1iPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivV2nsrc%253D&md5=51c2c737a5e85782c9441de53ffded79</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fol800108u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol800108u%26sid%3Dliteratum%253Aachs%26aulast%3DHynes%26aufirst%3DP.%2BS.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DDixon%26aufirst%3DD.%2BJ.%26atitle%3DOrganocatalytic%2520asymmetric%2520total%2520synthesis%2520of%2520%2528R%2529-Rolipram%2520and%2520formal%2520synthesis%2520of%2520%25283S%252C4R%2529-Paroxetine%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26spage%3D1389%26epage%3D1391%26doi%3D10.1021%2Fol800108u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i70"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02101">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_36274"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b02101?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02101</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental procedures for compounds <b>2a</b>–<b>d</b>, <b>12a</b>–<b>f</b>,<b>h</b>–<b>l</b>, <b>13a</b>,<b>b</b>,<b>d</b>–<b>h</b>,<b>j</b>,<b>k</b>,<b>m</b>,<b>o</b>–<b>q</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02101/suppl_file/jm9b02101_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings for all compound included in the article and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02101/suppl_file/jm9b02101_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02101/suppl_file/jm9b02101_si_001.pdf">jm9b02101_si_001.pdf (1.2 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02101/suppl_file/jm9b02101_si_002.csv">jm9b02101_si_002.csv (4.86 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b02101&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-17%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b02101%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b02101" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799d72228e83c58","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
